# Chapter 117: Tobacco Use Disorder

## The Biological and Neurological Basis of Tobacco Use Disorder

### Introduction

Tobacco Use Disorder (TUD), as conceptualized in modern psychiatry, is a chronic, relapsing brain disease characterized by compulsive drug-seeking and use, despite harmful consequences (Jayaswal & Singh, 2025; Robson & McNeill, 2021). While sociocultural and environmental factors play a significant role in the initiation and maintenance of tobacco use (Bobo & Husten, 2000; Mette, 2016), the persistence of this behavior is fundamentally rooted in profound biological and neurological changes induced by chronic exposure to nicotine, the primary psychoactive and addictive agent in tobacco (Henningfield et al., 1991; Nutt & Nestor, 2018; Glasner, 2024). The evolution of the concept of smoking from a mere "habit" to a recognized addictive disorder underscores the powerful pharmacological effects of nicotine, which are now understood to be comparable to those of other major drugs of abuse such as heroin, cocaine, and alcohol (Carmo et al., 2005; Henningfield et al., 1991; Jain, 2003).

The transition from experimental or recreational use to a state of dependence is a complex process involving the interplay of drug pharmacology, individual personality, and environmental influences (Benowitz, 1992; Gerada & Ashworth, 1997). For tobacco, this transition is remarkably efficient; most individuals who experiment with tobacco progress to regular use and subsequent dependence (Sargent & DiFranza, 2003; Benowitz, 1992). This high addictive potential is a central feature of TUD and is driven by nicotine's ability to produce tolerance, physical dependence, and a distinct withdrawal syndrome upon cessation (Rigotti, 2003; Patkar et al., 2003). The disorder is not merely a reflection of a lack of willpower but a manifestation of a hijacked brain reward system, where the compulsive drive to use the drug overrides rational decision-making (López, 2021; Baumeister, 2017).

Understanding TUD as a brain disease is critical for both public health policy and clinical practice (Frohlich, 2008; Satcher, 1994). It shifts the focus from a moral failing to a medical condition requiring long-term management, much like other chronic illnesses such as diabetes or hypertension (Rigotti, 2003; Reed et al., 2024). This biological perspective illuminates why quitting is so difficult and relapse is common, even when smokers are highly motivated to stop (Heffner & Anthenelli, 2011; Brigham, 1998). The drive to smoke is maintained by a combination of positive reinforcement (the pleasurable effects of nicotine) and negative reinforcement (the alleviation of aversive withdrawal symptoms) (Baker et al., 2004; Warburton, 1989).

This chapter will provide a comprehensive overview of the biological and neurological mechanisms that underlie the development, maintenance, and treatment of Tobacco Use Disorder. It will explore the intricate neuropharmacology of nicotine, detailing its effects on key neurotransmitter systems and neural circuits. Furthermore, it will examine the genetic underpinnings that confer individual vulnerability to nicotine dependence, the structural and functional brain changes associated with chronic smoking, and the unique neurodevelopmental risks posed by tobacco initiation during adolescence. Finally, the chapter will connect these fundamental biological processes to the mechanisms of current and future treatments, providing a scientific foundation for understanding why tobacco use persists as a global public health threat and how it can be more effectively addressed (Crofton & Simpson, 2002; Robson & McNeill, 2021).

### Neurobiological Systems

The addictive nature of tobacco is primarily driven by the pharmacological actions of nicotine on the central nervous system (CNS) (Henningfield et al., 1995; Nutt & Nestor, 2018). Nicotine acts as a potent psychoactive substance that rapidly enters the brain after inhalation and modulates the activity of several crucial neurotransmitter systems, leading to the complex behavioral and psychological phenomena that characterize TUD, including reinforcement, tolerance, withdrawal, and craving (Glasner, 2024; Patkar et al., 2003).

#### Neuropharmacology of Nicotine

Nicotine's primary mechanism of action is as an agonist at nicotinic acetylcholine receptors (nAChRs), which are ligand-gated ion channels found throughout the CNS and peripheral nervous system (Le Houezec, 1998; Nutt & Nestor, 2018). These receptors are composed of various subunits, and their specific composition determines their pharmacological properties and anatomical location (Henningfield et al., 1995). The α4β2 nAChR subtype is considered the main receptor mediating nicotine dependence due to its high affinity for nicotine and its strategic location in key brain reward pathways (Sesia & Grace, 2012; Reed et al., 2024; Nutt & Nestor, 2018).

When a smoker inhales tobacco smoke, nicotine is rapidly absorbed through the lungs and reaches the brain within seconds, a pharmacokinetic profile that is critical to its high addictive potential (Le Houezec, 2003; Henningfield et al., 1995). This rapid delivery produces a bolus of nicotine that binds to and activates nAChRs, mimicking the action of the endogenous neurotransmitter acetylcholine (Galanti, 2006). This activation leads to the opening of the ion channel, allowing an influx of cations (primarily sodium and calcium) and causing neuronal depolarization. This initial activation is followed by a period of receptor desensitization, where the receptor becomes temporarily unresponsive to further stimulation (Patkar et al., 2003). This dynamic cycle of activation and desensitization is fundamental to the processes of tolerance and withdrawal.

#### The Dopaminergic Reward Pathway

The reinforcing and rewarding effects of nicotine, which are central to the development and maintenance of addiction, are primarily mediated through its modulation of the mesolimbic dopamine system (Sesia & Grace, 2012; Nutt & Nestor, 2018). This system, often referred to as the brain's "reward pathway," includes dopaminergic neurons originating in the ventral tegmental area (VTA) that project to structures such as the nucleus accumbens (NAc) and the prefrontal cortex (PFC) (Zheng, 2022; Batta, 2018).

Nicotine directly stimulates α4β2 nAChRs located on the cell bodies of VTA dopamine neurons (Sesia & Grace, 2012; Lewis, 2010). This stimulation increases the firing rate of these neurons, leading to a surge of dopamine release in the NAc (Glasner, 2024; Nutt & Nestor, 2018). This dopamine release is experienced as pleasure, euphoria, and reward, thereby positively reinforcing the act of smoking (Zheng, 2022; Henningfield et al., 1995). The brain learns to associate the act of smoking with this rewarding state, which is a critical step in the formation of an addiction (López, 2021). The repeated flooding of the reward circuit with dopamine leads to neuroadaptive changes that are the hallmark of addiction (Batta, 2018).

Furthermore, nicotine also acts on nAChRs located on the presynaptic terminals of glutamatergic and GABAergic neurons that regulate the activity of VTA dopamine neurons. By enhancing the release of the excitatory neurotransmitter glutamate and inhibiting the release of the inhibitory neurotransmitter GABA, nicotine further amplifies dopamine release in the NAc, strengthening its rewarding effects (Sesia & Grace, 2012).

#### Other Implicated Neurotransmitter Systems

While the dopamine system is central, nicotine's effects are widespread, influencing numerous other neurotransmitter systems that contribute to the multifaceted experience of smoking and withdrawal (Galanti, 2006).

*   **Norepinephrine (Noradrenaline):** Nicotine stimulates the release of norepinephrine, which contributes to its arousal and stimulant effects, including increased alertness, concentration, and performance on some cognitive tasks (Broom & Yamamoto, 2007; Heishman, 1999). This system is also implicated in the stress and anxiety associated with nicotine withdrawal (Broom & Yamamoto, 2007).
*   **Serotonin:** Nicotine modulates serotonergic systems, which are involved in mood regulation, appetite, and sleep (Stage et al., 1996). The effects on serotonin may contribute to the mood-altering properties of smoking and the depressive symptoms often seen during withdrawal (Lembke et al., 2007; Vázquez et al., 2003). Some antidepressants, like bupropion, which are effective for smoking cessation, also have effects on these pathways (Selby, 2006).
*   **Endogenous Opioids:** Nicotine stimulates the release of endogenous opioids (endorphins), which contribute to its analgesic (pain-reducing) and pleasure-enhancing effects (Zheng, 2022). This interaction may explain why smokers sometimes report smoking to cope with pain and why opioid antagonists have been explored, with limited success, in smoking cessation (Deehan et al., 2015).
*   **Glutamate and GABA:** As mentioned, nicotine modulates the balance between the brain's primary excitatory (glutamate) and inhibitory (GABA) systems (Peoples, 2002). Chronic nicotine exposure leads to long-term changes in these systems, contributing to the hyperexcitability and anxiety seen during withdrawal (Sesia & Grace, 2012).

#### Neuroadaptation, Tolerance, and Withdrawal

Chronic exposure to nicotine leads to significant neuroadaptations in the brain as it attempts to compensate for the continuous presence of the drug (Henningfield et al., 1995; Sesia & Grace, 2012). A key adaptation is the upregulation of nAChRs (Patkar et al., 2003). The brain increases the number of nAChRs to counteract the prolonged desensitization caused by nicotine. This upregulation contributes to tolerance, where a smoker needs to consume more nicotine to achieve the same desired effects, and to the severity of the withdrawal syndrome (Pomerleau et al., 1993).

When a dependent smoker abstains from tobacco, nicotine levels drop, and the upregulated nAChRs become unoccupied and hypersensitive (McRobbie & West, 2013). This leads to a state of neuronal hyperexcitability and a disruption in the balance of neurotransmitter systems, manifesting as the nicotine withdrawal syndrome (Hughes, 1991; Sesia & Grace, 2012). Symptoms include intense craving, irritability, anxiety, difficulty concentrating, restlessness, increased appetite, and depressed mood (Hughes, 1991; Hesami et al., 2010; Parrott et al., 1996). These aversive symptoms are powerful motivators for relapse, as the smoker learns that another cigarette will quickly alleviate the discomfort—a process of negative reinforcement that strongly maintains the addiction (Baker et al., 2004; West & Schneiders, 1987). The persistence of craving and other withdrawal symptoms, some of which can last for months, underscores the profound and lasting neurobiological changes that define TUD (Hughes, 1991; Ifdil et al., 2021).

### Genetic and Molecular Basis

The development of Tobacco Use Disorder is not solely a function of nicotine exposure; there is substantial individual variability in who initiates smoking, who progresses to dependence, and who succeeds in quitting (Benowitz, 1992; Pomerleau et al., 1993). A significant portion of this variability can be attributed to genetic factors, which influence multiple facets of smoking behavior, from the initial sensitivity to nicotine's effects to the rate of its metabolism and the severity of withdrawal symptoms (Kandyala et al., 2011; Griffith, 2018). Drug addiction is a complex process involving a confluence of pharmacological, familial, personality, and genetic factors (Benowitz, 1992).

#### Heritability of Smoking Behaviors

Twin and family studies have provided compelling evidence for the heritability of smoking behaviors. These studies consistently demonstrate that genetic factors contribute significantly to the risk of smoking initiation, the progression to regular use, the quantity of cigarettes smoked, the level of nicotine dependence, and the ability to quit (Griffith, 2018; Kandyala et al., 2011). Estimates suggest that genetic influences account for a substantial portion of the variance in these behaviors, highlighting a biological predisposition that interacts with environmental influences (Benowitz, 1992). This genetic vulnerability may manifest as differences in how individuals respond to nicotine, influencing whether the initial experience is perceived as pleasurable or aversive, which can in turn affect the likelihood of continued use (Pomerleau et al., 1993).

#### Genes Encoding Nicotinic Receptors

Given that nicotine's primary targets in the brain are nAChRs, genes that code for the subunits of these receptors have been a major focus of research (Chu et al., 2009). Variations, or polymorphisms, in these genes can alter the structure, function, and expression of nAChRs, thereby influencing an individual's response to nicotine.

A cluster of genes on chromosome 15, which includes the genes for the α5, α3, and β4 nAChR subunits (CHRNA5-A3-B4), has been strongly and consistently associated with nicotine dependence and smoking-related diseases (Nutt & Nestor, 2018). Specific variants in the CHRNA5 gene, for example, have been linked to a higher risk of heavy smoking and an increased likelihood of developing nicotine dependence (Kandyala et al., 2011). These genetic variants may lead to less functional α5-containing receptors, which are thought to play a role in limiting the rewarding effects of high nicotine doses. Individuals with these variants might therefore be less sensitive to the aversive effects of high nicotine levels, allowing them to smoke more heavily and increasing their risk for dependence (Sesia & Grace, 2012). Polymorphisms in the gene for the α4 subunit (CHRNA4), a key component of the high-affinity α4β2 receptor, have also been implicated in smoking behaviors, potentially by altering the brain's sensitivity to nicotine's rewarding effects (Chu et al., 2009).

#### Genes Involved in Nicotine Metabolism

Individual differences in how the body metabolizes nicotine also play a crucial role in smoking behavior and dependence (Benowitz, 1992). Nicotine is primarily metabolized in the liver by the cytochrome P450 enzyme system, with the enzyme CYP2A6 being responsible for the majority of this process (Kandyala et al., 2011). Genetic variations in the CYP2A6 gene lead to significant differences in the rate of nicotine metabolism among individuals (Selby, 2006).

Individuals who are "slow metabolizers" due to less active variants of the CYP2A6 gene break down nicotine more slowly, resulting in higher and more sustained levels of nicotine in the brain from each cigarette (Benowitz, 1992). Consequently, these individuals tend to smoke fewer cigarettes per day, are less likely to become dependent, and have higher success rates when they attempt to quit (Kandyala et al., 2011). Conversely, "fast metabolizers" clear nicotine more rapidly, leading them to smoke more frequently to maintain desired nicotine levels, which increases their exposure to tobacco toxins and heightens their risk of dependence (Patkar et al., 2003; Benowitz, 1992). The interaction between smoking and caffeine metabolism, which also involves CYP enzymes (CYP1A2), further illustrates the complex interplay of genetic factors and substance use; smoking induces CYP1A2, leading to faster caffeine clearance, a phenomenon that reverses upon smoking cessation (Murphy et al., 1988; Selby, 2006).

#### Genes of the Dopaminergic and Other Neurotransmitter Systems

Because nicotine's rewarding effects are mediated by the dopamine system, genes involved in dopamine signaling have been investigated as potential contributors to TUD. Polymorphisms in genes for dopamine receptors (such as the D2 receptor) and the dopamine transporter (DAT) have been studied, with some evidence suggesting they may influence smoking initiation, nicotine dependence, and withdrawal severity (Batra, 2000; Kandyala et al., 2011). The theory is that genetic variations affecting dopamine function could alter an individual's baseline reward sensitivity or their response to nicotine-induced dopamine release, thereby modifying their vulnerability to addiction (Piazza et al., 1996). For example, a lower density of D2 receptors has been linked to increased impulsivity and a greater propensity for addictive behaviors in general (Batra, 2000).

Similarly, genes related to other neurotransmitter systems modulated by nicotine, such as the serotonergic and noradrenergic systems, are also candidate genes for influencing smoking behavior (Chu et al., 2009). For instance, variations in genes affecting serotonin transport and receptor function could impact mood regulation and contribute to the likelihood of smoking as a form of self-medication for depressive or anxious symptoms (Lembke et al., 2007; Hong et al., 2022).

In conclusion, the molecular and genetic basis of TUD is polygenic and complex, involving numerous genes that interact with each other and with a host of environmental factors (Benowitz, 1992; Griffith, 2018). Understanding these genetic predispositions is crucial not only for identifying individuals at high risk but also for developing personalized smoking cessation strategies that target the specific biological vulnerabilities of each smoker (Kandyala et al., 2011).

### Brain Structure and Function

Chronic tobacco use induces significant and lasting changes in both the structure and function of the human brain, reflecting the neuroadaptive processes that underlie nicotine addiction (Glasner, 2024). While the source material is limited in providing direct neuroimaging studies on tobacco users, we can infer a great deal about the affected brain regions and circuits from our understanding of the neuropharmacology of nicotine and by drawing parallels with findings from other substance use disorders, such as cocaine addiction, which involve similar reward pathways (Herdener et al., 2015; Goldstein, 2008). These alterations are not merely correlates of smoking but are fundamental to the compulsive drug-seeking, impaired decision-making, and high rates of relapse that characterize Tobacco Use Disorder (TUD).

#### Key Brain Regions and Neural Circuits

The neurobiological framework of TUD centers on the brain's reward and motivation circuitry, which is powerfully modulated by nicotine (López, 2021). The primary circuit implicated is the mesolimbic dopamine pathway, which includes the ventral tegmental area (VTA), the nucleus accumbens (NAc), and their connections to the prefrontal cortex (PFC), amygdala, and hippocampus (Sesia & Grace, 2012; Nutt & Nestor, 2018).

*   **Ventral Tegmental Area (VTA) and Nucleus Accumbens (NAc):** As previously discussed, nicotine directly activates dopamine neurons in the VTA, causing a surge of dopamine in the NAc (Glasner, 2024). This action is central to the acute reinforcing effects of smoking (Zheng, 2022). Chronic smoking leads to neuroadaptations within this circuit, including the upregulation of nAChRs, which sensitizes the system to nicotine and contributes to the intense craving experienced during abstinence (Patkar et al., 2003; Sesia & Grace, 2012). Studies on other addictive drugs like cocaine show that prolonged drug self-administration leads to compulsive drug-seeking that is resistant to aversive consequences, a behavioral change thought to be encoded within this VTA-NAc pathway (Vanderschuren & Everitt, 2004).

*   **Prefrontal Cortex (PFC):** The PFC is critical for executive functions, including decision-making, impulse control, and assigning value to stimuli (Goldstein, 2008). In addiction, the function of the PFC is profoundly disrupted. Nicotine-induced dopamine release in the PFC can enhance cognitive functions like attention in the short term (Heishman, 1999), but chronic use leads to hypofrontality—a state of reduced PFC activity, particularly during abstinence (Goldstein, 2008). This impairment in PFC function contributes to the poor decision-making and loss of self-control characteristic of addiction, where the immediate reward of smoking is prioritized over long-term negative consequences (Baumeister, 2017; Vonasch et al., 2017). Research on cocaine addiction has shown that addicted individuals have an impaired ability to process rewards and exercise control, which is directly linked to changes in PFC responsiveness (Goldstein, 2008). It is highly plausible that similar deficits underlie TUD.

*   **Amygdala:** The amygdala is a key brain region for processing emotions, particularly fear, anxiety, and stress (Broom & Yamamoto, 2007). In TUD, the amygdala plays a dual role. It is involved in processing the rewarding aspects of smoking cues, but it becomes particularly active during withdrawal, contributing to the negative affective state (e.g., irritability, anxiety, stress) that drives relapse through negative reinforcement (Sesia & Grace, 2012; Parrott, 1995). The link between smoking and stress is strong; smokers often report smoking to relieve stress, but this relief is largely the alleviation of withdrawal-induced negative mood (Parrott, 1995; Heishman, 1999; Stein et al., 2008).

*   **Hippocampus:** The hippocampus is essential for learning and memory, particularly for encoding the context associated with rewarding experiences (Konopka, 2014). In TUD, the hippocampus helps to form powerful memories that link environmental cues (e.g., the sight of a cigarette pack, the smell of coffee, finishing a meal) with the rewarding effects of nicotine (West & Schneiders, 1987). When a former smoker encounters these cues, the hippocampus can trigger intense craving and relapse, even long after physical withdrawal has subsided (Schlagintweit & Barrett, 2016).

#### Functional Connectivity and Brain Network Alterations

Addiction is increasingly viewed as a disorder of brain networks, where the communication and functional connectivity between key regions are altered (Herdener et al., 2015). In chronic smokers, it is hypothesized that the connectivity between the PFC and reward-related regions like the NAc is weakened. This breakdown in "top-down" control from the PFC allows the "bottom-up" drives for drug-seeking, originating from the NAc and amygdala, to dominate behavior (Goldstein, 2008). This imbalance helps explain why addicted individuals find it so difficult to resist cravings and impulses to smoke, even when they are fully aware of the health risks and genuinely wish to quit (Baumeister, 2017; Rigotti, 2003).

Chronic cocaine use, for example, is associated with structural changes and altered functional connectivity, particularly in fronto-striatal circuits, which may promote a premature aging of the brain (Herdener et al., 2015; Goldstein, 2008). Given the overlapping neurocircuitry, it is probable that chronic nicotine exposure induces similar patterns of brain changes. For instance, chronic smoking has been associated with brain atrophy and cognitive decline, effects that are likely mediated by structural and functional alterations in these critical networks (Krishnan, 2024).

#### Neuroimaging Findings

While the provided literature does not contain specific fMRI or PET studies on tobacco users, findings from other substance use disorders provide a template for what is expected in TUD. Neuroimaging studies of cocaine addiction reveal reduced dopamine D2 receptor availability in the striatum, which is linked to impaired PFC function and compulsive drug use (Goldstein, 2008). It is plausible that similar D2 receptor deficits are present in individuals with severe nicotine dependence. Furthermore, cue-reactivity studies consistently show that exposure to drug-related cues (like images of smoking) activates the reward circuitry, including the VTA, NAc, and amygdala, and that the magnitude of this activation can predict craving and relapse (Kosten, 1992).

In summary, chronic tobacco use reshapes the brain's functional and structural landscape. It weakens the neural systems responsible for self-control and rational decision-making (PFC) while strengthening the circuits that drive compulsive, cue-triggered drug-seeking behaviors (VTA-NAc, amygdala, hippocampus). This neural reorganization is the biological substrate of addiction, transforming smoking from a voluntary choice into a compulsive, difficult-to-control disorder (López, 2021; Glasner, 2024).

### Developmental Neurobiology

Adolescence is a critical period of neurodevelopment characterized by significant maturation of brain circuits involved in reward processing, motivation, and executive control (Gaiha & Halpern‐Felsher, 2020). This developmental stage is also when the vast majority of tobacco use is initiated (Sargent & DiFranza, 2003; Harvey & Chadi, 2016). The adolescent brain is uniquely vulnerable to the neurotoxic and addictive effects of nicotine, and early exposure can lead to a more severe and intractable form of dependence, as well as lasting alterations in brain structure and function (Henningfield & Jude, 1999; Schraufnagel, 2015; Krishnan, 2024). Understanding the interplay between nicotine and the developing brain is crucial for explaining the high rates of adolescent addiction and for designing effective prevention strategies (Kassel, 2000; Harvey & Chadi, 2016).

#### Adolescent Vulnerability to Nicotine Addiction

Experimentation with tobacco during adolescence is a significant public health problem, with early initiation being a strong predictor of lifelong dependence (Sargent & DiFranza, 2003; Medina-Mora et al., 2002). Several factors contribute to this heightened vulnerability. Social influences, such as peer pressure and smoking by family members, play a powerful role in initiation (May, 1999; Sargent & DiFranza, 2003; Mays et al., 2014). However, the biological response of the adolescent brain to nicotine is a key determinant in the transition from experimentation to addiction (Henningfield & Jude, 1999).

Studies suggest that adolescents can develop symptoms of nicotine dependence, such as craving and withdrawal, surprisingly quickly, sometimes after smoking only a few cigarettes (Sargent & DiFranza, 2003; Kassel, 2000). This rapid onset of dependence suggests that the adolescent brain is more sensitive to the rewarding and neuroadaptive effects of nicotine compared to the adult brain (Chellian et al., 2022). Nicotine addiction is established more strongly when exposure occurs during adolescence (Indian Council of Medical Research, 2019). The developing brain, particularly the still-maturing prefrontal cortex responsible for impulse control and decision-making, is less equipped to override the powerful rewarding signals triggered by nicotine in the mesolimbic dopamine system (Gaiha & Halpern‐Felsher, 2020; Krishnan, 2024).

Animal models support this heightened vulnerability. For example, adolescent rats show a greater sensitivity to the rewarding properties of nicotine and are more likely to self-administer the drug compared to adult rats (Chellian et al., 2022). Furthermore, adolescent exposure to alcohol, another commonly used substance, has been shown to increase the rewarding effects of other drugs like heroin later in life, suggesting a cross-sensitization process that may also apply to nicotine (Galaj et al., 2020; Shaykin et al., 2024).

#### Long-Term Consequences of Adolescent Nicotine Exposure

Nicotine exposure during the critical window of adolescent brain development can cause permanent structural and functional changes (Stanwick, 2015; Krishnan, 2024). Nicotine acts as a neurotoxin on the developing brain, interfering with the normal processes of synaptic pruning and maturation (Schraufnagel, 2015). This disruption can lead to lasting deficits in cognitive function, particularly in areas of attention and memory (Compton & Broussard, 2010), and may increase the risk for developing psychiatric disorders later in life (Glazier, 2010).

The developing brains of children and adolescents are particularly susceptible to the development of tobacco and nicotine dependence (Groner et al., 2015; Public Health England, 2017). Early and heavy cannabis use, another drug often initiated in adolescence, has been linked to altered brain structure and impaired cognitive function, and it is plausible that nicotine has similar detrimental effects (Konopka, 2014; Yager, 2014). For instance, chronic nicotine exposure during adolescence may alter the trajectory of prefrontal cortex development, leading to long-term impairments in executive control and an increased propensity for impulsivity and risk-taking behaviors (Gaiha & Halpern‐Felsher, 2020).

#### The "Gateway" Hypothesis and Polysubstance Use

The concept of tobacco as a "gateway drug" suggests that its use during adolescence increases the likelihood of subsequent use of other substances like alcohol and illicit drugs (Tullis et al., 2003; Medina-Mora et al., 2002). Biologically, this can be explained by the principle of cross-sensitization. Nicotine-induced changes in the brain's reward pathways can make these circuits more sensitive to the rewarding effects of other drugs (Bruijnzeel, 2024; Krishnan, 2024). Animal studies show that pre-exposure to nicotine increases the rewarding effects of other substances like alcohol and cocaine (Deehan et al., 2015). This priming of the brain's reward system by nicotine may lower the threshold for developing an addiction to other substances (Tullis et al., 2003; Chellian et al., 2022).

Epidemiological data strongly support this association. Adolescents who smoke are far more likely to drink alcohol and use marijuana and other illicit drugs compared to their non-smoking peers (Myers & Kelly, 2006; Newcomb & Bentler, 1986; Komro & Toomey, 2002). While some argue that marijuana may also act as a gateway to tobacco (Tullis et al., 2003), the sequence most commonly observed is initiation with legal substances like tobacco and alcohol, followed by progression to illicit drugs (Newcomb & Bentler, 1986; Medina-Mora et al., 2002). The rise of new nicotine delivery systems, such as electronic cigarettes (e-cigarettes), has raised new concerns about this gateway effect, as these products are increasingly popular among youth and may serve as an entry point to nicotine addiction and subsequent combustible tobacco use (Stanwick, 2015; Leventhal et al., 2019; Gaiha & Halpern‐Felsher, 2020).

In conclusion, the neurobiology of adolescence confers a unique and heightened risk for the development of TUD. Nicotine exposure during this sensitive period not only fosters a more rapid and severe addiction but also has the potential to alter the course of brain development with lasting consequences for cognition, mental health, and vulnerability to other substance use disorders (Harvey & Chadi, 2016; Schraufnagel, 2015). This underscores the critical importance of public health policies and clinical interventions aimed at preventing tobacco initiation among youth (Sargent & DiFranza, 2003; Groner et al., 2015).

### Treatment Mechanisms

Understanding the biological basis of Tobacco Use Disorder (TUD) is fundamental to developing and implementing effective treatments. Modern therapeutic approaches, both pharmacological and behavioral, are designed to counteract the neurobiological changes induced by chronic nicotine exposure (Patkar et al., 2003). These treatments aim to manage withdrawal symptoms, reduce craving, and disrupt the learned associations that maintain smoking behavior, thereby increasing the chances of successful long-term abstinence (Rigotti, 2003; Jain, 2003).

#### Pharmacological Interventions

Pharmacotherapy is a cornerstone of TUD treatment, with several medications approved for their safety and efficacy in promoting smoking cessation (He, 2008; Hartmann‐Boyce & Aveyard, 2016). These agents work by targeting the underlying neuropharmacological mechanisms of nicotine dependence.

**1. Nicotine Replacement Therapy (NRT):** NRT is the most widely used pharmacotherapy and comes in various forms, including transdermal patches, gum, lozenges, inhalers, and nasal sprays (Devalcheruvu & Nalli, 2007; Tonstad, 1999). The primary mechanism of NRT is to provide a slower, more controlled delivery of nicotine to the brain, thereby alleviating the physiological and psychological symptoms of withdrawal without providing the rapid, reinforcing bolus of nicotine delivered by a cigarette (Le Houezec, 2003; Hughes, 1988).

By partially stimulating the nAChRs, NRT reduces the severity of withdrawal symptoms such as irritability, anxiety, and difficulty concentrating (Hughes, 1991; Cerny, 2002). This allows the individual attempting to quit to focus on breaking the behavioral and psychological habits associated with smoking (MacDonald, 1998). The slower pharmacokinetic profile of NRT products makes them significantly less addictive than cigarettes (Le Houezec, 2003; Hughes, 1988). Although some level of dependence on NRT can occur, it is generally considered a safer, long-term alternative to continued smoking (Mulry, 1988; Mendelsohn, 2015). Combination therapy, using a long-acting patch for baseline nicotine levels and a short-acting form (like gum or lozenge) for acute cravings, has been shown to be particularly effective, likely by better mimicking the smoker's daily nicotine exposure (Tonstad, 1999; Devalcheruvu & Nalli, 2007).

**2. Bupropion (Sustained-Release):** Bupropion is an atypical antidepressant that has been proven effective for smoking cessation, independent of its antidepressant effects (Selby, 2006; He, 2008). Its primary mechanism of action is thought to be the inhibition of norepinephrine and dopamine reuptake in the brain (Selby, 2006; Tonstad & Els, 2010). By increasing the extracellular levels of these neurotransmitters, bupropion may mimic some of nicotine's effects on alertness and mood, and more importantly, it may stabilize the dopaminergic reward system (Selby, 2006). This helps to reduce the severity of withdrawal symptoms, particularly depressed mood and craving (Jiloha, 2014). Additionally, bupropion may act as a non-competitive antagonist at certain nAChRs, which could further reduce the reinforcing effects of nicotine if a person lapses and smokes a cigarette (Warner & Shoaib, 2005, as cited in Selby, 2006).

**3. Varenicline:** Varenicline is a partial agonist at the α4β2 nAChR, the receptor subtype most critical for nicotine's reinforcing effects (Nutt & Nestor, 2018; Tonstad & Els, 2010). As a partial agonist, varenicline has a dual mechanism of action. First, it binds to and moderately stimulates the α4β2 receptors, which leads to a modest and sustained release of dopamine (Reed et al., 2024). This agonist activity is sufficient to alleviate craving and withdrawal symptoms during abstinence (Tonstad & Els, 2010). Second, because varenicline has a high affinity for the receptor, it effectively blocks nicotine from binding (Nutt & Nestor, 2018). This antagonist activity means that if a person smokes while taking varenicline, the nicotine from the cigarette cannot produce its usual rewarding dopamine surge, making the act of smoking less satisfying and reinforcing (Steinberg & Williams, 2013). This reduction in smoking's reward value helps to extinguish the behavior and prevent a lapse from turning into a full relapse (Heffner & Anthenelli, 2011).

#### Behavioral and Psychosocial Interventions

While pharmacotherapies target the physiological aspects of dependence, behavioral interventions are crucial for addressing the powerful psychological and environmental components of TUD (Lowe, 2001). Addiction is not just about physical dependence; it is a learned behavior reinforced by countless repetitions in specific contexts (Logan, 2017).

*   **Cognitive Behavioral Therapy (CBT) and Counseling:** These approaches help smokers identify high-risk situations, thoughts, and feelings that trigger the urge to smoke (West & Schneiders, 1987). Patients learn new coping strategies to manage stress, negative affect, and cravings without resorting to smoking (Devalcheruvu & Nalli, 2007; Fernández Clemente et al., 2001). This involves cognitive restructuring to change unhelpful beliefs about smoking (e.g., "I need a cigarette to relax") and developing alternative behaviors (e.g., deep breathing, going for a walk) (Rose & Walters, 2012). The combination of behavioral counseling and pharmacotherapy is consistently found to be the most effective treatment strategy (Reed et al., 2024; Batra, 2002).

*   **Motivational Interviewing (MI):** Many smokers are ambivalent about quitting (Rigotti, 2003). MI is a counseling style that helps resolve this ambivalence by exploring the patient's own reasons for wanting to change (Hu & Yu, 2009). It is a patient-centered approach that avoids confrontation and supports self-efficacy, making it particularly useful for smokers who are not yet ready to make a quit attempt (Burch & Martín-López, 2016).

*   **Self-Control and Relapse Prevention:** Successful cessation requires self-control to resist the urge to smoke (Muraven, 2010). Research suggests that self-control can be strengthened through practice, which may lower the risk of a lapse (Muraven, 2010). Relapse prevention models focus on helping individuals manage lapses without progressing to a full relapse (Shiffman et al., 1996). This involves reframing a lapse not as a failure, but as a learning opportunity, and developing strategies to cope with the "Abstinence Violation Effect"—feelings of guilt and loss of control that can follow an initial slip-up (Shiffman et al., 1996).

#### Harm Reduction Strategies

For smokers who are unable or unwilling to quit completely, harm reduction strategies aim to reduce the health consequences of continued tobacco use (Fagerström, 1999; Kunze, 2000). This can involve reducing the number of cigarettes smoked per day, often with the aid of NRT to manage cravings (Abdullah, 2005; Jimenez-Ruiz et al., 2025). The biological rationale is that reducing smoke exposure will decrease the intake of toxins, though smokers may compensate by inhaling more deeply from fewer cigarettes (Benowitz et al., 1986). More recently, electronic cigarettes (e-cigarettes) have emerged as a popular but controversial harm reduction tool (Polosa et al., 2013; Farsalinos & LeHouezec, 2015). By delivering nicotine in an aerosol without tobacco combustion, they are considered substantially less harmful than conventional cigarettes (Britton et al., 2016; McNeill et al., 2015). They may serve as a substitute for smoking, satisfying both nicotine dependence and the behavioral rituals of smoking, potentially aiding in cessation or reduction for some individuals (Polosa & Caponnetto, 2013; Buettner‐Schmidt et al., 2021).

### Future Directions

Despite significant advances in understanding the biological underpinnings of Tobacco Use Disorder (TUD), many questions remain unanswered, and new challenges continue to emerge. The evolving landscape of tobacco and nicotine products, coupled with a deeper appreciation for the heterogeneity of the disorder, necessitates a forward-looking research agenda focused on refining treatments, improving prevention, and adapting to new public health threats.

#### Personalized Medicine and Pharmacogenetics

A key future direction lies in the development of personalized medicine for smoking cessation (Kandyala et al., 2011). As outlined in the genetics section, there is substantial individual variability in nicotine metabolism and receptor sensitivity, which influences smoking behavior and treatment response (Benowitz, 1992). Future research should focus on translating this genetic knowledge into clinical practice. For instance, identifying a smoker's CYP2A6 genotype to determine if they are a "slow" or "fast" nicotine metabolizer could guide the selection and dosing of pharmacotherapy (Kandyala et al., 2011). Fast metabolizers might benefit from higher doses of NRT or non-nicotine medications like varenicline, while slow metabolizers might respond well to standard or lower doses (Selby, 2006). Similarly, identifying polymorphisms in nAChR genes could help predict which individuals are most likely to respond to agents like varenicline that target these receptors (Nutt & Nestor, 2018). This approach requires larger, well-controlled studies to identify robust gene-treatment interactions and develop cost-effective clinical tools for genetic screening (Stewart et al., 2006).

#### Novel Pharmacological Targets

While current medications are effective, a large proportion of smokers still fail to achieve long-term abstinence, highlighting the need for novel therapeutic targets (Jain, 2003). Research into the broader neurochemical effects of nicotine points to several promising avenues. For example, given the role of the glutamate system in craving and relapse, medications that modulate glutamate transmission could be beneficial (Peoples, 2002). The endocannabinoid system is also deeply interconnected with reward and motivation, and its modulation could influence nicotine's reinforcing effects (Metrik, 2022). Furthermore, developing therapeutic vaccines that induce the production of nicotine-specific antibodies is an innovative approach (Maurer & Bachmann, 2006; Cerny & Cerny, 2009). These antibodies would bind to nicotine in the bloodstream, preventing it from crossing the blood-brain barrier and reaching its receptors in the brain, thereby blunting its rewarding effects and helping to prevent relapse (Maurer & Bachmann, 2006; Cerný, 2009). While early trials have shown promise, optimizing vaccine efficacy to generate sufficiently high and sustained antibody levels remains a challenge (Cerny, 2002).

#### The Challenge of Electronic Cigarettes and Novel Nicotine Products

The rapid rise of electronic cigarettes (e-cigarettes) and other novel nicotine products (e.g., nicotine pouches) presents both a potential opportunity for harm reduction and a significant public health challenge (Polosa et al., 2013; Farsalinos & LeHouezec, 2015; Miļuna-Meldere, 2025). While likely far less harmful than combustible tobacco, the long-term health effects of chronic vaping are unknown (Rowell & Tarran, 2015; Shields et al., 2017). Urgent research is needed to understand the toxicology of inhaled flavorings, propylene glycol, and vegetable glycerin, as well as the cardiovascular and pulmonary consequences of long-term use (Darabseh et al., 2020; Liew, 2020; Jones et al., 2023).

From a neurobiological perspective, it is crucial to understand the addiction potential of these new devices (Cobb et al., 2015). Different devices and e-liquids deliver nicotine with varying efficiency and pharmacokinetics (Farsalinos et al., 2014). Products that deliver nicotine rapidly to the brain may have a higher addiction liability, posing a risk for non-smokers, particularly adolescents, who are increasingly experimenting with these products (Stanwick, 2015; Schraufnagel, 2015; Leventhal et al., 2019). The "gateway" hypothesis—that vaping could lead to combustible cigarette use in youth—needs rigorous longitudinal investigation from both behavioral and neurobiological standpoints (Gaiha & Halpern‐Felsher, 2020; Chellian et al., 2022). Conversely, understanding how to optimize these devices as effective smoking substitutes for adult smokers is a critical harm reduction goal (Polosa & Caponnetto, 2013; Hájek, 2014).

#### Neurobiology of Vulnerable Populations

Smoking prevalence remains disproportionately high among individuals with psychiatric disorders, such as schizophrenia and depression, and those with other substance use disorders (Robson, 2018; Lasser et al., as cited in Selby, 2006; Dom, 2025). These populations often exhibit higher levels of nicotine dependence and face greater challenges in quitting (Gottlieb & Evins, 2007; Heffner & Anthenelli, 2011). Future research must delve deeper into the shared neurobiological substrates that link these disorders. For example, nicotine's ability to transiently improve cognitive deficits in schizophrenia (the "self-medication" hypothesis) suggests that treatments combining smoking cessation with cognitive enhancement could be more effective (Compton & Broussard, 2010; Patkar et al., 2003). Understanding the complex interactions between nicotine, alcohol, and other drugs at the receptor and circuit level is also essential for treating polysubstance use, which is the norm rather than the exception (Zacny, 1990; Miller & Bennett, 1996; Deehan et al., 2015).

Finally, the neurodevelopmental effects of nicotine on the adolescent brain require continued investigation, especially with the rise of vaping among youth (Henningfield & Jude, 1999; Krishnan, 2024). Long-term studies are needed to determine how early nicotine exposure alters brain structure, function, and lifelong vulnerability to addiction and mental illness. This knowledge is paramount for strengthening public policy and prevention efforts aimed at protecting future generations (Groner et al., 2015; Harvey & Chadi, 2016).

### Conclusion

Tobacco Use Disorder is a deeply entrenched brain disease, driven by the powerful addictive properties of nicotine acting on sophisticated neural circuits (López, 2021; Glasner, 2024). The journey from an initial, often voluntary, act of smoking to a state of compulsive use is marked by a cascade of biological changes that fundamentally alter brain structure and function (Henningfield et al., 1995). Nicotine hijacks the brain's mesolimbic dopamine system, transforming the act of smoking into a powerfully reinforced behavior (Sesia & Grace, 2012; Nutt & Nestor, 2018). Through its action on nicotinic acetylcholine receptors, it orchestrates a symphony of neurotransmitter release, producing transient effects of pleasure, arousal, and cognitive enhancement that smokers come to rely on (Warburton, 1989; Heishman, 1999).

The brain, in its attempt to maintain homeostasis, undergoes profound neuroadaptations, most notably an upregulation of nAChRs (Patkar et al., 2003). This cellular recalibration fosters tolerance and lays the groundwork for a potent withdrawal syndrome upon cessation, characterized by intense craving, anxiety, irritability, and cognitive deficits (Hughes, 1991; McRobbie & West, 2013). This aversive state creates a powerful negative reinforcement loop, where relapse becomes a means to escape discomfort, cementing the cycle of addiction (Baker et al., 2004).

Individual vulnerability to this cycle is not uniform but is shaped by a complex tapestry of genetic factors (Benowitz, 1992; Kandyala et al., 2011). Variations in genes encoding nAChR subunits and nicotine-metabolizing enzymes create a spectrum of susceptibility, influencing everything from initial sensitivity to the likelihood of successful cessation (Griffith, 2018). This genetic predisposition is particularly impactful during adolescence, a critical neurodevelopmental window where the brain is uniquely vulnerable to nicotine's lasting effects, increasing the risk of a more severe, lifelong addiction and other psychiatric comorbidities (Henningfield & Jude, 1999; Schraufnagel, 2015).

This biological understanding provides a rational foundation for treatment. Pharmacotherapies like NRT, bupropion, and varenicline are not simply "crutches" but are targeted interventions designed to normalize brain chemistry, alleviate withdrawal, and reduce the reinforcing value of smoking, thereby enabling individuals to engage more effectively with behavioral therapies that address the psychological and environmental triggers of their addiction (Jain, 2003; Reed et al., 2024).

The fight against the global tobacco epidemic is far from over (Crofton & Simpson, 2002). The emergence of novel nicotine products like e-cigarettes presents new and complex challenges, blurring the lines between harm reduction and a potential new pathway to addiction for youth (Stanwick, 2015; Polosa et al., 2013). Moving forward, a continued and deepened investigation into the neurobiology of nicotine dependence is essential. By further elucidating the mechanisms of addiction, identifying new therapeutic targets, and understanding the unique vulnerabilities of different populations, science can continue to inform more effective clinical strategies and public health policies to mitigate the devastating impact of Tobacco Use Disorder on human health (Satcher, 1994).

## References

1. Aartsen, M. (2014). Ageing and the Development of Alcohol Use and Misuse. https://doi.org/10.1002/9781118430965.ch10
2. Abbass, S. K. (2008). EFFECTS OF SMOKING AND AGE ON THE VALIDITY OF PARTIAL DENTURE AFTER TWO YEARS OF USE: STATISTICAL STUDY. Journal of university of Anbar for pure science. https://doi.org/10.37652/juaps.2008.15364
3. Abdullah, A. S. (2005). How far should we promote smoking reduction in order to promote smoking cessation?. PubMed.
4. Acuff, S. F., & Strickland, J. C. (2025). Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target. Addiction. https://doi.org/10.1111/add.70048
5. Adamson, R. H. (1995). Caffeine Dependence Syndrome. JAMA. https://doi.org/10.1001/jama.1995.03520420029022
6. Ahamed, M., Chhabra, K. G., Reche, A., & Paul, P. (2022). Tobacco cessation by prescription - A 180 degree turn. Journal of Family Medicine and Primary Care. https://doi.org/10.4103/jfmpc.jfmpc_2414_21
7. Ahmed, S. H. (2010). Escalation of Drug Use. Neuromethods. https://doi.org/10.1007/978-1-60761-934-5_10
8. Albertson, T. E., Offerman, S., & Kenyon, N. J. (2006). 16 How Recreational Drugs Affect Asthma. https://doi.org/10.1385/1-59745-014-6:327
9. Alderman, C. P., & Nyfort‐Hansen, K. (2000). Nitrous Oxide Abuse in a Community Setting: Case Report. The Australian Journal of Hospital Pharmacy. https://doi.org/10.1002/jppr2000303109
10. Ali, S. A. H. (2022). Editorial: Vaping and Cardiovascular health � An opportunity or a risk?. The Journal of Cardiovascular Diseases. https://doi.org/10.55958/jcvd.v18i2.107
11. Aljamali, N. M., Al-Qraawy, W. K. N., & Helal, T. A. (2022). Review on carcinogens materials in chemical laboratories. International Journal of Molecular Biology and Biochemistry. https://doi.org/10.33545/26646501.2022.v4.i1a.26
12. Allen, B. M. (2016). The real substance abuse problem within the SAPS : on the soapbox. Servamus online duty/Servamus.
13. Alm, B., Lagercrantz, H., & Wennergren, G. (2006). Stop SIDS – sleeping solitary supine, sucking soother, stopping smoking substitutes. Acta Paediatrica. https://doi.org/10.1080/08035250600582830
14. Almeida, J. D. C., & Campos, J. Á. D. B. (2014). • Consumo de álcool por adultos brasileiros: uma revisão da literatura.
15. Alonso, I. M., Meana, J. J., & Vargas, L. P. (1999). Nicotina y tabaquismo: nuevas perspectivas : avances en farmacología de drogodependencias.
16. Alves, L. L., & Menezes, A. P. S. (2017). PREVALÊNCIA DE UTILIZAÇÃO DO ÁLCOOL NA ADOLESCÊNCIA E EFEITOS TOXICOLÓGICOS DE SEU ABUSO. ANAIS CONGREGA MIC - ISBN:978-65-86471-05-2  e  ANAIS  MIC JR. - ISBN:978-65-86471-06-9.
17. AMANDA, M. P., Humaedi, S., & Santoso, M. B. (2017). PENYALAHGUNAAN NARKOBA DI KALANGAN REMAJA (ADOLESCENT SUBSTANCE ABUSE). Prosiding Penelitian dan Pengabdian kepada Masyarakat. https://doi.org/10.24198/jppm.v4i2.14392
18. Ames, G. M., & Cunradi, C. B. (2004). Alcohol use and preventing alcohol-related problems among young adults in the military. Alcohol Research & Health.
19. Amin, Z., Zulkifly, S., & Iskandar, S. D. (2017). Vaping as Smoking Cessation Methods: Is it a Solution or a New Problem ?. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2017.00169.3
20. Amrith, R. T., & Ganashree, P. (2013). Acute Effect of Gutkha Chewing on Cardiopulmonary Efficiency in Short Term Users. Journal of Alcoholism and Drug Dependence. https://doi.org/10.4172/2329-6488.1000115
21. Anta, R. M. O., Ortega, A. I. J., García, R. M. M., Mora, A. M. L., & Lozano-Estevan, M. D. C. (2021). Nutritional problems in smokers and passive smokers. Nutrición Hospitalaria. https://doi.org/10.20960/nh.03794
22. Apodaca, T. R., & Moser, C. N. (2010). The Use and Abuse of Prescription Medication to Facilitate or Enhance Sexual Behavior Among Adolescents. Clinical Pharmacology & Therapeutics. https://doi.org/10.1038/clpt.2010.264
23. Araújo, P. S. A. D. (2013). Álcool e alcoolismo: uma análise da efetividade do trabalho com familiares de dependentes do grupo AL-ANON novo rumo (DAS-UFRN).
24. areta, L. A. (2021). SOSIALISASI BAHAYA ROKOK GUNA MENINGKATKAN KESADARAN MASYRARAKAT AKAN BESARNYA DAMPAK BURUK ROKOK BAGI KESEHATAN. https://doi.org/10.31219/osf.io/f38y9
25. Ashipala, D. O., Tomas, N., & Joel, M. H. (2020). Smoking. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-7998-2139-7.ch006
26. Assari, S., & Sheikhattari, P. (2024). Higher Neighborhood Crime Rates Don't Always Predict Early Initiation of Tobacco, Marijuana, and Alcohol. Trends journal of sciences research. https://doi.org/10.31586/jsmhes.2024.1049
27. Author, N. G. (2007). Drug Retention Times. https://doi.org/10.2172/908420
28. Aynsley, A., Bradley, R., Buchanan, L., Burrows, N., & Bush, M. (2017). Childhood adversity, substance misuse and young people’s mental health..
29. Baig, A., & Shaukat, M. (2025). Vaping culture: An emerging epidemic and its impact. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.21748
30. Baker, A., Callister, R., Kelly, P. J., & Kypri, K. (2012). 'Do more, smoke less!' Harm reduction in action for smokers with mental health/substance use problems who cannot or will not quit.
31. Baker, A., Callister, R., Kelly, P. J., & Kypri, K. (2012). ‘Do more, smoke less!’ Harm reduction in action for smokers with mental health/substance use problems who cannot or will not quit. Drug and Alcohol Review. https://doi.org/10.1111/j.1465-3362.2012.00461.x
32. Baker, T. B., Brandon, T. H., & Chassin, L. (2004). Motivational Influences on Cigarette Smoking. Annual Review of Psychology. https://doi.org/10.1146/annurev.psych.55.090902.142054
33. Ballén, M. A., Gualdrón, A. J., Álvarez, D. L., & Rincón, A. (2006). El cigarrillo: implicaciones para la salud. DOAJ (DOAJ: Directory of Open Access Journals).
34. Barrera, A. M. B. (2005). Las drogas en Galicia. Semata: Ciencias sociais e humanidades.
35. Barroso, C. R. D., & Guidoreni, C. G. (2018). Alterações neuropsicológicas causadas pelo uso crônico de cocaína.
36. Bartlett, S. J., Wadden, T. A., & Vogt, R. A. (1996). Psychosocial consequences of weight cycling.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.64.3.587
37. Batra, A. (2000). Tabakabhängigkeit und Raucherentwöhnung bei psychiatrischen Patienten. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2000-11646
38. Batra, A. (2002). [Tobacco dependence--evidence-based treatment strategies].. PubMed.
39. Batta, A. (2018). Addiction-How and Type. Global Journal of Addiction & Rehabilitation Medicine. https://doi.org/10.19080/gjarm.2018.05.555656
40. Baumeister, R. F. (2017). Addiction, cigarette smoking, and voluntary control of action: Do cigarette smokers lose their free will?. Addictive Behaviors Reports. https://doi.org/10.1016/j.abrep.2017.01.003
41. Bautista, R. G. (2020). Adicción a cocaína Estudio del receptor dopaminérgico D3 (D3R) como posible diana farmacológica en la prevención de las recaídas en su consumo. Proyecto de investigación:.
42. Beach, S. R. H., Dogan, M. V., Lei, M., Cutrona, C. E., Gerrard, M., Gibbons, F. X., Simons, R. L., Brody, G. H., & Philibert, R. A. (2015). Methylomic Aging as a Window onto the Influence of Lifestyle: Tobacco and Alcohol Use Alter the Rate of Biological Aging. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.13830
43. Benalcázar, P., & Ofelia, C. (2010). Causas y consecuencias del consumo de alcohol por parte de los estudiantes de la Facultad de Jurisprudencia en bares cercanos a la universidad.
44. Benowitz, N. L. (1992). The Genetics of Drug Dependence: Tobacco Addiction. New England Journal of Medicine. https://doi.org/10.1056/nejm199209173271210
45. Benowitz, N. L., Jacob, P., Kozlowski, L. T., & Yu, L. (1986). Influence of Smoking Fewer Cigarettes on Exposure to Tar, Nicotine, and Carbon Monoxide. New England Journal of Medicine. https://doi.org/10.1056/nejm198611203152102
46. Benowitz, N. L., Porchet, H., Sheiner, L. B., & Jacob, P. (1988). Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clinical Pharmacology & Therapeutics. https://doi.org/10.1038/clpt.1988.107
47. Benzeval, M., Bond, L., Campbell, M., Egan, M., Lorenc, T., Petticrew, M., & Popham, F. (2014). How does money influence health.
48. Berezhnova, I., Antonov, N. S., Sakharova, G. M., Donitova, V. V., Kotov, A. A., & Latif, E. (2014). ELECTRONIC CIGARETTE: ASSESSMENT OF SAFETY AND RISK FOR HEALTH. PULMONOLOGIYA. https://doi.org/10.18093/0869-0189-2014-0-3-122-127
49. Bergozza, L. (2001). Alcool, fumo, droghe.. No problem!. La percezione del rischio nell'adolescenza. S &amp; P SALUTE E PREVENZIONE.
50. Bergé, A. S., & Bustamante, R. M. (2021). Les altres dianes del trastorn per ús d'alcohol: Afectacions sitèmiques derivades del consum excessiu d'alcohol. Mètode: Revista de difusió de la investigació.
51. Bermúdez, J. L., Morales, Ó. A., & León, M. D. L. Á. H. (2017). Factores asociados al inicio del consumo de chimó. Acta Bioclínica.
52. Bertolotti, M., & Catellani, P. (2016). Salute o benessere? Effetti di framing nella comunicazione alimentare rivolta agli anziani. RICERCHE DI PSICOLOGIA. https://doi.org/10.3280/rip2016-001006
53. Bhalala, J. N. (2014). Stress Manage by Yoga. International Journal of Indian Psychology. https://doi.org/10.25215/0104.034
54. Billert, H., & Florek, E. (2010). Smoking cigarettes and other dependencies in pregnancy.
55. Bistuer, M. R. F., Herrero, M. T. V., Alberich, J., & López‐González, Á. A. (2014). Consumo de alcohol y comportamientos violentos. Aspectos médico-legales: una revisión desde la jurisprudencia española.
56. Bistuer, M. R.-F., Herrero, M. T. V., Alberich, J., & López‐González, Á. A. (2014). Consumo de alcohol y comportamientos violentos. Aspectos médico-legales: una revisión desde la jurisprudencia española.(Alcohol and violent behavior. Legal medical aspects: A review from the Spanish case law).
57. Bittoun, R., Borne, I. V. D., & Adriaanse, H. (1995). The Impact of Age on Smoking Cessation. Tobacco and Health. https://doi.org/10.1007/978-1-4615-1907-2_175
58. Blank, M. D., & Eissenberg, T. (2015). Commentary on Brose <i>et al</i>. (2015): Protecting individual and public health by regulating electronic cigarette nicotine delivery. Addiction. https://doi.org/10.1111/add.12955
59. Bobo, J. K., & Husten, C. G. (2000). Sociocultural influences on smoking and drinking.. PubMed.
60. Bobzien, M. J. (2023). A Systematic Review of Research to Determine Toxicity of Involuntary Tobacco Smoking as Compared to First Hand Smoking and if Chronic Involuntary Tobacco Smoking during Childhood Causes Skeletal Diseases Later in Life. Jurnal Teknokes. https://doi.org/10.35882/teknokes.v16i3.617
61. Bohn, A., Khodaee, M., & Schwenk, T. L. (2003). Ephedrine and Other Stimulants As Ergogenic Aids. Current Sports Medicine Reports. https://doi.org/10.1249/00149619-200308000-00009
62. Bolinder, G., & Gilljam, H. (2015). Smokeless Tobacco - Health Hazards or Less Harm?. Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research. https://doi.org/10.1159/000369503
63. Bona, C. M. D., Pazotti, A. F., Diniz, C., & Gaio, D. M. (2016). Prevenção de “recaída” em dependentes químicos. Anais do EVINCI - UniBrasil.
64. Bordbari, A., Soltani, M., Ashoori, Y., Najarcolaii, F. M., & Zakariaei, Z. (2025). Unwanted Clinical Complications Following the Consumption of <i>Death Coffee</i>: A Case Series. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.70013
65. Borniger, J. C., Don, R. F., Boyd, R. T., & Nelson, R. J. (2018). Do Cigarettes Have Long-lasting Effects on Children’s Sleep?. Frontiers for Young Minds. https://doi.org/10.3389/frym.2018.00007
66. Borrelli, B., Bartlett, Y. K., Tooley, E. M., Armitage, C. J., & Wearden, A. (2015). Prevalence and Frequency of mHealth and eHealth Use Among US and UK Smokers and Differences by Motivation to Quit. Journal of Medical Internet Research. https://doi.org/10.2196/jmir.4420
67. Boztaş, M. H., & Arısoy, Ö. (2010). Uçucu Madde Bağımlılığı ve Tıbbi Sonuçları. https://doi.org/10.18863/pgy.72420
68. Bradford, A. R., & Bradford, T. J. (2012). Health benefits of strength training.
69. Braun, H., Geyer, H., Burke, L. M., Stear, S. J., & Castell, L. M. (2011). A–Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 22. British Journal of Sports Medicine. https://doi.org/10.1136/bjsports-2011-090180
70. Braéckman, C. (2009). Un peu d’indulgence ! voyons !! ou Comment arrêter de fumer !.
71. Brenner-Hartmann, J. (2003). Drogen und Fahreignung - wann ist ein Kurs zur Wiederherstellung der Fahreignung sinnvoll und was kann er leisten? -.
72. Brigham, J. (1998). Dying to Quit: Why We Smoke and How We Stop.
73. Brincks, A. M., Perrino, T., Estrada, Y., & Prado, G. (2022). Preventing alcohol use among Hispanic adolescents through a family-based intervention: The role of parent alcohol misuse.. Journal of Family Psychology. https://doi.org/10.1037/fam0001038
74. Britton, J., Arnott, D., McNeill, A., & Hopkinson, N. S. (2016). Nicotine without smoke—putting electronic cigarettes in context. BMJ. https://doi.org/10.1136/bmj.i1745
75. Brnich, N., & Colombres, N. B. (2018). La previa”¿Fenómeno de tolerancia social?. Revista de la Facultad de Ciencias Médicas de Córdoba. https://doi.org/10.31053/1853.0605.v0.n0.21169
76. Broom, S. L., & Yamamoto, B. K. (2007). Role of norepinephrine in substance abuse. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544156.022
77. Broussard, B., & Compton, M. T. (2021). Staying Healthy. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190920685.003.0011
78. Bruijnzeel, A. W. (2024). Deciphering the Multidimensional Effects of Tobacco Smoke and E-cigarette Aerosol in Humans and Rodents: From Behavior to Inflammation and Beyond. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntae035
79. Buettner‐Schmidt, K., Swanson, K. M., Maack, B., Barnacle, M., Miller, D. R., Orr, M., & Gag, M. H. (2021). E-cigarettes for tobacco cessation. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000798228.69915.64
80. Buran, M., Phinney, K., & Samet, J. M. (2024). Tobacco Smoke. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780197662526.003.0027
81. Burch, J., & Martín-López, J. E. (2016). Clinical question: What are the effects of motivational interviewing for the prevention of alcohol misuse in young adults, mostly assessed as higher risk?.
82. Burch, J., & Tort, S. (2017). Clinical question: How does portion size or package or tableware size affect selection and consumption of food and tobacco?.
83. Byrne, J. J., & Saade, G. R. (2020). Smoking, Vaping, and Nicotine Exposure. https://doi.org/10.1002/9781119635307.ch2
84. Cabral, C. D. R., & Morais, I. C. O. D. (2019). TRATAMENTO FARMACOLÓGICO DA DEPENDÊNCIA DO ÁLCOOL. Mostra Científica da Farmácia.
85. Cabral, G. A. L., Curi, T. R. L., Abbas, N. A. B., Lacerda, J. S., Pereira, A. C., & Romualdo, G. S. (2020). A relação entre o uso da cannabis e o despertar de psicoses. Revista Brasileira Multidisciplinar. https://doi.org/10.25061/2527-2675/rebram/2020.v23i1.704
86. Calero, J. D. R., Rey, E. J. A. D., & Rey, M. (1998). El consumo de drogas por adolescentes y jóvenes. Tarbiya: Revista de investigación e innovación educativa.
87. Campbell, B., Wilborn, C., Bounty, P. L., Taylor, L., Nelson, M., Greenwood, M., Ziegenfuss, T. N., Lopez, H. L., Hoffman, J. R., Stout, J. R., Schmitz, S., Collins, R., Kalman, D., António, J., & Kreider, R. B. (2013). International Society of Sports Nutrition position stand: energy drinks. Journal of the International Society of Sports Nutrition. https://doi.org/10.1186/1550-2783-10-1
88. Canchy, L. (2020). Le choix de la cocaïne, une question de délai.
89. Caponnetto, P., Campagna, D., Papale, G., Russo, C., & Polosa, R. (2012). The emerging phenomenon of electronic cigarettes. Expert Review of Respiratory Medicine. https://doi.org/10.1586/ers.11.92
90. Caponnetto, P., Maglia, M., & Polosa, R. (2015). Commentary on Dawkins<i>et al</i>. (2015): Electronic cigarettes - from smoking cessation to smoking sensation and back. Addiction. https://doi.org/10.1111/add.12854
91. Carmo, J. T. D., Pueyo, A. A., & López, E. Á. (2005). La evolución del concepto de tabaquismo. Cadernos de Saúde Pública. https://doi.org/10.1590/s0102-311x2005000400002
92. Carrasco-Farfán, C. A., Quispe-Nolazco, C. M., Quispe-Nolazco, J. A., & Ávalos-Moreyra, L. (2015). Nuevas vías de administración de alcohol en adolescentes. Revista Peruana de Medicina Experimental y Salud Pública. https://doi.org/10.17843/rpmesp.2015.324.1779
93. Castiglione, L. M. B. (2016). Diabetes and Depression Cognitive Therapy. Journal of Diabetes Metabolic Disorders & Control. https://doi.org/10.15406/jdmdc.2016.03.00092
94. Castledine, S. G. (2008). The problems of alcohol and cigarette abuse: BJN100 years ago. British Journal of Nursing. https://doi.org/10.12968/bjon.2008.17.19.31463
95. Cattacin, S. (2012). Spielräume und Regulierungen in einer berauschenden Gesellschaft. Seismo eBooks.
96. Cañarte-Quimis, J. G., Villarreal-Calderón, L. A., & Villigua-Pincay, D. F. (2023). Prevención del consumo de estupefacientes y otras adicciones. MQRInvestigar. https://doi.org/10.56048/mqr20225.7.4.2023.589-609
97. Cerny, T. (2002). The War against Nicotine and Tobacco: New Tools?. Oncology Research and Treatment. https://doi.org/10.1159/000067432
98. Cerny, T., & Cerný, E. (2009). Vaccines against nicotine. Human Vaccines. https://doi.org/10.4161/hv.5.4.7310
99. Ceylan, N., Özdemir, F. M. A., Çelık, H. İ., Azapağası, E., Yazıcı, M. U., & Yüksel, D. (2020). A rare case of intoxication related to concurrent exposure to butane gas and energy drink. Journal of Substance Use. https://doi.org/10.1080/14659891.2020.1821804
100. Chaffee, B. W., Castillo, C. G., Couch, E. T., Urata, J., Halpern‐Felsher, B., & Hoeft, K. S. (2024). Adolescents’ Perceptions, Experiences, and Reactions to “Fake” Vaping Devices. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2024.112534
101. Chaffee, B. W., Couch, E. T., & Walsh, M. (2015). Smokeless Tobacco in Sport and Use Among Adolescents.
102. Chaffee, B. W., Couch, E. T., & Walsh, M. (2015). Smokeless Tobacco in Sport and Use Among Adolescents. RePEc: Research Papers in Economics.
103. Chaitanya, B. K., & Madhuri, I. (2021). EFFECT OF ORAL TOBACCO ON VITAL DATA. Indian Journal Of Applied Research. https://doi.org/10.36106/ijar/4101865
104. Chassin, L., Presson, C. C., Sherman, S. J., & Kim, K. (2002). Long-term psychological sequelae of smoking cessation and relapse.. Health Psychology. https://doi.org/10.1037//0278-6133.21.5.438
105. Chaturvedi, A., Chaturvedi, H., Kalra, J., & Kalra, S. (2008). Doping droops.. PubMed.
106. Chellian, R., Behnood‐Rod, A., & Bruijnzeel, A. W. (2022). Development of Dependence in Smokers and Rodents With Voluntary Nicotine Intake: Similarities and Differences. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntac280
107. Chiamulera, C., Leone, R., & Fumagalli, G. F. (2007). Smokeless tobacco use in sports: ‘legal doping’?. Addiction. https://doi.org/10.1111/j.1360-0443.2007.01993.x
108. Choi, N. G., & DiNitto, D. M. (2014). Role of New Diagnosis, Social Isolation, and Depression in Older Adults’ Smoking Cessation. The Gerontologist. https://doi.org/10.1093/geront/gnu049
109. Choudhury, R. S. (2021). Body Image Concerns, Unhealthy Weight Control Behaviors in Teenagers and the Role of Tobacco Policy. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.4168248
110. Clemente, L. F., Trullén, A. P., & Blázquez, C. M. (2001). Terapias psicológicas en la deshabituación tabáquica. Psiquis: Revista de psiquiatría, psicología médica y psicosomática.
111. Cm, N., & Ac, V. B. (2016). [Refeeding in a teenager with an eating disorder; when the patient refuses, but the doctor is obliged to intervene].. PubMed.
112. Coambs, R. B., Jarry, J. L., Polivy, J., & Herman, C. P. (1998). Weight gain after smoking cessation in women: The impact of dieting status. International Journal of Eating Disorders. https://doi.org/10.1002/(sici)1098-108x(199807)24:1<53::aid-eat5>3.0.co;2-
113. Cobb, C. O., Hendricks, P. S., & Eissenberg, T. (2015). Electronic cigarettes and nicotine dependence: evolving products, evolving problems. BMC Medicine. https://doi.org/10.1186/s12916-015-0355-y
114. Coelho, D. P., Marongio, I. S., Nascimento, M. E. M. F., Barboza, V. A. N., Félix, L. F., Marques, L. V. D. S., & Garcia, S. C. M. (2024). O uso de cigarros eletrônicos atrelado a infecções pulmonares em jovens. Congresso Médico Acadêmico UniFOA.. https://doi.org/10.47385/cmedunifoa.1576.10.2024
115. Compton, M. T., & Broussard, B. (2010). Staying Healthy. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0020
116. Cornish, J., & O’Brien, C. P. (1996). Crack Cocaine Abuse: An Epidemic with Many Public Health Consequences. Annual Review of Public Health. https://doi.org/10.1146/annurev.pu.17.050196.001355
117. Correa, A. L. N., & Tumelero, S. (2005). Capacidade de VO2 máximo para indivíduos fumantes e não fumantes durante o exercício físico. Lecturas: Educación física y deportes.
118. Corsino, L., Svetkey, L. P., Ayotte, B. J., & Bosworth, H. B. (2009). Patient Characteristics Associated with Receipt of Lifestyle Behavior Advice. North Carolina Medical Journal. https://doi.org/10.18043/ncm.70.5.391
119. Costa, J. L. D., Aguiar, D. M. D., & Souto, Á. D. O. (2019). As consequências sociais, familiares, físicas e psíquicas do dependente de álcool.
120. Costes, J.-M., Bello, P., & Palle, C. (2003). [Addictions in France: current status].. PubMed.
121. Courte, W. P., Costa, L. V. M., Lara, F. P. L., Lourenço, H. L. D. O., Coppolla, M. B., Duarte, V. C., Parreira, S. A., & Souza, J. B. N. D. (2023). O uso prolongado do tabaco e suas consequências: uma revisão literária. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n6-010
122. Courtwright, D. T. (2003). Public health and drugs: why is policy so persistently irrational?. Addiction. https://doi.org/10.1046/j.1360-0443.2003.00434.x
123. Covey, L. S., Joseph, A. M., & Shoptaw, S. (2003). Response: Getting Tough With Smoking. Science & Practice Perspectives. https://doi.org/10.1151/spp032140
124. Cruz, J. A. V., & Ruiz, B. P. C. (2018). Inmunoterapia y Vacuna en Trastornos por Consumo de Sustancias (Drogas Ilícitas). Revista Médica del Hospital José Carrasco Arteaga. https://doi.org/10.14410/2018.10.1.rb.11
125. Ctm, S., & Schoemaker, C. (2008). Spelen met gezondheid. Leefstijl en psychische gezondheid van de Nederlandse jeugd.
126. Cummings, J. R. (2018). Leveraging Rewards to Reduce Health-Compromising Behavior.
127. Curicho-Casco, J. V., Acosta-Salas, E. N., García-Villacrés, J. A., & Benites, R. M. (2024). El alcohol y los tejidos bucodentales. Revista Arbitrada Interdisciplinaria de Ciencias de la Salud Salud y Vida. https://doi.org/10.35381/s.v.v8i1.3890
128. Currarini, S., Fumagalli, E., & Panebianco, F. (2013). Smoking and Social Interaction. SSRN Electronic Journal.
129. Currarini, S., Fumagalli, E., & Panebianco, F. (2013). Smoking and Social Interactions. Review of Environment, Energy and Economics - Re.
130. Cuthbertson, L., & Britton, J. (2010). Passive smoking and children’s health. Clinical Medicine. https://doi.org/10.7861/clinmedicine.10-2-113
131. Dadi, S. (2015). Smoking and its Effects on Men?s Sexual Health. Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences.
132. Dahlgren, A., Lidal, I. B., Mosdøl, A., Odgaard‐Jensen, J., Denison, E., & Vist, G. E. (2015). Effects of Information and Other Communication Initiatives on Physical Activity with One or More Other Lifestyle Habits Targeting the General Population [Internet].
133. Darabseh, M. Z., Selfe, J., Morse, C. I., & Degens, H. (2020). Is vaping better than smoking for cardiorespiratory and muscle function?. Multidisciplinary Respiratory Medicine. https://doi.org/10.4081/mrm.2020.674
134. Das, S., Vk, S., & Vardhan, A. (2016). Electronic cigarettes: Human Friend or Foe. International Journal of Current Research in Medical Sciences. https://doi.org/10.22192/ijcrms.2016.02.12.004
135. Davis, C. N., Ramer, N. E., Squeglia, L. M., Gex, K. S., McRae‐Clark, A. L., McKee, S. A., Roberts, W., Gray, K. M., Baker, N. L., & Tomko, R. L. (2024). Alcohol use and cannabis craving in daily life: Sex differences and associations among young adults. Alcohol Clinical and Experimental Research. https://doi.org/10.1111/acer.15461
136. Deehan, G. A., Waeiss, R. A., Hauser, S. R., Engleman, E. A., McBride, W. J., & Rodd, Z. A. (2015). SY18EVERYTHING MIXES WITH ALCOHOL: RECENT ADVANCES IN THE STUDY OF ALCOHOL POLYDRUG USESY18-1THE CO-ABUSE OF ALCOHOL AND NICOTINE: EXAMINING THE UNDERLYING BEHAVIORAL AND NEUROBIOLOGICAL MECHANISMS. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agv076.74
137. Delle, S., Kraus, L., Maspero, S., Pogarell, O., Hoch, E., & Lochbühler, K. (2024). Long-Term Effectiveness of a Quitline for Smoking Cessation: Results of a Randomized Controlled Trial. European Addiction Research. https://doi.org/10.1159/000541682
138. Delás, J., Blanqué, J. M., & González, V. B. (2010). El cannabis y sus peligros. El Ciervo: revista mensual de pensamiento y cultura.
139. Devalcheruvu, R. D., & Nalli, V. (2007). The Pharmacotherapy Of Smoking Cessation.
140. Dilber, D., Barić, H., Novinščak, T., & Čerkez-Habek, J. (2016). Herbal incense-related sudden death: case report. Journal of Substance Use. https://doi.org/10.3109/14659891.2016.1162212
141. Diniz, M. C. C., Vasconcelos, A. G. L. D., Monteiro, V. M., & Hartmann, C. (2007). CURRENT CONSIDERATIONS ABOUT DOPING. Fiep Bulletin - online.
142. Dix, B., Görner, K., Błeńska, M., Kortas, J., & Żukow, W. (2013). Nordic Walking jako forma aktywności dla ludzi w różnym wieku.
143. Dom, G. (2025). Alcohol and nicotine: quitting both or keep smoking?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2025.150
144. Donghi, A., & Alcaraz, L. (2007). DE LA COCAÍNA A LA ANOREXIA... ABSTINENCIA DE TODO. XIV Jornadas de Investigación y Tercer Encuentro de Investigadores en Psicología del Mercosur.
145. Doran, N., Myers, M. G., Luczak, S. E., Trim, R. S., Strong, D. R., & Tully, L. (2022). Non-daily Cigarette Smoking: Stability and Transition to Abstinence in Young Adults. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntac189
146. Douglass, R. S., & Heckman, G. (2010). Drug-related taste disturbance: a contributing factor in geriatric syndromes.. PubMed.
147. Drach, L. L., Maher, J. E., Braun, M. J. F., Murray, S. L., & Sazie, E. (2016). Substance Use, Disordered Eating, and Weight Gain. Journal of Correctional Health Care. https://doi.org/10.1177/1078345816634692
148. Drewe, J. (2003). Erwünschte und unerwünschte Wirkungen des Cannabiskonsums. Therapeutische Umschau. https://doi.org/10.1024/0040-5930.60.6.313
149. Duarte, G. R., Oliveira, J. V. R. D., & Silva, U. O. D. (2021). TABAGISMO: UM DESAFIO A SE PERFAZER. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. https://doi.org/10.47820/recima21.v2i10.805
150. Dubrosa, F., Sangiuolo, K., Franco, J., & Milanaik, R. (2023). Quick nic: novel smokeless nicotine products and pediatric trends. Current Opinion in Pediatrics. https://doi.org/10.1097/mop.0000000000001270
151. Dunbar, G. C., Morgan, D. D. V., & Perera, K. M. H. (1988). The Concurrent Use of Alcohol, Cigarettes and Caffeine in British Benzodiazepine Users as Measured by a General Population Survey. British Journal of Addiction. https://doi.org/10.1111/j.1360-0443.1988.tb02599.x
152. Dutra, R. F., Marques, F. E. M., & Matos, L. D. N. J. D. (2022). A Ação da Bebida Energética na Frequência Cardíaca de Recuperação Independe da Capacidade Funcional. Arquivos Brasileiros de Cardiologia. https://doi.org/10.36660/abc.20220596
153. Díaz-Jiménez, R., García‐Portilla, M. P., García-Álvarez, L., & Bobes, J. (2012). Impacto del tabaquismo en el trastorno bipolar.
154. Edwards, G., Marshall, E. J., & Cook, C. C. H. (2003). Alcohol and other drug problems. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543722.011
155. Edwards, R. (2019). Hardening is dead, long live softening; time to focus on reducing disparities in smoking. Tobacco Control. https://doi.org/10.1136/tobaccocontrol-2019-055067
156. Edwards, R. W., Oetting, E. R., & Beauvais, F. (1989). Drugs and Native-American Youth. Drugs & Society. https://doi.org/10.1300/j023v03n01_01
157. Eidelwein, G. C., Araújo, R. B., & Borba, L. R. (2012). A prática do mindfulness em grupo para dependentes de crack internados.
158. Einon, C. (2010). Chapter 13 Smoking cessation and mental illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199556250.003.0013
159. Eisen, L., Field, T., & Larson, S. (2019). Environmental Effects on the Fetus: The Examples of Alcohol, Cocaine, and Exercise. Taylor & Francis eBooks. https://doi.org/10.4324/9781315792194-4
160. Ekblom‐Bak, E., Ekblom, B., & Hellénius, M.-L. (2010). Minskat stillasittande lika viktigt som ökad fysisk aktivitet : [Less sitting as important as increased physical activity]. Läkartidningen/Läkartidningen.
161. Elhefny, R., Chaouch, M. A., Elessawy, A. F., & El-rab, E. G. (2016). Are we with e-cigarette as a friend or against it as a foe?. Egyptian Journal of Bronchology. https://doi.org/10.4103/1687-8426.193630
162. Enos, G. (2020). COMBINE follow‐up: Some heavy use of alcohol compatible with recovery. Alcoholism & Drug Abuse Weekly. https://doi.org/10.1002/adaw.32806
163. Ericsdotter, F. A., & Safi, S. N. (2015). Äta för att leva.
164. Espada, J. P., Pereira, J. R., & García-Fernández, J. M. (2016). Modelos sociales y consumo de alcohol en la adolescencia. Jano: Medicina y humanidades.
165. Estapà, J. C. (2009). Alimentación y ejercicio: el mejor cumpleaños de la diabetes. Diabéticos: Presente y futuro.
166. Eversman, M. H. (2015). Tobacco Harm Reduction: An Emerging Health Issue for Social Work. Journal of Social Work Practice in the Addictions. https://doi.org/10.1080/1533256x.2015.1091001
167. Fagerström, K. (2002). Quit or Die: Nothing in between?. Respiration. https://doi.org/10.1159/000064017
168. Fagerström, K. O. (1999). Interventions for treatment-resistant smokers. Nicotine & Tobacco Research. https://doi.org/10.1080/14622299050012071
169. Fagerström, K. O., & Bridgman, K. M. (2013). Tobacco harm reduction: The need for new products that can compete with cigarettes. Addictive Behaviors. https://doi.org/10.1016/j.addbeh.2013.11.002
170. Fahey, M. C., Little, M. A., Klesges, R. C., Talcott, G. W., Richey, P. A., Mehmet, K., & Krukowski, R. A. (2020). Use of Tobacco for Weight Control across Products among Young Adults in the U.S. Military. Substance Use & Misuse. https://doi.org/10.1080/10826084.2020.1846196
171. Falkin, G. P., Fryer, C. S., & Mahadeo, M. (2007). Smoking Cessation and Stress Among Teenagers. Qualitative Health Research. https://doi.org/10.1177/1049732307303384
172. Farisi, M. F. A., Pratiwi, R. P., Firmansyah, M. F., Isnaini, M. I., & Sarman, F. (2022). Dampak Mengkonsumsi Alkohol terhadap Perilaku Sosial Remaja. Biblio Couns Jurnal Kajian Konseling dan Pendidikan. https://doi.org/10.30596/bibliocouns.v5i2.10390
173. Farne, H., Norris-Cervetto, E., & Warbrick‐Smith, J. (2015). Haemoptysis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198716228.003.0014
174. Farrell, B., Shamji, S., Monahan, A., & Merkley, V. F. (2013). Reducing polypharmacy in the elderly. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. https://doi.org/10.1177/1715163513499530
175. Farsalinos, K., & LeHouezec, J. (2015). Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes). Risk Management and Healthcare Policy. https://doi.org/10.2147/rmhp.s62116
176. Farsalinos, K., Voudris, V., & Houezec, J. L. (2014). Risks of Attempting to Regulate Nicotine Flux in Electronic Cigarettes. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntu207
177. Faus, A. F. (2015). Análogos de las benztropinas como agentes terapéuticos para la adicción a la cocaína: Estudios preclínicos en modelos animales de conducta adictiva.
178. Fernández, M. D. F., & Ubago, J. G. (2008). Síndrome de dependencia del alcohol. Jano: Medicina y humanidades.
179. Ferreira, J. C. M., & Alves, J. C. B. (2009). ALCOOLISMO: DA DEPENDÊNCIA AOS BENEFÍCIOS DA ATIVIDADE FÍSICA. Fiep Bulletin - online.
180. Ferreira, M. P. A., Lessa, G. P. D. S. S., Gomes, J. M., Gonçalves, G. J. S., Canuto, R. T. A., Costa, M. V., Santos, G. S. D., Vasconcelos, G. H. D. F., Bezerra, J. V. A., Silva, R., Ferreira, I. D. M. L. M., Oliveira, M. A. J. D., & Silva, J. C. D. (2024). Impactos do cigarro eletrônico em adolescentes e adultos entre os anos de 2021 e 2023. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv7n3-454
181. Fidan, F., Pala, E., Ünlü, M., Sezer, M., & Kara, Z. (2015). Sigara Bırakmayı Etkileyen Faktörler ve Uygulanan Tedavilerin Başarı Oranları. DergiPark (Istanbul University). https://doi.org/10.18229/ktd.62331
182. Figueira, J. A. V., Valdevila-Santiesteban, R., Orellana-Román, C., Estrella-Almeida, D., & Vázquez, M. P. (2021). El problema del uso indebido de drogas en Ecuador. Correo Científico Médico.
183. Finkelstein, A., Rotman, E., Eisenkraft, A., Krivoy, A., Laish, I., Tashma, Z., Hoffman, A., & Yehezkelli, Y. (2005). [Political poisoning with dioxins--a weapon of chemical "disgracefulness"].. PubMed.
184. Fitriana, K. R. (2019). Efek Konsumsi Alkohol dan Merokok Pada Wanita Hamil. https://doi.org/10.35816/jiskh.v10i2.159
185. Flannery, D., Sisk-Franco, C., & Glover, P. N. (1995). The Conflict of Tobacco Education Among American Indians: Traditional Practice or Health Risk?. Tobacco and Health. https://doi.org/10.1007/978-1-4615-1907-2_203
186. Flynn, R. (2015). Street drug abuse and diabetes : living with diabetes.
187. Fogiel, O., Rak, M., Picheta, S., Wachholz, P., Skowronek, R., Anand, J. S., & Pawlas, N. (2024). Fatal poisoning by dietary supplements accompanied by massive rhabdomyolysis and multiple organ failure = Śmiertelne zatrucie suplementami diety przebiegające z masywną rabdomiolizą i niewydolnością wielonarządową. Archives of Forensic Medicine and Criminology. https://doi.org/10.4467/16891716amsik.24.012.20341
188. Folgar, M. I., Liñares, D., Ferreiro, S. G., Salgado, P. G., & Boubeta, A. R. (2021). Evaluación del Consumo de Drogas en Adolescentes con y sin TDAH. Nuevas Evidencias y Recomendaciones. Revista Iberoamericana de Diagnóstico y Evaluación - e Avaliação Psicológica. https://doi.org/10.21865/ridep60.3.04
189. Fonseca, A. C., & Simões, M. C. T. (2010). Os malefícios do tabaco na infância e na adolescência. Revista Portuguesa de Pedagogia. https://doi.org/10.14195/1647-8614_44-1_9
190. Forti, M. D., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O’Connor, J., Russo, M., Stilo, S. A., Marques, T. R., Mondelli, V., Dazzan, P., Pariante, C. M., David, A. S., Gaughran, F., Atakan, Z., Iyegbe, C., ... Murray, R. (2015). Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(14)00117-5
191. Frankenburg, F. R. (2021). One Fictional Opioid Overdose in Eighteenth-century England and One Attempted Opioid Overdose in Nineteenth-century America. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000923
192. Frazee, S. G., Muzina, D. J., & Nease, R. F. (2014). Strategies to Overcome Medication Nonadherence. JAMA. https://doi.org/10.1001/jama.2014.1760
193. FRCPEd, J. C. K. M., & Simpson, D. (2002). Tobacco: a Global Threat.
194. Frey, B. S., Benesch, C., & Stutzer, A. (2005). Does Watching TV Make Us Happy. RePEc: Research Papers in Economics.
195. Frey, B. S., Benesch, C., & Stutzer, A. (2005). Does Watching TV Make Us Happy?. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.774684
196. Frisher, M., & Wilson, H. (2006). Drug use desistance. Criminology & Criminal Justice. https://doi.org/10.1177/1748895806060670
197. Frohlich, K. L. (2008). Is tobacco use a disease?. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.080545
198. Frye, C. C. J., Rung, J. M., Nall, R. W., Galizio, A., Haynes, J. M., & Odum, A. L. (2018). Continuous nicotine exposure does not affect resurgence of alcohol seeking in rats. PLoS ONE. https://doi.org/10.1371/journal.pone.0202230
199. Gabriel, M. G., Mondon, M. A., Pleguezuelos, A. L., Arnau, M. M., Gálvez, M. M., & Vehils, S. M. (2019). Abordatge del tabaquisme a l’hospital de dia de salut mental. Ágora de enfermería.
200. Gache, P., & Wenger, O. (2003). La transmission familiale de l‘alcoolisme : mythe ou réalité ¿. Hépato-Gastro & Oncologie Digestive.
201. Gaiha, S. M., & Halpern‐Felsher, B. (2020). Public Health Considerations for Adolescent Initiation of Electronic Cigarettes. PEDIATRICS. https://doi.org/10.1542/peds.2019-2056e
202. Galaj, E., Barrera, E. D., Morris, D., Ma, Y., & Ranaldi, R. (2020). Aberrations in Incentive Learning and Responding to Heroin in Male Rats After Adolescent or Adult Chronic Binge‐Like Alcohol Exposure. Alcoholism Clinical and Experimental Research. https://doi.org/10.1111/acer.14341
203. Galanti, L. (2006). [Tobacco use treatment].. PubMed.
204. Galera, S. A. F. (2013). El enfrentamiento al uso del crack.
205. Galvis-Blanco, S. J., Morales, O., Cuellar-Santaella, M. C.-S., Mira-Morales, M., & Sánchez-Villa, S. (2023). Cigarrillos Electrónicos y vaping en adolescentes: estado del arte. IATREIA. https://doi.org/10.17533/udea.iatreia.240
206. Galán, R., Gómez, M. J. L., & Chaves, M. J. G. (2003). Jóvenes y uso de drogas en un área de salud de Extremadura. Metas de Enfermería.
207. García, A. M. (2016). Efectos a largo plazo de la exposición al alcohol y a la cocaína durante la adolescencia en modelos animales: factores de riesgo y posibles tratamientos en la adicción a la cocaína.
208. García, G. M. R. (2014). Regulaciones que hacen humo:los males de una excesiva regulación contra los cigarrillos. Revista de Economía y Derecho.
209. García-Hjarles, M. A. (2015). Estilo de vida y salud reproductiva. Universidad de San Martín de Porres – USMP.
210. Gawin, F. H. (1991). Cocaine Addiction: Psychology and Neurophysiology. Science. https://doi.org/10.1126/science.2011738
211. Gcw, W.-V., Hsj, P., Bm, V. G., Mar, T., & Droomers, M. (2008). Meervoudig ongezond gedrag in Nederland: Een exploratie van risicogroepen en samenhang met omgeving, gezondheid en zorggebruik.
212. George, A., & Waller, G. (2005). Motivators for smoking in women with eating disorders. European Eating Disorders Review. https://doi.org/10.1002/erv.623
213. Gerada, C., & Ashworth, M. (1997). ABC of mental health: Addiction and dependence II: Alcohol. BMJ. https://doi.org/10.1136/bmj.315.7104.358
214. Gerada, C., & Ashworth, M. T. (1997). ABC of mental health: Addiction and dependence I: Illicit drugs. BMJ. https://doi.org/10.1136/bmj.315.7103.297
215. Gerson, M. (2015). Cigarette électronique vs substituts nicotiniques. Médecine.
216. Gil, F. G., Andrade, A. G. D., & Castaldelli-Maia, J. M. (2016). Discussing prevalence, impacts, and treatment of substance use disorders in athletes. International Review of Psychiatry. https://doi.org/10.1080/09540261.2016.1212821
217. Gil-Antuñano, N. P., & Pérez-Sevillano, F. G. (2010). Alimentación, nutrición, hidratación y ejercicio físico.
218. Giovacchini, C. X., Alexander, L. E. C., & Que, L. G. (2022). Electronic Cigarettes: A Pro–Con Review of the Current Literature. The Journal of Allergy and Clinical Immunology In Practice. https://doi.org/10.1016/j.jaip.2022.07.009
219. Giovannoni, M. L. (2017). Hábitos masticatorios como factores de riesgo de la enfermedad periodontal en una población del Sur de la India. TDX (Tesis Doctorals en Xarxa).
220. Girma, S. (2013). Socio - Economic Consequences of Alcoholism in Addis Ababa City. LAP LAMBERT Academic Publishing eBooks.
221. Glasner, S. (2024). What Do Nicotine and Tobacco Do to the Brain and Behavior?. Addiction. https://doi.org/10.1093/wentk/9780190946555.003.0005
222. Glazier, K. (2010). Tobacco-induced diseases: An emphasis on mental health conditions that may result from cigarette use. PsycEXTRA Dataset. https://doi.org/10.1037/e741462011-007
223. Glover, M., Breier, B. H., & Bauld, L. (2016). Could Vaping be a New Weapon in the Battle of the Bulge?. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntw278
224. Goedert, G. R., Silva, I. H., BARON, J., Ascoli, K. G., Daniel, M. M., ALTHAUS, M. C., & Machado, K. (2022). Cigarro Eletrônico Entre os Jovens: Consumo, Influência Midiática e Políticas Públicas. Revista InterAção. https://doi.org/10.47296/interao.v3i1.326
225. Goldman, D., & Barr, C. S. (2002). Restoring the Addicted Brain. New England Journal of Medicine. https://doi.org/10.1056/nejmcibr021948
226. Goldstein, R. Z. (2008). Self-Control in Cocaine Addiction (440th Brookhaven Lecture).
227. Gonidakis, F. (2015). Compulsive Bowel Emptying and Rectal Prolapse in Eating Disorders. Presentation of Two Cases. Archives of Depression and Anxiety. https://doi.org/10.17352/2455-5460.000005
228. Goniewicz, M. Ł. (2015). Abstract CN02-03: Quitting or switching? Health benefits and risk of electronic cigarettes. Cancer Prevention Research. https://doi.org/10.1158/1940-6215.prev-14-cn02-03
229. González‐Ponce, B. M., Sánchez, D. D., Pachón, M. P. C., Cáceres, A. D. L. R., & Fernández‐Calderón, F. (2019). Estudio fiesta y drogas: rasgos de personalidad y consumo de drogas entre asistentes a festivales de música.
230. Goodyer, P. (2013). The pleasure dilemma. Of Substance: The National Magazine on Alcohol, Tobacco and Other Drugs.
231. Gordo, P. M. (2015). Consumo intensivo de alcohol y actividad prefrontal en adolescentes: impulsividad y control ejecutivo.
232. Gorini, G. (2015). [Tobacco control experience in the debate on marijuana legalisation].. PubMed.
233. Gorny, S. W. (1994). Inhalant Abuse as an Adolescent Drug Problem: An.
234. Gossop, M. (2013). Alcohol, still the forgotten drug. Addiction. https://doi.org/10.1111/add.12045
235. Gottlieb, J. D., & Evins, A. E. (2007). How to Treat Nicotine Dependence in Smokers with Schizophrenia: Improve Patients' Health, Help Them Kick Addiction with This Practical Approach. Current psychiatry.
236. Graham, K., Carver, V., & Brett, P. J. (1995). Alcohol and Drug Use by Older Women: Results of a National Survey. Canadian Journal on Aging / La Revue canadienne du vieillissement. https://doi.org/10.1017/s0714980800016457
237. Granados-Sánchez, J. L., Andrade-Tun, E. L., & Serrano-Bores, Ú. G. (2020). El consumo de tabaco en estudiantes del turno vespertino de la carrera de seguridad pública de la universidad de quintana roo, campus Chetumal.. Vinculatégica EFAN. https://doi.org/10.29105/vtga6.2-547
238. Grant, C. N., & Bélanger, R. E. (2017). Cannabis and Canada’s children and youth. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxx017
239. Grant, C. N., & Bélanger, R. E. (2017). Le cannabis et les enfants et adolescents canadiens. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxx018
240. Graul, J. M. (2014). Einfluss des Rauchens auf das Riechvermögen des Menschen.
241. Grave, R. D. (2024). The Benefit of Healthy Lifestyle in the Era of New Medications to Treat Obesity. Diabetes Metabolic Syndrome and Obesity. https://doi.org/10.2147/dmso.s447582
242. Grief, S. N., & Miranda, R. L. (2010). Weight loss maintenance.. PubMed.
243. Griffith, C. (2018). Genetics, Inheritability Factors and Addiction. Clinical & Medical Biochemistry Open Access. https://doi.org/10.4172/2471-2663.1000143
244. Grigoryev, K., Vykhristyuk, O., & Grigoryev, A. I. (2024). Vaping, as a reincarnation of smoking, requires solving the problem of harm to health in essence. Meditsinskaya sestra. https://doi.org/10.29296/25879979-2024-05-01
245. Groenewoud, J., Lange, J. D., & Bosch, H. I. D. (2009). Omgaan met afweergedrag bij eten en drinken van bewoners met dementie.
246. Groner, J. A., Walley, S. C., Etzel, R. A., Wilson, K. M., Farber, H. J., Balk, S. J., & Moore, J. E. (2015). Public Policy to Protect Children From Tobacco, Nicotine, and Tobacco Smoke. PEDIATRICS. https://doi.org/10.1542/peds.2015-3109
247. Grzybowski, A., & Dziuda, M. R. (1999). [Cotinine--the biomarker of exposure to tobacco smoke].. PubMed.
248. Guardia, L. D., Cavallaro, M., & Cena, H. (2015). The risks of self-made diets: the case of an amateur bodybuilder. Journal of the International Society of Sports Nutrition. https://doi.org/10.1186/s12970-015-0077-8
249. Gupta, C., & Prakash, D. (2020). Nutraceutical Intervention for Treatment of Alcoholism and Drinking Problems. Apple Academic Press eBooks. https://doi.org/10.1201/9780367821517-15
250. Guzmán, J. L. (2010). Dopaje: premisas para la valoración ética. Aula de la farmacia: revista profesional de formación continuada.
251. Gómez, A. P. (1995). Adicción y enfermedad: mito y realidad.
252. Gómez, M. P., & Flores, L. G. A. (1998). Efectos sobre la salud de la exposición crónica al humo del tabaco en fumadores y no fumadores.
253. Gürses, M. S., Türkmen, N., Eren, B., Çeti̇n, S., & Gündoğmuş, Ü. N. (2014). Death due to combined intake of ethanol and toluene: a case report.. PubMed.
254. Hanewinkel, R., & Ulbricht, S. (2024). Beabsichtigte und unbeabsichtigte Wirkungen von E-Zigaretten in klinischen Studien – ein Plädoyer für (mehr) Transparenz. Pneumologie. https://doi.org/10.1055/a-2243-9399
255. Hans, S. L. (1994). Sex Differences in Children of Substance-Abusing Parents. Humana Press eBooks. https://doi.org/10.1007/978-1-4612-0299-8_18
256. Harlow, A. F., Vogel, E. A., Tackett, A. P., Cho, J., Han, D., Wong, M., Cockburn, M., Sussman, S., Unger, J. B., Leventhal, A. M., & Barrington‐Trimis, J. L. (2023). Adolescent Use of Flavored Non-Tobacco Oral Nicotine Products. American Academy of Pediatrics eBooks. https://doi.org/10.1542/9781610027052-part01-adolescent
257. Hartmann‐Boyce, J., & Aveyard, P. (2016). Drugs for smoking cessation. BMJ. https://doi.org/10.1136/bmj.i571
258. Harvey, J., & Chadi, N. (2016). Preventing smoking in children and adolescents: Recommendations for practice and policy. Paediatrics & Child Health. https://doi.org/10.1093/pch/21.4.209
259. Hasanah, H. (2014). BABY SMOKER: PERILAKU KONSUMSI ROKOK PADA ANAK DAN STRATEGI DAKWAHNYA. Sawwa Jurnal Studi Gender. https://doi.org/10.21580/sa.v9i2.635
260. Hałasiński, P., Musielak, M., & Piotrowski, I. (2022). Napoje energetyczne wśród młodzieży — tendencja i mechanizmy farmakologiczne niekorzystnego wpływu na układ sercowo-naczyniowy. Przegląd literatury. Folia Cardiologica. https://doi.org/10.5603/fc.a2022.0013
261. He, J. (2008). A Review of Pharmacotherapy for Treating Tobacoo Use and Dependence. Medicine & Philosophy(Clinical Decision Making Forum Edition).
262. Hedaoo, S. A., & Mahapatra, D. K. (2020). Exploring the Hidden Ethnobotanical Treasures for Treating or Managing Chronic Alcoholism. Apple Academic Press eBooks. https://doi.org/10.1201/9781003057932-2
263. Heffner, J. L., & Anthenelli, R. M. (2011). Strategies to Help Patients Break the Chains of Tobacco Addiction: Evidence-Based Treatments Can Help Patients Quit despite Psychiatric Illness. Current psychiatry.
264. Heikkinen, A. M., Leknes, K. N., Gustafsson, A., Damgaard, C., & Bunæs, D. F. (2022). Áhrif tóbaksvara á heilbrigði tannhalds og niðurstöður tannhaldsmeðferðar. Tannlæknablaðið. https://doi.org/10.33112/tann.40.2.3
265. Heishman, S. J. (1999). Behavioral and cognitive effects of smoking: Relationship to nicotine addiction. Nicotine & Tobacco Research. https://doi.org/10.1080/14622299050011971
266. Henkin, R. I. (2015). Taste and Smell Dysfunction in the United States. Journal of Otology & Rhinology. https://doi.org/10.4172/2324-8785.1000e107
267. Henningfield, J. E., & Jude, N. O. (1999). Prevention of nicotine addiction: Neuropsychopharmacological issues. Nicotine & Tobacco Research. https://doi.org/10.1080/14622299050011581
268. Henningfield, J. E., Cohen, C., & SLADE, J. D. (1991). Is nicotine more addictive than cocaine?. British Journal of Addiction. https://doi.org/10.1111/j.1360-0443.1991.tb01809.x
269. Henningfield, J. E., Schuh, L. M., & Heishman, S. J. (1995). Pharmacological Determinants of Cigarette Smoking. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7445-8_32
270. Henry, S. L., Jamner, L. D., & Whalen, C. K. (2012). I (should) Need a Cigarette: Adolescent Social Anxiety and Cigarette Smoking. Annals of Behavioral Medicine. https://doi.org/10.1007/s12160-011-9340-7
271. Herdener, M., Esposito, F., Hänggi, J., Preller, K. H., Stämpfli, P., Kirschner, M., Seifritz, E., & Quednow, B. (2015). Structural and functional brain changes in chronic cocaine users. Suchttherapie. https://doi.org/10.1055/s-0035-1557702
272. Hernández‐Pérez, A., García‐Gómez, L., Robles‐Hernández, R., Thirión-Romero, I., Osio-Echánove, J., Rodríguez‐Llamazares, S., Baler, R., & Pérez‐Padilla, R. (2023). Addiction to tobacco smoking and vaping. Revista de investigaci�n Cl�nica. https://doi.org/10.24875/ric.23000117
273. Hesami, Z., Alvanpour, A., Sharif-Kashani, B., Tafti, S. F., & Heydari, G. (2010). Severity of Nicotine Withdrawal Symptoms after Smoking Cessation.
274. Hesse, M. (2010). Enhancement drugs: are there limits to what we should enhance and why?. BMC Medicine. https://doi.org/10.1186/1741-7015-8-50
275. Hidalgo, L. F. (2015). El tabaco como factor de riesgo en el cáncer de pulmón. Nuberos científica.
276. Hillson, R. (2018). Urinary symptoms in diabetes. Practical Diabetes. https://doi.org/10.1002/pdi.2167
277. Hjort, P. F., Waaler, H. T., Tverdal, A., Graff‐Iversen, S., & Trygg, K. (1996). [Do people exercise less than they think?].. PubMed.
278. Hodge, J. G., & Scanlon, M. (2014). The Legal Anatomy of Product Bans to Protect the Public's Health. SSRN Electronic Journal.
279. Hodge, J. G., Scanlon, M., Corbett, A., & Sorensen, A. A. (2010). The Consumable Vice: Caffeine, Public Health, and the Law.
280. Hodge, J. G., Scanlon, M., Corbett, A., & Sorensen, A. A. (2010). The consumable vice: caffeine, public health, and the law..
281. Holliday, R., Chaffee, B. W., Jakubovics, N. S., Kist, R., & Preshaw, P. M. (2021). Electronic Cigarettes and Oral Health. Journal of Dental Research. https://doi.org/10.1177/00220345211002116
282. Hong, S. W., Teesdale‐Spittle, P., Page, R., Ellenbroek, B., & Truman, P. (2022). Biologically Active Compounds Present in Tobacco Smoke: Potential Interactions Between Smoking and Mental Health. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2022.885489
283. Hope, B. T. (1999). Cocaine and a Mechanism for Long-Term Changes in Gene Expression. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-710-9_21
284. Hossain, A., Hossain, Q. Z., Azad-uz-zaman, Q., & Rahman, F. (2015). Factors Influencing Teenager to Initiate Smoking in South-west Bangladesh. Universal Journal of Public Health. https://doi.org/10.13189/ujph.2015.030603
285. Houezec, J. L. (1998). Nicotine: abused substance and therapeutic agent.. PubMed.
286. Houezec, L. (2003). Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.. PubMed.
287. Hua, J. P., Cano, M., Batki, S. L., & Pennington, D. (2023). Impact of Alcohol Use, Traumatic Stress, and Cigarette Smoking on Cognitive Functioning in Veterans With Co-occurring Alcohol Use Disorder and Posttraumatic Stress Disorder.. PubMed. https://doi.org/10.1093/milmed/usac282
288. Huang, L.-C., Liu, W., & Chou, S. T. (2013). Howcare. https://doi.org/10.1145/2492517.2500237
289. Huas, D., & Pessione, F. (1999). [Problem drinking].. PubMed.
290. Hughes, J. (1991). Symptoms of Tobacco Withdrawal. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1991.01810250054007
291. Hughes, J. R. (1988). Dependence potential and abuse liability of nicotine replacement therapies.. PubMed.
292. Huizink, A. C. (2022). Trends and associated risks in adolescent substance use: E-cigarette use and nitrous oxide use. Current Opinion in Psychology. https://doi.org/10.1016/j.copsyc.2022.101312
293. Hutter, M. (1996). EINFLUSS ILLEGALER DROGEN AUF FAHRTUECHTIGKEIT UND FAHREIGNUNG AUS VERKEHRSPSYCHOLOGISCHER SICHT.
294. Hwang, S., Hwang, J. H., Moon, J. S., & Lee, D.-H. (2012). Environmental tobacco smoke and children's health. Korean Journal of Pediatrics. https://doi.org/10.3345/kjp.2012.55.2.35
295. Hybels, C. F., & Blazer, D. G. (2010). Epidemiology of Alcohol Problems and Drinking Patterns. https://doi.org/10.1002/9780470669600.ch107
296. Hájek, P. (2014). Electronic cigarettes have a potential for huge public health benefit. BMC Medicine. https://doi.org/10.1186/s12916-014-0225-z
297. Ifdil, I., Fadli, R. P., Rangka, I. B., Suranata, K., & Situmorang, D. D. B. (2021). Anxiety, Depression, Psychological Symptoms, Negative Effects, and Other Symptoms of Nicotine Withdrawal. Addictive Disorders & Their Treatment. https://doi.org/10.1097/adt.0000000000000288
298. Ifland, J., & Roselle, R. S. (2017). DSM 5 SUD Criterion 9 Use in Spite of Consequences. https://doi.org/10.1201/9781315119922-21
299. Ikeda, S. (2016). The Paradox of Self-Destructive Choices. Advances in Japanese business and economics. https://doi.org/10.1007/978-4-431-55793-7_1
300. Ilabaca, A., Villouta, M. F., Sateler, J., & Wulf, A. D. (2006). Tratamiento del Uso y la Dependencia Tabáquicos. Revista Chilena de Medicina Familiar.
301. Intyre, M. S. M. (2014). Factors Related to Simultaneous Cocaine and Alcohol Use for Clients in Treatment. Journal of Alcoholism and Drug Dependence. https://doi.org/10.4172/2329-6488.1000193
302. Irvine, H. (2016). More reasons why Dutch GPs are happier. BMJ. https://doi.org/10.1136/bmj.i437
303. Isyaka, S. M., Ibrahim, S., & Abdullahi, A. M. (2025). Review on Selected Toxic, Narcotics and Psychoactive Plants Used in Nigeria. https://doi.org/10.64290/bima.v9i1a.897
304. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Alcohol. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0649
305. Jain, A. (2003). Treating nicotine addiction. BMJ. https://doi.org/10.1136/bmj.327.7428.1394
306. Jain, A., Keshri, A., Deepali, K., Nandy, A., Singh, A., & Srivastava, A. K. (2024). Prevalence of Tobacco Use and Alcohol Consumption among Adolescents. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/9789815274400124010012
307. Jain, T., Eashwar, A., Jr., M. C. S., & Keerthana, R. (2022). Tobacco Consumption and Legislations Regarding Tobacco Use in India – Is It Time for A Policy Change?. National Journal of Community Medicine. https://doi.org/10.55489/njcm.131020222409
308. Jargin, S. V. (2015). Some Aspects of Nonbeverage Alcohol Consumption in the Former Soviet Union. Psychiatry Journal. https://doi.org/10.1155/2015/507391
309. Jarry, J. L., Coambs, R. B., Polivy, J., & Herman, C. P. (1998). Weight gain after smoking cessation in women: The impact of dieting status. International Journal of Eating Disorders. https://doi.org/10.1002/(sici)1098-108x(199807)24:1<53::aid-eat5>3.0.co;2-#
310. Jarry, J. L., Coambs, R. B., Polivy, J., & Herman, C. P. (1998). Weight gain after smoking cessation in women: The impact of dieting status. International Journal of Eating Disorders. https://doi.org/10.1002/(sici)1098-108x(199807)24:1<53::aid-eat5>3.3.co;2-p
311. Jarvis, M. (1998). Psychological profile of complier versus noncomplier.
312. Jawad, M. (2015). Waterpipe Tobacco Smoking: A Less Harmful Alternative?. Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research. https://doi.org/10.1159/000369505
313. Jayaswal, A., & Singh, D. P. (2025). Substance Abuse and Its Addiction Among Young Adults. INTERNATIONAL JOURNAL OF PROFESSIONAL STUDIES. https://doi.org/10.37648/ijps.v20i01.012
314. Jc, P., & Sommese, T. (1995). Acute effects of cigarette smoking withdrawal: a review of the literature.. PubMed.
315. Jennings, G., & Parati, G. (2010). Blood pressure up in a puff of smoke. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e32833e0d14
316. Jerez, A. F. H., Gil, F., & Martínez, A. P. (1999). Nuevas perspectivas en el análisis de drogas de abuso para el año 2000. Revista electrónica de ciencia penal y criminología.
317. Jerônimo, T. K. D. S., Filho, R. A. M., Oliveira, P. A. P. D., Agripino, G. G., & Marinho, S. A. (2025). Impactos do consumo de bebidas energéticas na saúde. Contribuciones a las Ciencias Sociales. https://doi.org/10.55905/revconv.18n.9-203
318. Jetty, R., Banerji, A., Berry, M., Fraser-Roberts, L., Goldade, R., Irvine, J. C., Menard, K., Pelletier, V., Wong, S., Bell, S., Morningstar, M., Monkman, L., Ryan, A. C., Vides, E., Wiebe, P. K., & Mazerolle, M. (2017). Tobacco use and misuse among Indigenous children and youth in Canada. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxx124
319. Jia, L., & Gold, J. A. (2020). Hallucinogen Use in College Students: Current Trends and Consequences of Use. Current Psychopharmacologye. https://doi.org/10.2174/2211556009666200311140404
320. Jiloha, R. (2014). Pharmacotherapy of smoking cessation. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.124726
321. Johnson-Moreno, H. (2003). To Your Health: Sensible Self-Care Can Help CPAs Maintain Stamina in the Run-Up to Those Filing Deadlines. Journal of accountancy online/Journal of accountancy.
322. Johnson‐Ferguson, L., & Forti, M. D. (2021). From heavy cannabis use to psychosis: is it time to take action?. Irish Journal of Psychological Medicine. https://doi.org/10.1017/ipm.2021.33
323. Johnstone, A. M. (2006). Fasting – the ultimate diet?. Obesity Reviews. https://doi.org/10.1111/j.1467-789x.2006.00266.x
324. Jones, C. A., Wallace, M. B., Bandaru, P., Woodbury, E. D., Mohler, P. J., & Wold, L. E. (2023). E-cigarettes and arrhythmogenesis: a comprehensive review of pre-clinical studies and their clinical implications. Cardiovascular Research. https://doi.org/10.1093/cvr/cvad113
325. Jones, C., & Weatherburn, D. (2001). Reducing Cannabis Consumption. BOCSAR NSW Crime and Justice Bulletins.
326. Jorge-Cárdenas, X. D. S. (2020). Percepción, riesgo y consumo de drogas en universitarios. Universidad Veracruzana eBooks. https://doi.org/10.25009/uv.2164.1513
327. Jose, J. V., Arya, J. S., & Thykkattil, S. J. (2024). Understanding the Concept of Madya and Madatyaya with Respect to Alcohol Use Disorders. International Journal For Multidisciplinary Research. https://doi.org/10.36948/ijfmr.2024.v06i03.23214
328. Joshi, M., Joshi, A., & Bartter, T. (2014). Marijuana and lung diseases. Current Opinion in Pulmonary Medicine. https://doi.org/10.1097/mcp.0000000000000026
329. Joyce, K. M., Thompson, K., Tibbo, P., Good, K. P., O'Leary, E., Perrot, T. S., Hudson, A. L., & Stewart, S. H. (2021). The Impact of Depressed Mood and Coping Motives in those with Pre-Menstrual Dysphoric Disorder on Cannabis Use Quantity across the Menstrual Cycle. https://doi.org/10.26828/cannabis.2021.01.000.40
330. Jun, Y. J., Kim, H., & Park, S. (2014). Suicidal Death by Nicotine Poisoning. Korean Journal of Legal Medicine. https://doi.org/10.7580/kjlm.2014.38.4.167
331. Juranić, B., Mikšić, Š., Rakošec, Ž., & Vuletić, S. (2018). Smoking Habit and Nicotine Effects. IntechOpen eBooks. https://doi.org/10.5772/intechopen.77390
332. Juárez-Jiménez, M.-D.-L.-V. (2015). Consumo de alcohol, tabaco y drogas ilegales de los profesionales internos residentes de Andalucía y el consejo clínico.
333. Jêdrzejczak, M. (2002). [Drug addiction among service soldiers--causes of phenomenon development].. PubMed.
334. Kadir, S. A., Doni, C., Rasyid, M. T., Astuti, N. K., Arif, N., & Ashar, A. N. P. C. (2024). The Influence of Drug Abuse on the Young Generation. Formosa Journal of Applied Sciences. https://doi.org/10.55927/fjas.v3i2.7783
335. Kalayasiri, R. (2024). Caffeine addiction and mental health of employees in an organization in Bangkok. Deleted Journal. https://doi.org/10.56808/2673-060x.5433
336. Kale, D., Jackson, S., Brown, J., Garnett, C., & Shahab, L. (2024). Social smoker identity and associations with smoking and quitting behaviour: A cross-sectional study in England. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2024.111345
337. Kalra, S., Bhogal, S., Kumar, K., Ragupathi, N. K. D., & Kaushal, R. K. (2021). The Negative Impact of Food Neophobia on the People of Chandigarh Tri-City, India. SPAST Abstracts.
338. Kamenetzky, G., & Mustaca, A. E. (2005). Modelos Animales para el Estudio del Alcoholismo. Terapia psicológica.
339. Kamrul, R., Bunka, D., CRAWLEY, A. E., Schuster, B., & LeBras, M. (2019). Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.. PubMed.
340. Kandyala, R., Nalabolu, G. R., Pinisetty, S., & Rajashekaran, S. T. (2011). Tobacco Addiction - Blame it on Genes!. International journal of oral and maxillofacial pathology.
341. Kaneko, J., & Hanada, M. (2016). Why Do Elderly Individuals in Japan Eat Alone?. Journal of Rural Problems. https://doi.org/10.7310/arfe.52.166
342. Kaplan, D. L. (2007). What’s Wrong with Functional Foods?. Journal of Philosophical Research. https://doi.org/10.5840/jpr_2007_15
343. Kaplan, R. M. (1996). Carrot Addiction. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048679609062670
344. Karpinski, J. P., Timpe, E. M., & Lubsch, L. (2010). Smoking Cessation Treatment for Adolescents. The Journal of Pediatric Pharmacology and Therapeutics. https://doi.org/10.5863/1551-6776-15.4.249
345. Kaskie, B., Martinos, F., Bhagianadh, D., Arora, K., Moore, A., Nguyen, A. L., & Bobitt, J. (2025). Taking Care of Themselves: Cannabis Use Among Informal Care Partners of Older Adults. Cannabis and Cannabinoid Research. https://doi.org/10.1177/25785125251380073
346. Kassel, J. D. (2000). Are Adolescent Smokers Addicted to Nicotine? The Suitability of the Nicotine Dependence Construct as Applied to Adolescents. Journal of Child & Adolescent Substance Abuse. https://doi.org/10.1300/j029v09n04_03
347. Katz, M. H. (2006). Special topics. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511811692.015
348. Katz, M. H. (2011). Special topics. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511974175.014
349. Kaufman, N. J., & Mahoney, M. (2015). E-Cigarettes: Policy Options and Legal Issues Amidst Uncertainty. The Journal of Law Medicine & Ethics. https://doi.org/10.1111/jlme.12209
350. Kavanagh, D. J., Young, R. M., White, A., Saunders, J. B., Shockley, N., Wallis, J., & Clair, A. (2002). Start Over and Survive: A Brief Intervention for Substance Misuse in Early Psychosis. https://doi.org/10.1002/9780470713846.ch14
351. Kay, A., Taylor, T., Barthwell, A. G., Wichelecki, J., & Leopold, V. (2010). Substance Use and Women's Health. Journal of Addictive Diseases. https://doi.org/10.1080/10550881003684640
352. Kelly, J. F., & Bergman, B. G. (2020). A Bridge Too Far: Individuals With Regular and Increasing Very Heavy Alcohol Consumption Cannot be Considered as Maintaining “Recovery” Due to Toxicity and Intoxication-related Risks. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000759
353. Kempton, S. J., Burish, N. M., & Rao, V. K. (2014). Electronic Cigarettes. Plastic & Reconstructive Surgery. https://doi.org/10.1097/prs.0000000000000196
354. Kengadaran, S., Anusha, D., Caplan, D. J., Sivasamy, S., & Divyaraj, P. (2025). Smokeless Tobacco Products in India – A Scoping Review. SBV Journal of Basic Clinical and Applied Health Science. https://doi.org/10.4103/sbvj.sbvj_29_25
355. Ketkowit, K., Thavondunstid, P., Kompor, P., Champhosri, W., Skulsuksai, G., Klannamtip, P., Muphaiboon, P., & Junraksa, P. (1989). Narcotic Problem in KhonKaen Correctional Institution For Drug-Addicted Offenders.. ศรีนครินทร์เวชสาร (Srinagarind Medical Journal).
356. Keto, J., Rautio, N., Ylisaukko‐oja, T., Linden, K., & Koponen, H. (2015). [Tobacco withdrawal in individuals suffering from mental disorders].. PubMed.
357. Khairnar, M., Wadgave, U., & Khairnar, S. M. (2017). Effect of Alcoholism on Oral Health: A Review. Journal of Alcoholism and Drug Dependence. https://doi.org/10.4172/2329-6488.1000266
358. Khan, K. S. A., Yasmeen, K., & Imam, M. A. (2013). Influence of Alcohol Addicted Parents in the Development of Alcoholic Behaviour of their Children. Indian Journal of Health and Wellbeing.
359. Khan, T., Huda, A. B., Al-Jibury, M., & Tin, Z. (2022). A case of acute lung injury due to an e-cigarette. Clinical Medicine. https://doi.org/10.7861/clinmed.22-4-s16
360. Kherfouchi, M. (2015). ETUDE D’UN MODELE DE PRISE EN CHARGE THERAPEUTIQUE DES TOXICOMANES EN ALGERIE. Revue des Sciences Humaines.
361. Khodaee, A., Reed, A. J., & Khodaee, M. (2025). Electronic Cigarette Use (Vaping) Among Adolescents: A Narrative Review of an Emerging Public Health Epidemic. Cureus. https://doi.org/10.7759/cureus.89422
362. Kicel, B. A., Ba, J. H. O.-Z., & Kinalski, P. M. (2014). Health behaviors during pregnancy. Ginekologia i Położnictwo medical project.
363. Kiernan, M. C. (2002). Adolescent tobacco use: prevention and cessation.. PubMed.
364. Kiianmaa, K., Hyytiä, P., & Sinclair, J. D. (2003). Development of an Animal Model of Ethanol Abuse: Genetic Approach. Humana Press eBooks. https://doi.org/10.1385/0-89603-217-5:29
365. Kim, D. G., Powers, S., & Gitto, L. (2024). Death Due to Caffeine and Methamphetamine Toxicity: A Case Report. Cureus. https://doi.org/10.7759/cureus.66634
366. Kim, S. (2016). 음식과 질병을 통해 본 조선왕들의 생로병사에 관한 연구. 한국외식산업학회지.
367. Kindinger, E., & Vester, K. (2024). Weight-Loss Diets. https://doi.org/10.1093/acrefore/9780197762530.013.138
368. Kitzen, J. M., McConaha, J. L., Bookser, M. L., Pergolizzi, J. V., Taylor, R., & Raffa, R. B. (2019). e‐Cigarettes for smoking cessation: Do they deliver?. Journal of Clinical Pharmacy and Therapeutics. https://doi.org/10.1111/jcpt.12833
369. Klein, M. D., Sokol, N., & Stroud, L. R. (2019). Electronic Cigarettes: Common Questions and Answers.. PubMed.
370. Knapp, M., & McCabe, D. (2022). Substance Use Risk Reduction. CRC Press eBooks. https://doi.org/10.1201/9781003178330-8
371. Kolte, B., & Schmidt-Semisch, H. (2002). Controlled Smoking: Implications for Research on Tobacco use. Journal of Drug Issues. https://doi.org/10.1177/002204260203200220
372. Komro, K. A., & Toomey, T. L. (2002). Strategies to prevent underage drinking.. PubMed.
373. Kondratavičiūtė, G., Banionis, D., Laima, S., Chmieliauskas, S., Vasiljevaitė, D., Petreikis, P., & Badaras, R. (2025). Sudden Unexpected Death and Alcohol Addiction: Case Report on Disulfiram Use. Acta medica Lituanica. https://doi.org/10.15388/amed.2025.32.1.5
374. Konopka, L. M. (2014). Marijuana use: neuroscience perspective. Croatian Medical Journal. https://doi.org/10.3325/cmj.2014.55.281
375. Koplan, K., David, S. P., & Rigotti, N. A. (2008). Smoking cessation. BMJ. https://doi.org/10.1136/bmj.39248.531748.47
376. Kosten, T. R. (1992). Can Cocaine Craving Be a Medication Development Outcome?. American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.1992.tb00029.x
377. Kosten, T. R. (1992). Can Cocaine Craving Be a Medication Development Outcome?: Drug Craving and Relapse in Opioid and Cocaine Dependence. American Journal on Addictions. https://doi.org/10.3109/10550499209004025
378. Kottusch, P. A., Tillmann, M., & Püschel, K. (2010). [Survival time without food and drink].. PubMed.
379. Kovacs, M. (2013). The Effects of Caloric Preload and Dietary Restraint on Smoking and Eating Behavior.
380. Krishnan, J. (2024). Nicotine. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/9789815223828124010011
381. Kuczkowski, K. M. (2002). Ethanol and tobacco abuse in pregnancy: Anaesthetic considerations. Southern African Journal of Anaesthesia and Analgesia. https://doi.org/10.1080/22201173.2002.10872968
382. Kumar, J., Kushwaha, S., Tomar, A., Ramanna, T., Prabhakar, I., & Chaudhry, M. (2015). Tobacco and Oral Health . The Journal of Dentists. https://doi.org/10.12974/2311-8695.2015.03.01.2
383. Kumar, K. G., Sreedharan, J. K., Krishna, G. G., & Jose, A. M. (2024). Understanding E-cigarette Use in India: Challenges, Health Implications, and Regulatory Responses. Indian Journal of Respiratory Care. https://doi.org/10.5005/jp-journals-11010-1095
384. Kumar, R. (2019). A STUDY OF THE DRUG CONSUMPTION ON THE INDIVIDUALS. Journal of the Gujarat Research Society.
385. Kuntz, B., Zeiher, J., Starker, A., & Lampert, T. (2018). Bekämpfung des Rauchens: Erfolge in der Tabakkontrollpolitik. Public Health Forum. https://doi.org/10.1515/pubhef-2018-0045
386. Kunze, M. (2000). Maximizing help for dissonant smokers. Addiction. https://doi.org/10.1046/j.1360-0443.95.1s1.1.x
387. Kunze, M. (2000). Maximizing help for dissonant smokers. Addiction. https://doi.org/10.1080/09652140032026
388. Kuttivila, M. S. T., & saxena, V. L. (2021). A STUDY TO EVALUATE THE EFFECTIVENESS OF GROUP THERAPY ON STRESS AMONG THE ALCOHOLICS IN SELECTED DEADDICTION CENTRES IN KERALA. THE GENESIS. https://doi.org/10.47211/tg.2021.v08i04.013
389. Kycler, M., Rzepczyk, S., Veer, J. V. D., Świderski, P., & Żaba, C. (2024). E-cigarettes, e-liquids and drug vaping – forensic perspectives on electronic nicotine delivery systems. Problems of Forensic Sciences. https://doi.org/10.4467/12307483pfs.23.014.19430
390. Körkel, J., & Reimer, J. (2014). Konsumreduktion. Suchttherapie. https://doi.org/10.1055/s-0034-1394416
391. Köse, Y. D. D. O., Alkurt, A. G. D. M., Dilsiz, D. D. A., & Arabaci, Y. D. D. T. (2013). Dişsizliğin Beslenme Alışkanlıkları ve Vücut Ağırlığı Üzerine Etkileri. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi. https://doi.org/10.17567/dfd.95308
392. Laborda, M. Q. (2015). Tabaquismo y motivación para dejar de fumar en el área de Salud Mental del Centro San Juan de Dios de Ciempozuelos.
393. Lachs, J. (2014). Drugs: The Fallacy of Avoidable Consequences. Fordham University Press eBooks. https://doi.org/10.5422/fordham/9780823256747.003.0023
394. Laerte, D. S. D., Maria, R. U. C., & Lucia, G. N. (2018). CIGARRILLO ELECTRÓNICO. ¿UN PRODUCTO SEGURO?. morfovirtual2018.
395. Lamis, D. A., Ellis, J. B., Chumney, F. L., & Dula, C. S. (2009). Reasons for Living and Alcohol Use Among College Students. Death Studies. https://doi.org/10.1080/07481180802672017
396. Lamy, S., Delavene, H., & Thibaut, F. (2014). [Licit and illicit substance use during pregnancy].. PubMed.
397. Larsson, M. (2022). [Nicotine, alcohol and opioids - three interacting substances].. PubMed.
398. Laxmeshwar, B. S., & HIREMATH, S. R. (2017). Proper nutrition for athletes. INTERNATIONAL JOURNAL OF PHYSICAL EDUCATION. https://doi.org/10.15740/has/ijpe/10.1and2/34-45
399. Lech, M., & Ostrowska, L. (2017). Psychologiczne aspekty otyłości. Forum Zaburzeń Metabolicznych.
400. Leduc, C., & Quoix, É. (2015). Is there a role for e-cigarettes in smoking cessation?. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/1753465815621233
401. Lee, L., Shearston, J. A., & Weitzman, M. (2016). New Alternative Tobacco Products – A Threat to Adolescent Health. Pediatrics in Review. https://doi.org/10.1542/pir.2015-0146
402. Lee, M., & Barron, M. L. (2017). The Legalization of Marijuana and Fertility Implications. Journal of Midwifery Women’s Health and Nursing Practice. https://doi.org/10.29199/2637-9260/mwnp-101016
403. Lee, M., & Barron, M. L. (2017). The Legalization of Marijuana and Fertility Implications. Journal of Midwifery Women’s Health and Nursing Practice. https://doi.org/10.29199/mwnp.101016
404. Lefebvre, A. D., Sears, R. W., & Ossege, J. M. (2019). Encouraging Empowerment Among Group Members. Routledge eBooks. https://doi.org/10.4324/9781315145914-9
405. Lembke, A., Johnson, K., & DeBattista, C. (2007). Depression and smoking cessation: does the evidence support psychiatric practice?. PubMed.
406. Lepore, S. J., Collins, B. N., Killam, H. W., & Barry, B. R. (2021). Supportive Accountability and Mobile App Use in a Tobacco Control Intervention Targeting Low-Income Minority Mothers Who Smoke: Observational Study. JMIR mhealth and uhealth. https://doi.org/10.2196/28175
407. Leslie, E., Smirnov, A., Najman, J. M., & Scott, J. (2016). Alcohol use and motivations for drinking among types of young adult illicit stimulant users. https://doi.org/10.52922/ti150606
408. Leu, M. G., & Norris, T. E. (2002). Patient-focused Wireless Messages for Diabetes. American Medical Informatics Association Annual Symposium.
409. Leventhal, A. M., Goldenson, N. I., Cho, J., Kirkpatrick, M. G., McConnell, R., Stone, M. D., Pang, R. D., Audrain‐McGovern, J., & Barrington‐Trimis, J. L. (2019). Flavored E-cigarette Use and Progression of Vaping in Adolescents. PEDIATRICS. https://doi.org/10.1542/peds.2019-0789
410. Levine, D., & Johnson, R. W. (2015). Psychiatric Aspects of Cigarette Smoking. Advances in psychosomatic medicine. https://doi.org/10.1159/000411836
411. Lewis, K. (2010). Chapter 2 The physiological and psychological effects of smoking. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199556250.003.0002
412. Li, G. (2024). Ways to Reduce the Health Risks of Cigarettes in the Next Decade. MedScien. https://doi.org/10.61173/96777t90
413. Li, T.-K., Lumeng, L., McBride, W. J., Murphy, J. M., Froehlich, J. C., & Morzorati, S. L. (1988). Pharmacology of Alcohol Preference in Rodents. Advances in Alcohol & Substance Abuse. https://doi.org/10.1300/j251v07n03_11
414. Liana, L. T. W., & ADOLF, L. L. (2019). PENYALAHGUNAAN KONSUMSI ALKOHOL PADA MINUMAN KERAS BAGI REMAJA TERHADAP KESEHATAN. https://doi.org/10.31219/osf.io/2j795
415. Liebregts, N., Pol, P. V. D., Graaf, R. D., Laar, M. V., Brink, W. V. D., & Korf, D. J. (2014). Persistence and desistance in heavy cannabis use: the role of identity, agency, and life events. Journal of Youth Studies. https://doi.org/10.1080/13676261.2014.992320
416. Liew, C. H. (2020). Potential cardiovascular implications of electronic cigarettes: how evident is the evidence?. Journal of Public Health. https://doi.org/10.1093/pubmed/fdaa137
417. Lilly, R. (2003). Bulimia nervosa. BMJ. https://doi.org/10.1136/bmj.327.7411.380
418. Lima, I. M. B. D. (2016). Níveis de resiliência e qualidade de vida em mulheres que fazem consumo excessivo de álcool em João Pessoa-PB.
419. Lima, P. V. S. F. D., & Faustino, A. M. (2013). Aspectos gerais do tabagismo entre idosos no Brasil: revisão de literatura. Revista Gestão & Saúde. https://doi.org/10.18673/gs.v4i1.23013
420. Liras, A., Martín, S. L., García, R., Maté, I., & Padilla, V. (2007). [Smoking habit: physiopathology and prevention]..
421. Livne, O., Potter, K., Schuster, R. M., & Gilman, J. M. (2023). Longitudinal Associations Between Cannabis Use and Cognitive Impairment in a Clinical Sample of Middle-Aged Adults Using Cannabis for Medical Symptoms. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2022.0310
422. Lj, T., & En, B. (2000). Alcohol consumption among the elderly: dispelling the myths.. PubMed.
423. Logan, F. A. (2017). The Smoking Habit 1. Routledge eBooks. https://doi.org/10.4324/9780203787434-11
424. Lopes, P. M. A., Dias, A. P. S., Zanini, É. R. S., Camboin, F. F., Seimetz, G., & Ferreira, L. (2012). Smoking Sue e os Efeitos do Tabagismo. 10º Congresso Internacional da Rede Unida.
425. Lowe, J. B. (2001). [Behavioral approaches in tobacco control]. PubMed.
426. Lowenfels, A. B., & Maisonneuve, P. (2004). Tobacco and alcohol interaction. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526872.003.0036
427. Ludwig, D. S. (2012). Weight Loss Strategies for Adolescents. JAMA. https://doi.org/10.1001/jama.2011.2011
428. Lumpe, E., Pascale, A., Stephenson, M., Barr, P. B., Cooke, M., Latvala, A., Maes, H. H., Aaltonen, S., Piirtola, M., Viken, R. J., Rose, R. J., Sipilä, P. N., Keski‐Rahkonen, A., Vuoksimaa, E., Kaprio, J., Dick, D. M., & Salvatore, J. E. (2024). Etiology and correlates of alcohol misuse in early midlife. Alcohol Clinical and Experimental Research. https://doi.org/10.1111/acer.15513
429. Lázaro, M. I. M. D., & Rubio, M. D. R. B. (2006). Consumo de cocaína en jóvenes españoles. Pediatría Atención Primaria.
430. López, D. M., Bugueno, I. M., Ormazábal, F. R., & Garrido‐Urrutia, C. (2015). Bruxismo Secundario al Consumo Recreacional de Éxtasis: Revisión de la Literatura. International journal of odontostomatology. https://doi.org/10.4067/s0718-381x2015000200006
431. López, J. M. (2021). Introduction: Willpower hijacked. The science of addictions. Mètode Revista de difusió de la investigació. https://doi.org/10.7203/metode.12.21075
432. Ma, Z.-Q., Kuller, L. H., Fisher, M. A., & Ostroff, S. M. (2013). Use of Interrupted Time-Series Method to Evaluate the Impact of Cigarette Excise Tax Increases in Pennsylvania, 2000–2009. Preventing Chronic Disease. https://doi.org/10.5888/pcd10.120268
433. MacDonald, P. (1998). Time-Limited, Goal-Oriented Therapy: Diary of a Stop-Smoking Group. Group Analysis. https://doi.org/10.1177/0533316498311009
434. Magomedov, A. D. (2015). Ислам и потребление хмельных напитков в Дагестане: к истории вопроса. Исламоведение.
435. Maio, G. R., Haddock, G., & Jarman, H. L. (2007). Social psychological factors in tackling obesity. Obesity Reviews. https://doi.org/10.1111/j.1467-789x.2007.00330.x
436. Makovicky, P. J., Matlach, R., & Makovický, P. (2021). Lethal alcohol intoxications cases: thinking about the causes. Vnitřní lékařství. https://doi.org/10.36290/vnl.2021.132
437. Maksimovskiy, A. L., Fortier, C. B., Milberg, W., & McGlinchey, R. E. (2019). A structural MRI study of differential neuromorphometric characteristics of binge and heavy drinking. Addictive Behaviors Reports. https://doi.org/10.1016/j.abrep.2019.100168
438. Malleck, D. (2020). Introduction to Volume IV. Routledge eBooks. https://doi.org/10.4324/9780429436079-2
439. Mann, T., Tomiyama, A. J., & Comer, L. K. (2007). Triggers of eating in everyday life. PsycEXTRA Dataset. https://doi.org/10.1037/e633982013-689
440. Marczylo, T., Goldsmith, N., Zhuikova, E., & Alexis, B. (2016). Of mice and Men; Neurobehavioral and toxicological effects of e-cigarettes exposure.. Frontiers in Human Neuroscience. https://doi.org/10.3389/conf.fnhum.2016.220.00019
441. Marques, P. S., & Oliveira, M. S. D. (2016). SAÚDE MENTAL E INTELECTUAL NO TRABALHO. Proceedings of World Congress on Communication and Arts. https://doi.org/10.14684/wcca.v8.190-191
442. Marsaudon, A., & Rochaix, L. (2019). Impact d’un choc de santé sur les modes de vie, exploitation de la cohorte Gazel. Revue française d économie. https://doi.org/10.3917/rfe.191.0183
443. Marter, D. F. V., Levesque, D. A., Mauriello, L. M., & Aguiar, E. D. (2016). Acceptability of Responsible Drinking, a Theoretically Tailored mHealth Intervention to Target Risky Drinking Among Employed Adults. Iproceedings. https://doi.org/10.2196/iproc.6142
444. Martin, L., & Milot, A. (2007). Assessing Substance Use and Abuse Among Adolescents: A Guide for Out-Of-School Time Program Practitioners. PsycEXTRA Dataset. https://doi.org/10.1037/e720592007-001
445. Martínez, M. T. L. (2014). Consumo de alcohol en jóvenes y adolescentes: una mirada ecológica.
446. Matassini, M. (2016). incentivi all'adozione di stili di vita più salutari: un'analisi economica.
447. Mateshvili, M., Bakuradze, M., & Phagava, H. (2022). Health effects of cigarette smoking – review of the past 5 years. TSMU COLLECTION OF SCIENTIFIC WORKS. https://doi.org/10.52340/csw.2020.54.01
448. Maughan, R., Al-Kharusi, W., Binnett, M. S., Budgett, R., Burke, L. M., Coyle, E. F., Elwani, R., Guézennec, C.-Y., Limna, J., Mujika, I., Ramadan, J., Schamasch, P., Shirreffs, S. M., & Vennard, P. (2010). Fasting and sports: a summary statement of the IOC workshop. British Journal of Sports Medicine. https://doi.org/10.1136/bjsm.2010.073064
449. Maurer, P., & Bachmann, M. F. (2006). Therapeutic vaccines for nicotine dependence.. PubMed.
450. May, C. (1999). Perceptions of self, self-esteem, and the adolescent smoker. Health Education Journal. https://doi.org/10.1177/001789699905800302
451. Mays, D., Gilman, S. E., Rende, R., Luta, G., Tercyak, K. P., & Niaura, R. (2014). Parental Smoking Exposure and Adolescent Smoking Trajectories. PEDIATRICS. https://doi.org/10.1542/peds.2013-3003
452. McBride, J. S., Altman, D. G., Klein, M.-L., & White, W. L. (1998). Green tobacco sickness. Tobacco Control. https://doi.org/10.1136/tc.7.3.294
453. McNeill, A. D., Brose, L. S., Calder, R. I., Hitchman, S. C., Hájek, P., & McRobbie, H. (2015). E-cigarettes: an evidence update. A report commissioned by Public Health England..
454. McRobbie, H., & West, O. C. (2013). Natural history of tobacco withdrawal: implications for smoking cessation treatment. https://doi.org/10.2217/ebo.12.262
455. McRobbie, H., West, O. C., & Hájek, P. (2010). How Addictive Can Cigarettes Be? Two Case Reports. The Journal of Smoking Cessation. https://doi.org/10.1375/jsc.5.1.102
456. Mecheri, H., Noël, Y., & Darcheville, J. C. (2005). Effets addictogènes de la nicotine chez l'animal : Facteurs biologiques et comportementaux impliqués,. HAL (Le Centre pour la Communication Scientifique Directe).
457. Medina-Mora, M. E., Peña-Corona, M. P., Cravioto, P., Villatoro, J., & Kuri, P. (2002). Del tabaco al uso de otras drogas: ¿el uso temprano de tabaco aumenta la probabilidad de usar otras drogas?. Salud Pública de México. https://doi.org/10.1590/s0036-36342002000700016
458. Mehra, A., Sharma, N., & Grover, S. (2018). Pagophagia in a Female with Recurrent Depressive Disorder: A Case Report with Review of Literature. Turkish Journal of Psychiatry. https://doi.org/10.5080/u22798
459. Melnichenko, G. А., & Butrova, S. A. (2010). Vliyanie tabakokureniya na zdorov'e i massu telacheloveka. Obesity and metabolism. https://doi.org/10.14341/2071-8713-5273
460. Mendelsohn, C. (2015). Three Decades of High-Dose Nicotine Gum Dependence Treated With Nicotine Patches. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntv124
461. Mendoza, C. G., Martínez, C. A. L., & Gutiérrez, A. G. T. (2020). Consumo de psicofármacos: una problemática de salud actual. DOAJ (DOAJ: Directory of Open Access Journals).
462. Menecier, P., Verny, M., Fernandez, L., & Ploton, L. (2016). Alcoholic abstinence in elderly subjects with misuse of alcohol. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2016.0600
463. Menezes, N. G. A., Silva, G. K. R. D., & Ferreira, C. S. (2014). Atuação do Enfermeiro Frente à Dependência Química da Cocaína.. Semana de Pesquisa e Extensão da Universidade Tiradentes - SEMPESq-SEMEX.
464. Mercer, K., Li, M., & Grindrod, K. (2015). Do wearable activity trackers have a place in pharmacies?. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. https://doi.org/10.1177/1715163515579221
465. Mercer, S. L., Khan, L. K., Green, L. W., Rosenthal, A., Nathan, R., Husten, C. G., & Dietz, W. H. (2005). Drawing possible lessons for obesity prevention and control from the tobacco control experience. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566007.003.0011
466. Meredith, P. (1996). Therapeutic implications of drug 'holidays'. European Heart Journal. https://doi.org/10.1093/eurheartj/17.suppl_a.21
467. Mermelstein, R., & Brikmanis, K. (2018). Nicotine and Tobacco Use. Routledge eBooks. https://doi.org/10.4324/9781315167534-9
468. Metrik, J. (2022). Alcohol and Cannabinoids - From the Editors. Alcohol research. https://doi.org/10.35946/arcr.v42.1.10
469. Mette, C. (2016). Quelle influence des conditions de travail sur la consommation de tabac.
470. Meyer, S. (2016). Further reasons why alcohol and stress don’t-and shouldn’t-mix. Advances in Obesity Weight Management & Control. https://doi.org/10.15406/aowmc.2016.05.00130
471. Mileva, B., Dikov, T., Goshev, M., Georgieva, M., Tsranchev, I. I., Angelov, M., Alexandrov, A., Ateriya, N., & Ivanova, V. (2024). Death Following Methyl Alcohol Intoxication: Gross Autopsy and Histological Findings. Cureus. https://doi.org/10.7759/cureus.65498
472. Millatmal, T., Daughton, D. M., Thompson, A. B., Floreani, A. A., Romberger, D. J., Epperson, K., Larson, L., & Rennard, S. I. (1994). Smoking reduction: an alternative approach for smokers who cannot quit.. PubMed.
473. Miller, W. R., & Bennett, M. E. (1996). Treating Alcohol Problems in the Context of Other Drug Abuse.. PubMed.
474. Miloslavich, K., & Wardle, M. C. (2024). Anger is more strongly associated with alcohol and tobacco use and use disorders compared to other substances in American adults. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2024.2331721
475. Mirambeaux-Villalona, R., Granda‐Orive, J. I. D., Arroyo-Cózar, M., Calero-Pardo, S., Vaquero-Lozano, P., Vargas-Espinal, J. C., Sánchez-Carpintero, M., & Jiménez-Ruíz, C. A. (2025). Reducción hasta dejarlo: papel de la terapia sustitutiva con nicotina. https://doi.org/10.69703/pt.v27i1.4
476. Miranda, I. D. A., Sobrinho, W. D., Vieira, Í. C. A. P., Neto, A. M. D. S., Oliveira, M. K. D., Sousa, M. C. D. C., Silva, D. A. C. E., Oliveira, M. A. S. D., & Pereira, V. S. (2022). EFEITOS ADVERSOS ASSOCIADOS AO USO DE CIGARRO ELETRÔNICO. Revista Multidisciplinar em Saúde. https://doi.org/10.51161/rems/3574
477. Miranda, N. R., Riaño, D. N., Estrada, E. M., & Espinosa, F. Á. (2017). Vivir con luz. No a las drogas. Revista Boletín Redipe.
478. Mishra, S. (2017). Are e-cigarettes beneficial for public health: Hume's guillotine – The debate continues?. Indian Heart Journal. https://doi.org/10.1016/j.ihj.2017.11.007
479. Misra, M., Shulman, D. I., & Weiss, A. (2013). Anorexia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.98.5.zeg35a
480. Mlcochová, M. V. (2013). Smoking and Nutrition. Journal of Nutritional Therapeutics. https://doi.org/10.6000/1929-5634.2013.02.04.5
481. Mocanu, L., & Nita, E.-L. (2021). Addictive Behaviours among Adolescences and Emergent Adults. The International Conference "The European Integration - Realities and Perspectives".
482. Modak, B., Karmakar, S., Chowdhury, D. R., Majumder, A., & Ghosh, S. (2021). Effects of tobacco in mind and body: A public concern. International Journal of Applied Dental Sciences. https://doi.org/10.22271/oral.2021.v7.i3a.1271
483. Mohammadreza, S., Siminozar, M., & Solmaz, M. (2013). Islam and Addiction. Pharmaceutical Sciences.
484. Mohsen, S., El‐Gilany, A., & Essam, N. (2024). Effect of Ramadan fasting on changes in smoking and vaping behaviors and withdrawal symptoms severity: a cross-sectional study. Journal of Addictive Diseases. https://doi.org/10.1080/10550887.2024.2354565
485. Morean, M. E., & L’Insalata, A. M. (2017). Electronic cigarette use among individuals with a self‐reported eating disorder diagnosis. International Journal of Eating Disorders. https://doi.org/10.1002/eat.22793
486. Moreano, S., & Elizabeth, E. (2016). Plan educativo para disminuir el sedentarismo en personas obesas que acuden a consulta externa en el Centro de Salud de Latacunga.
487. Moreira, F. V., Fontes, L. S., Percio, S. R., & Prates, M. E. (2024). Cigarro eletrônico: uma revisão acerca dos principais danos à saúde da população. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv7n5-443
488. Moreira, M. J., Barroso, F. M. C., Sá, D. B. D., & Rocha, M. F. (2018). DANOS OROFACIAIS CAUSADOS PELO USO EXCESSIVO DA COCAÍNA: UMA PERSPECTIVA DO CENÁRIO BRASILEIRO. Jornada Odontológica dos Acadêmicos da Católica.
489. Morera, P. B., & Araya, C. C. (2017). Intoxicacion por monoxido de carbono. Medicina Legal de Costa Rica.
490. Morewedge, C. K., Huh, Y. E., & Vosgerau, J. (2010). Thought for Food: Imagined Consumption Reduces Actual Consumption. Science. https://doi.org/10.1126/science.1195701
491. Morgan, F., Weightman, A., Morgan, H., Whitehead, S., Carter, B., Jones, S. L., Byrne, E., & Turley, R. (2013). Tobacco: harm-reduction approaches to smokingShort title: Tobacco: harm reduction.Review 3: The effectiveness of long-term harm reduction approaches without the prior intentionof quitting.
492. Morgan, F., Weightman, A., Whitehead, S., Morgan, H., Carter, B., Byrne, E., Turley, R., & Cleves, A. (2012). Tobacco: harm-reduction approaches to smokingShort title: Tobacco: harm reduction.Review 2: The effectiveness of tobacco harm reduction approaches with the intention of quitting(i.e. ‘cutting down to quit’ or ‘reduction to stop smoking’), with and without assistance.
493. Mosquera, J. T., & Menéndez, M. C. (2006). Alcohol etílico: un tóxico de alto riesgo para la salud humana socialmente aceptado. Revista de la Facultad de Medicina.
494. Moura, P., Nauter, G. E., Kubrusly, R. C. C., & Pereira, M. S. (2024). Usar, abusar e depender de drogas. https://doi.org/10.22409/nes.v1i1.64282
495. Mulry, J. T. (1988). Nicotine Gum Dependency: A Positive Addiction. Drug Intelligence & Clinical Pharmacy. https://doi.org/10.1177/106002808802200409
496. Mulyadi, A., Laksananno, G. S., Prihandana, S., & Nurcholis, N. (2024). PEMBERDAYAAN REMAJA DALAM UPAYA PENCEGAHAN PENYALAHGUNAAN NARKOBA DI KELURAHAN DEBONG KULON KOTA TEGAL. https://doi.org/10.31983/jimat.v1i1.11009
497. Muraven, M. (2010). Practicing self-control lowers the risk of smoking lapse.. Psychology of Addictive Behaviors. https://doi.org/10.1037/a0018545
498. Muraven, M., Collins, R. L., & Neinhaus, K. (2002). Self-control and alcohol restraint: An initial application of the Self-Control Strength Model.. Psychology of Addictive Behaviors. https://doi.org/10.1037//0893-164x.16.2.113
499. Murphy, T. L., McIvor, C., Yap, A., Cooksley, W. G. E., Halliday, J. W., & Powell, L. W. (1988). THE EFFECT OF SMOKING ON CAFFEINE ELIMINATION: IMPLICATIONS FOR ITS USE AS A SEMIQUANTITATIVE TEST OF LIVER FUNCTION. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.1988.tb01003.x
500. Musdja, M. Y. (2016). THE RISK OF CONSUMING HARAM FOOD BASED ON MEDICAL ASPECTS.
501. MV, S., & THIRUMAL, S. (2024). A Study on Influence of Drugs on Families and Peer Group. International Journal For Multidisciplinary Research. https://doi.org/10.36948/ijfmr.2024.v06i03.17808
502. Myers, M. G., & Kelly, J. F. (2006). Cigarette smoking among adolescents with alcohol and other drug use problems.. PubMed.
503. Ménétrey, A., Augsburger, M., Giroud, C., & Mangin, P. (2001). [Cannabis and automobile driving].. PubMed.
504. Múñoz, R., & Manuel, P. (2019). Consumo de alcohol y tabaco y su relación con hábitos alimenticios, actividad física y comportamiento sexual de estudiantes de las Universidades de Córdoba y Castilla La Mancha.
505. Mühlig, S. (2015). Zur Effektivität der Ansätze zum kontrollierten Rauchen – Ein Update. Suchttherapie. https://doi.org/10.1055/s-0035-1557519
506. Müller, M. J. (1999). [Alcohol and body weight].. PubMed.
507. Nachiappan, A. C., & Selvavinayagam, T. S. (2017). E-cigarettes: promise or threat?. International Journal of Community Medicine and Public Health. https://doi.org/10.18203/2394-6040.ijcmph20173710
508. Nahvi, S., & Rastegar, D. A. (2020). Nicotine and Tobacco. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0007
509. Nainggolan, M., Zahara, E., & Saparuddin, S. (2010). PERANAN HAKIM DALAM MEMBERIKAN PERLINDUNGAN HUKUM TERHADAP ANAK KORBAN PENYALAHGUNAAN NARKOTIKA (STUDI PENGADILAN NEGERI LUBUK PAKAM). DOAJ (DOAJ: Directory of Open Access Journals).
510. Nanjappan, D., Lavanya, B., Das, K. M. J. M., Saha, K., Kiran, A., Reshie, J. A., Barman, K., & Molla, K. H. (2023). A STUDY TO ASSESS THE EFFECTIVENESS OF STRUCTURE TEACHING PROGRAMME ON KNODLEDGE REGARDING HAZARDNESS OF SMOKING AND TOBACCO CHEWING AMONG ADOLESCENTS AT SMT. NAGARATHNAMMACOLLEGE OF NURSING, BENGALURU. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/17949
511. Naughton, F. (2015). Daily e-cigarette use increases quit attempts and reduces smoking with no effect on cessation. Evidence-Based Nursing. https://doi.org/10.1136/eb-2015-102173
512. Navisya, N., Syavqie, E., Sandery, M. R., & Putra, Y. A. (2024). Implikasi Yuridis Penyalagunaan Narkotika Golongan I Jenis Sabu yang Beratnya Melebihi 5 gram. Deleted Journal. https://doi.org/10.57235/jalakotek.v1i2.2370
513. Nayır, E., Karacabey, B., Kırca, Ö., & Özdoğan, M. (2016). Electronic cigarette (e-cigarette). Journal of Oncological Sciences. https://doi.org/10.1016/j.jons.2016.04.001
514. Neuspiel, D. R. (2012). Marijuana. Pediatrics in Review. https://doi.org/10.1542/pir.33.7.333
515. Newcomb, M. D., & Bentler, P. M. (1986). Frequency and Sequence of Drug Use: A Longitudinal Study from Early Adolescence to Young Adulthood. Journal of Drug Education. https://doi.org/10.2190/1vkr-y265-182w-evwt
516. Newman, R. K., Dijkstra, B. L., & Gibson, J. (2019). Disk Battery Ingestion. StatPearls.
517. Nicy, G. S. (2015). HUBUNGAN TINGKAT KECEMASAN DENGAN PERILAKU MEROKOK MAHASISWA TEKNIK ANGKATAN 2011 DI FAKULTAS TEKNIK UNIVERSITAS ANDALAS.
518. Nierengarten, M. M. B. (2016). Talking to teens about marijuana. Contemporary pediatrics.
519. Nieva, G. (2015). Tractament del tabaquisme: psicopatologia i personalitat. TDX (Tesis Doctorals en Xarxa).
520. Nilsson, P. (2003). Varför sluta? - En intervjustudie om varför man slutar med droger efter en längre tids användning.
521. Novotny, T. E., Hardin, S. R., Hovda, L. R., Novotny, D. J., McLean, M. K., & Khan, S. A. (2011). Tobacco and cigarette butt consumption in humans and animals. Tobacco Control. https://doi.org/10.1136/tc.2011.043489
522. Nunes, E. D. S. (2006). Consumo de tabaco. Efeitos na saúde.. Revista Portuguesa de Medicina Geral e Familiar. https://doi.org/10.32385/rpmgf.v22i2.10231
523. Nurhamidah, S., Sophia, P., & Astuti, A. P. K. (2024). PENGARUH MEROKOK ELEKTRIK TERHADAP PENYAKIT LAMBUNG : LITERATURE REVIEW. Healthy Tadulako Journal (Jurnal Kesehatan Tadulako). https://doi.org/10.22487/htj.v10i3.1379
524. Nurhayati, M., & Faridah, H. (2022). ANALISIS DAN KAJIAN KRIMINOLOGI HUKUM DALAM KASUS MINUMAN BERAKHOL PADA ANAK DIBAWAH UMUR DI DESA MULYASARI. The Juris. https://doi.org/10.56301/juris.v6i2.598
525. Nutt, D., & Nestor, L. J. (2018). Nicotine addiction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198797746.003.0011
526. Nygaard, I., Bryant, C. M., Dowell, C., & Wilson, D. (2002). Lifestyle interventions for the treatment of urinary incontinence in adults. Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd003505
527. ODEN, M. S. (2015). If Drug Abuse Is the Answer, Then What Is the Question?. Routledge eBooks. https://doi.org/10.1201/b19237-14
528. Oliveira, H. F., & Azevedo, M. R. D. D. (2018). Tabagismo na Adolescência. Novas Edições Acadêmicas eBooks.
529. Oliveros, L. M., Noda, D. O., Delgado, Z. P., & Hernández, C. G. (2018). Consideraciones sobre las adicciones en la formación del profesional de Ciencias Médicas. Revista Médica Electrónica.
530. Ollila, H., Broms, U., Kaprio, J., Laatikainen, T., & Patja, K. (2010). [Evaluation of tobacco addiction among adolescents and its treatment within the health care].. Duodecim.
531. Oosterhout, J. P. M. V., Riel, A. V., Kruijssen, A. M. V., & Unnik-Treurniet, R. A. V. (2023). [Intoxication of a child by an oral nicotine pouch].. PubMed.
532. Opentu, J. S., Rahmawati, R., Hasanuddin, F., & Mahmud, R. (2021). Latihan Relaksasi Nafas Dalam Pada Pasien Hipertensi Dalam Pemenuhan Kebutuhan Rasa Aman Nyaman. Jurnal Mitrasehat. https://doi.org/10.51171/jms.v11i2.306
533. Oronowicz, R., Kmiotek, W., Różańska-Smuszkiewicz, G., Smuszkiewicz-Różański, P., Karuś, A., Jama, G., Staszczak, P., Jaworska, B., Ragan, D., & Długosz, J. (2024). Health effects of using popular alternatives to smoking - a review of the literature. Quality in Sport. https://doi.org/10.12775/qs.2024.20.53829
534. Ortmann, J., Doberentz, E., Schyma, C., Musshoff, F., & Madea, B. (2017). Vergiftung mit Frostschutz- und Lösungsmittel.
535. Orucova, S. (2024). WAYS TO PREVENT BAD HABITS THAT MAY ARISE AMONG SCHOOL CHILDREN. Elmi əsərlər.. https://doi.org/10.69682/azrt.2024.91(1).95-98
536. Osborne, C., & McQuillan, S. (2022). Substance Abuse. CRC Press eBooks. https://doi.org/10.1201/9781003039235-49
537. Osibogun, O., Li, W., Jebai, R., & Kalan, M. E. (2024). Cigarettes and e-cigarettes use among US adults with multimorbidity. Drug and Alcohol Dependence Reports. https://doi.org/10.1016/j.dadr.2024.100231
538. Overgaard, K., Hansen, H. S., Hansen, M., Kiens, B., Kvorning, T., Nielsen, L., Rasmussen, L. B., & Aagaard, P. (2009). [Physical activity and dietary supplements].. PubMed.
539. OZTRK, O., Selçuk, M. Y., Yalçın, B. M., & NAL, M. (2016). DOES SELF-CONTROL MEAN EVERYTHING FOR SMOKING CESSATION?. Turkish Journal of Family Medicine & Primary Care. https://doi.org/10.5455/tjfmpc.213976
540. Page, J. B. (2014). Drug Abuse/Dependence. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society. https://doi.org/10.1002/9781118410868.wbehibs090
541. Paixão, A., Ganhão, I., & Trigo, M. (2021). Co-use of tobacco and cannabis: Complicated partnerships. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.1534
542. Palmer, S. H., Carlisle, C., & Tulloch, T. (2017). Smoking Cessation and Nicotine Replacement Therapy in Hospitalized Adolescents: A Literature Review. https://doi.org/10.1542/peds.140.1_meetingabstract.40
543. Palmés, F. R., Robaina, N. E. F., Fernández, J. R. C., & Tadeo, E. R. (2008). Valoración de estudiantes fumadores sobre la influencia del tabaco en algunos aspectos de su vida personal y social.
544. Pangtey, A., Tiwari, R. C., Dikshit, M., Sharma, V. B., & Mittal, B. (2024). THE PERSISTENT GRIP OF CHEWING TOBACCO AND ITS HARMFUL EF-FECTS ON AN INDIVIDUAL – A REVIEW ARTICLE. International Ayurvedic Medical Journal. https://doi.org/10.46607/iamj2312112024
545. Paravidino, V. B., Mediano, M. F. F., & Sichieri, R. (2021). Physical Exercise, Energy Expenditure and Weight Loss: An Assumption not Always Observed in Practice. International Journal of Cardiovascular Sciences. https://doi.org/10.36660/ijcs.20200090
546. Pardo, G., & Pilar, M. (2015). Influences of social stress in the rewarding effects of mdma and alcohol.
547. Parey, N. A. (2018). Brief Overview of Substance Abuse; Causes, Consequences and Management. Journal of Nursing Science & Practice.
548. Parrott, A. C. (1995). Smoking Cessation Leads to Reduced Stress, but Why?. International Journal of the Addictions. https://doi.org/10.3109/10826089509055846
549. Pastor, F. P. (2002). Imagen social de las bebidas alcohólicas. Adicciones. https://doi.org/10.20882/adicciones.521
550. Patkar, A. A., Vergare, M. J., Batra, V., Weinstein, S. P., & Leone, F. T. (2003). Tobacco Smoking: Current Concepts in Etiology and Treatment. Psychiatry. https://doi.org/10.1521/psyc.66.3.183.25159
551. Patrick, M. E., & Azar, B. (2018). High-Intensity Drinking.. PubMed.
552. Patten, S. B. (2021). Vaping and Mental Health.. Journal of the Canadian Academy of Child and Adolescent Psychiatry.
553. Payne, W. A., & Hahn, D. B. (1986). Understanding Your Health.
554. Pedrosa, S. M. (2016). O uso nocivo de crack: percepções de pessoas em tratamento da dependência.
555. Peiffer, G., Underner, M., & Perriot, J. (2020). [Shisha smoking: infatuation and harmfulness]..
556. Peltier, M. R., Flores, J. M., Smith, P. H., Roberts, W., Verplaetse, T. L., Moore, K. E., Hacker, R. L., Oberleitner, L., & McKee, S. A. (2019). Smoking Across the Menopausal Transition in a 10-Year Longitudinal Sample: The Role of Sex Hormones and Depressive Symptoms. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntz069
557. Peoples, R. W. (2002). Alcohol Actions on Glutamate Receptors. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-306-4_23
558. Pepper, J. K., Coats, E. M., Nonnemaker, J., & Loomis, B. R. (2018). How Do Adolescents Get Their E-Cigarettes and Other Electronic Vaping Devices?. American Journal of Health Promotion. https://doi.org/10.1177/0890117118790366
559. Peral, A. A., Zulueta, B. L.-B., Seoane, G. M., & Madueño, G. G. (2018). Sé lo que cenaste ayer.. Seram.
560. Peral, A. A., Zulueta, B. L.-B., Seoane, G. M., & Madueño, G. G. (2018). Sé lo que cenaste ayer.: ¡Lo que comes, puede matarte!. Seram.
561. Periškić, T., Ilić, B., Živkov, S., & Terzić, A. (2006). Heart rhythm disorder after consumption of energy drink Guarana. ABC - časopis urgentne medicine.
562. Perkins, K. A., Fonte, C., Ashcom, J., Broge, M., & Wilson, A. (2001). Subjective responses to nicotine in smokers may be associated with responses to caffeine and to alcohol.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/1064-1297.9.1.91
563. Perriot, J., Underner, M., Chapot, E., & Peiffer, G. (2023). Tobacco and cannabis co-use : toxicity, dependence and cessation management.. SCIREA Journal of Health. https://doi.org/10.54647/pmh330309
564. Pesta, D., Angadi, S. S., Burtscher, M., & Roberts, C. K. (2013). The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance. Nutrition & Metabolism. https://doi.org/10.1186/1743-7075-10-71
565. Petekkaya, S., Ayaz, N., Doğan, M., Oruç, M., Öner, B. S., Göktürk, C., Çelebi, A., Budak, A., Soylu, Ö., & Çelbiş, O. (2016). A Case of Sudden Death due to Lighter Refill Gas Inhalation / Cakmak Gazi Inhalasyonuna Bagli Ani Gelisen Olum Olgusu. Journal of Turgut Ozal Medical Center. https://doi.org/10.5455/jtomc.2015.2885
566. Phan, O., & Lascaux, M. (2016). Accompagnement des adolescents présentant des conduites addictives. Médecine thérapeutique / Pédiatrie. https://doi.org/10.1684/mtp.2016.0591
567. Piazza, P., Marinelli, M., Rougé‐Pont, F., Deroche‐Gamonet, V., Maccari, S., Simon, H., & Moal, M. L. (1996). Stress, glucocorticoids, and mesencephalic dopaminergic neurons: a pathophysiological chain determining vulnerability to psychostimulant abuse.. PubMed.
568. Pietrantoni, L., & Palazzi, M. (2001). Strategie di adattamento nell'astinenza da nicotina: un'analisi dei diari giornalieri. https://doi.org/10.1400/63935
569. Pinaryo, M. (2016). PENGARUH IKLAN LAYANAN MASYARAKAT PICTORIAL HEALTH WARNING (PHW) PADA BUNGKUS ROKOK DI WARUNG KOPI DOEL SURYA PONOROGO. ARISTO. https://doi.org/10.24269/ars.v4i1.182
570. Pindado, C. M., Pindado, C. M., & Castedo, C. R. (2024). ¿Es posible un mundo sin nicotina?. https://doi.org/10.69703/pt.v26i2.2
571. Pinto, B. C., Netto, B. A. O., Henriques, F. B. P., Pantuza, I. R. D. S., Veloso, I. A., Silva, L. J. A. D., França, M. C. R., & Alves, H. F. D. A. (2024). Efeitos cardiovasculares associados ao uso de cigarros eletrônicos. Contribuciones a las Ciencias Sociales. https://doi.org/10.55905/revconv.17n.12-040
572. Pitman, A., McDonald, K., Logeswaran, Y., Lewis, G., Cerel, J., Lewis, G., & Erlangsen, A. (2024). The role of depression and use of alcohol and other drugs after partner suicide in the association between suicide bereavement and suicide: cohort study in the Danish population. Psychological Medicine. https://doi.org/10.1017/s0033291724000448
573. Pizutelli, V., Manna, V. J., Dwyer, S., & Caradonna, S. J. (2023). Human Airway Mucociliary Tissue Cultures Chronically Exposed to E-Cigarette Vapors Exhibit Altered Cell Populations and Increased Secretion of Immunomodulatory Cytokines. https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.82_2023
574. Pizzoli, L. (2006). Cocaine and heroin abuse research.. Nova Science Publishers eBooks.
575. Plawecki, M. H., White, K., Kosobud, A., Grahame, N. J., Zimmermann, U., Crabb, D. W., & O’Connor, S. (2018). Sex Differences in Motivation to Self‐Administer Alcohol After 2 Weeks of Abstinence in Young‐Adult Heavy Drinkers. Alcoholism Clinical and Experimental Research. https://doi.org/10.1111/acer.13860
576. Polosa, R., & Caponnetto, P. (2013). Enabling smokers to refrain from smoking: role of electronic cigarettes. https://doi.org/10.2217/ebo.12.111
577. Polosa, R., Rodu, B., Caponnetto, P., Maglia, M., & Raciti, C. (2013). A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduction Journal. https://doi.org/10.1186/1477-7517-10-19
578. Pomerleau, O. F., Collins, A. C., Shiffman, S., & Pomerleau, C. S. (1993). Why some people smoke and others do not: New perspectives.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.61.5.723
579. Ponciano‐Rodríguez, G., & Castillo, C. A. C. (2020). El cigarrillo electrónico. Mitos y realidades. Segunda parte. Revista Digital Universitaria. https://doi.org/10.22201/codeic.16076079e.2020.v21n3.a7
580. Poposki, L., & Pašovska, S. (2016). Anti-smoking campaign – decreasing or increasing trend in cigarette consumption in the republic of Macedonia and the region.
581. Portillo, Á. A. G. (2020). La ingesta de alcohol y su rehabilitación en México.. Cultura y Droga. https://doi.org/10.17151/culdr.2020.25.29.7
582. Powers, J. M., LaRowe, L. R., Rubenstein, D., Paice, J. A., Hitsman, B., & Rini, C. (2025). Relationship between pain and nonopioid substance use in two national samples of cancer survivors. Cancer. https://doi.org/10.1002/cncr.35701
583. Prensky, E. H., Cohen, L. M., McChargue, D. E., & Gao, W. (2010). Effects of Sensory and Behavioral Substitutes Following an Experimentally Induced Stressor among Abstinent Smokeless Tobacco Users. American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.2009.00019.x
584. Prijić, Ž., & Igić, R. (2021). Cigarette smoking and medical students.. Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
585. Prijić, Ž., & Igić, R. (2021). Cigarette smoking and medical students.. PubMed.
586. Przewoźniak, K., & Koczkodaj, P. (2024). E-cigarettes – their use and harmfulness. A brief summary of current scientific knowledge. Nowotwory Journal of Oncology. https://doi.org/10.5603/njo.100382
587. Puebla, R. M., & Cid, I. L. (2002). Reflexiones sobre hábito de fumar y personal médico. Revista cubana de medicina militar.
588. Puente, E. O. V., Ángel-García, J. E. D., Méndez, A. P. C., Cisneros, M. A. L., González, S. C. E., & Mata, J. L. V. (2025). Reflexología Facial para Reducir el Estrés y Consumo de Alcohol en Adultos Mexicanos. Revista Veritas de Difusão Cientifica.. https://doi.org/10.61616/rvdc.v6i2.810
589. Pytell, J. D., & Rastegar, D. A. (2020). Cannabinoids. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0010
590. Quarto, F. H. A., Martins, T. D. D., & Moraes, C. F. (2025). Os efeitos remanescentes do cigarro no ex-tabagista de longa data: uma revisão da literatura. STUDIES IN HEALTH SCIENCES. https://doi.org/10.54022/shsv6n3-035
591. Rahman, M., Wk, Y., & Md, R. (2024). None. IIUM Medical Journal Malaysia. https://doi.org/10.31436/imjm.v23i01
592. Rakhmatullayev, A., Oltiyev, E., Boltayeva, Z., Khalimova, D., Umarova, M., & Jarilkasinova, G. (2025). Environmental aspects of exposure to tobacco smoke and methods for reducing its harm to the environment and human health. E3S Web of Conferences. https://doi.org/10.1051/e3sconf/202561404003
593. Ramaiah, V. V., Ss, M. A. R., Alfawzan, A. A., Mulla, M., Babaji, P., & Hr, L. S. (2020). Oral manifestations and oral health care among the illicit drug abusers: A review. Journal of Critical Reviews.
594. Ramdhani, M. (2013). Penerapan teknik kontrol diri untuk mengurangi konsumsi rokok pada kategori perokok ringan.
595. Ramu, B., & Mounika, I. (2018). Lifestyle drugs: concept and impact on society. Journal of Human Virology & Retrovirology. https://doi.org/10.15406/jhvrv.2018.06.00194
596. Ramírez, L. C. B., & Cava, M. J. (2009). Autoestima y consumo de alcohol en adolescentes. Inventio, la génesis de la cultura universitaria en Morelos.
597. Rassool, G. H., & Winnington, J. (2003). Adolescents and alcohol misuse. Nursing Standard. https://doi.org/10.7748/ns2003.04.17.30.46.c3373
598. Rawson, R. A., Huber, A., Brethen, P., Obert, J. L., & Gulati, V. (2002). Consumidores de cocaína y metanfetamina: diferencias, características y retención en tratamiento. RET: revista de toxicomanías.
599. Reed, B., Grissom, M., Turpin, M. A. C., & Starks, S. (2024). Addiction Medicine: Tobacco Use Disorder.. PubMed.
600. Reiff, S. T. (2013). El impacto de las desigualdades económicas en la salud de los españoles.
601. Research, I. C. O. M. (2019). White Paper on Electronic Nicotine Delivery System. The Indian Journal of Medical Research. https://doi.org/10.4103/ijmr.ijmr_957_19
602. Reuband, K.-H. (2008). Trends in Patterns of Consumption and Limited Effects of Penal Policies: The Case of Germany. Déviance et Société.
603. Revelo, S. P. (2024). Urticaria vasculítica por cocaína: Reporte de caso. Revista UNIANDES de Ciencias de la Salud. https://doi.org/10.61154/rucs.v7i1.3276
604. Ribeiro, B. M. D. S. S., & Teston, É. F. (2017). A UTILIZAÇÃO DE COCAÍNA DURANTE A GESTAÇÃO E AS CONSEQUÊNCIAS PARA CRIANÇA.
605. Ribeiro, M. A., Júnior, E. E. D. M., Brito, C. R. D. S., Paixão, A. G. D., Costa, D. G. M. D., Alves, V. L. D. S., Freitas, D. G. D., Costa, M. A. R. D., Filho, I. J. D. S., & Oliveira, R. F. D. (2024). Impacts of caffeine consumption in the workplace: from moderate use to dependence. Concilium. https://doi.org/10.53660/clm-3670-2409
606. Richard, E., Marclay, F., Berchtold, A., Akré, C., Saugy, M., Michaud, P., Cornuz, J., & Surı́s, J.-C. (2010). Importance de l'exposition au tabac chez les jeunes consommateurs de cannabis: un cheval de Troie ?.
607. Riczker, A. S., & Echanique, M. E. (2017). Acciones y efectos del etanol y las bebidas alcohólicas durante la adolescencia y juventud. Revista de la Facultad de Ciencias Médicas (Quito).
608. Riel, A. V., Vries, I. D., & Meulenbelt, J. (2003). [Health risks raised by ephedra in food supplements].. PubMed.
609. Rigotti, N. A. (1986). Atrial Fibrillation While Chewing Nicotine Gum. JAMA. https://doi.org/10.1001/jama.1986.03370080040015
610. Rigotti, N. A. (1986). Atrial fibrillation while chewing nicotine gum. JAMA. https://doi.org/10.1001/jama.255.8.1018
611. Rigotti, N. A. (2003). Putting the research into practice. BMJ. https://doi.org/10.1136/bmj.327.7428.1395
612. Rising, J. P., & Wasson-Blader, K. (2011). Menthol and initiation of cigarette smoking. Tobacco Induced Diseases. https://doi.org/10.1186/1617-9625-9-s1-s4
613. Ritonga, D. R., Khairunsyah, K., Sinaga, N. S., Rafly, M., Ginting, R., & Wahyudi, W. (2025). Gambaran Kebiasaan Merokok dan Paparan Rokok pada Remaja di Indonesia. Jurnal Ilmu Kedokteran dan Kesehatan Indonesia. https://doi.org/10.55606/jikki.v5i2.6124
614. Rn, B., Davis, R. E., Cb, L., Nelson, M. A., & Strauss, E. V. (1998). Physical fitness: how to help older patients live stronger and longer. (1).. PubMed.
615. Roberts, J. R. (2021). In Focus. Emergency Medicine News. https://doi.org/10.1097/01.eem.0000791944.22265.da
616. Roblin, L. (2007). Childhood obesity: food, nutrient, and eating-habit trends and influences. Applied Physiology Nutrition and Metabolism. https://doi.org/10.1139/h07-046
617. Robson, D. (2018). Supporting smoking cessation in people with a mental health condition. Nurse Prescribing. https://doi.org/10.12968/npre.2018.16.9.428
618. Robson, D., & McNeill, A. (2021). Tobacco Use Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623199.013
619. Rocha, M. I. D. U. M. D., Lera, J. P. B., Jardim, G. B. G., Mucellini, A. B., Cirolini, L., Jung, I. E. D. C., Mânica-Cattani, M. F., Silveira, A. F. D., Filho, O. C. D. S., & Cruz, I. B. M. D. (2010). Lifestyle, health characteristics and alcohol abuse in young adults who are non-daily smokers. Sao Paulo Medical Journal. https://doi.org/10.1590/s1516-31802010000600008
620. Rodak, K., Kokot, I., & Kratz, E. M. (2021). Caffeine as a Factor Influencing the Functioning of the Human Body—Friend or Foe?. Nutrients. https://doi.org/10.3390/nu13093088
621. Rodriguez, K. N. P., Jalca, A. D. C., Mero, A. R. P., & Loor, J. O. O. (2023). Consumo de sustancias ilícitas en jóvenes y sus alteraciones en el sistema nervioso.. Revista Científica Higía de la Salud. https://doi.org/10.37117/higia.v8i1.744
622. Rodríguez, C. F. V., Rodríguez, E. M. V., Fernández, J. A. C., Márquez, W. S., & Nuncio, H. R. S. (2015). HÁBITOS Y CONDUCTAS DE RIESGO PARA LA SALUD EN ADOLESCENTES. Editorial UAT.
623. Rodríguez, M. E., & Anglin, M. D. (1988). The Epidemiology of Alcohol Consumption in Spain. International Journal of Social Psychiatry. https://doi.org/10.1177/002076408803400203
624. Rodríguez‐Arias, M., Navarrete, F., Arenas, M. C., Aguilar, M., Rubio, G., Miñarro, J., & Manzanares, J. (2015). SY29-3SOCIAL DEFEAT IN ADOLESCENT MICE INCREASES VULNERABILITY TO ALCOHOL CONSUMPTION. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agv076.120
625. Rodríguez‐Martos, A., Brugal, M. T., & Villalbí, J. R. (2006). Nuevas y viejas adicciones: implicaciones para la salud pública. Gaceta Sanitaria. https://doi.org/10.1157/13086027
626. Rogers, P. G., & Baldwin, S. (1996). Controlled Smoking (Part I): A Last Resort?. Journal of Substance Misuse. https://doi.org/10.3109/14659899609084973
627. Rogers, T., Milkman, K. L., & Volpp, K. G. (2014). Commitment Devices. Obstetrical & Gynecological Survey. https://doi.org/10.1097/01.ogx.0000455018.85064.22
628. Rohsenow, D. J., & Monti, P. M. (1999). Does urge to drink predict relapse after treatment?. PubMed.
629. Roman, P. M., & Johnson, J. A. (1996). Alcohol's Role in Work-Force Entry and Retirement.. PubMed.
630. Romeo, J., Wärnberǵ, J., Nova, E., Díaz, L. E., Gómez‐Martínez, S., & Marcos, A. (2007). Moderate alcohol consumption and the immune system: A review. British Journal Of Nutrition. https://doi.org/10.1017/s0007114507838049
631. Romero‐Saldaña, M. (2025). Toxic habits and work stress: a combination that requires intervention at work, not just in the individual. Enfermería del trabajo.. https://doi.org/10.70324/ejohn.v4i2.83
632. Rose, G. S., & Walters, S. T. (2012). Theories of Motivation and Addictive Behavior.
633. Rovesti, S., Vivoli, R., & Bergomi, M. (2012). Stress indotto dalla guida di autoveicoli: studio di parametri psicofisiologici. Italian Journal of Public Health. https://doi.org/10.2427/6250
634. Rowell, T. R., & Tarran, R. (2015). Will chronic e-cigarette use cause lung disease?. AJP Lung Cellular and Molecular Physiology. https://doi.org/10.1152/ajplung.00272.2015
635. Rozzell‐Voss, K. N., Klimek, P., Eichen, D. M., Brown, T. A., & Blashill, A. J. (2023). Executive function differences as a function of parent‐reported binge eating and weight: Results from the adolescent brain cognitive development study. Obesity Science & Practice. https://doi.org/10.1002/osp4.703
636. Ruffin, L. (2019). The Roles of the Nurse During the Vaping Crisis. Iris Journal of Nursing & Care. https://doi.org/10.33552/ijnc.2019.02.000537
637. Russell, A. M., Colditz, J. B., Barry, A. E., Davis, R. E., Shields, S., Ortega, J. M., & Primack, B. A. (2021). Analyzing Twitter Chatter About Tobacco Use Within Intoxication-related Contexts of Alcohol Use: “Can Someone Tell Me Why Nicotine is So Fire When You’re Drunk?”. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntab195
638. Sahu, S., Nagarajappa, R., Sahoo, K., Naik, D., Sahu, N., Kiran, K., & Tutor, S. (2020). Vaping: Realities in its Effect on Oral Health. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v14i4.13079
639. Salas, U. E., & Hendricks, L. (2017). Ecstasy/MDMA Perceived Risk by Late Adolescents and Early Adults. International Journal of Drug Development and Research.
640. Salton, E. N. C., Alves, G. L. F., Duran, G. S., & Santos, A. D. O. D. (2022). TABAGISMO:ASPECTOS CULTURAIS E FISIOLÓGICOS. REVISTA FIMCA. https://doi.org/10.37157/fimca.v9i2.608
641. Sanctis, V. D., Soliman, N., Soliman, A., Elsedfy, H., Maio, S. D., Kholy, M. E., & Fiscina, B. (2017). Caffeinated energy drink consumption among adolescents and potential health consequences associated with their use: a significant public health hazard.. PubMed. https://doi.org/10.23750/abm.v88i2.6664
642. Sanders, B. (2021). Gangs, Drug Use, and Drug Selling in the United States. Oxford Research Encyclopedia of Criminology and Criminal Justice. https://doi.org/10.1093/acrefore/9780190264079.013.443
643. Santiago, F. (2014). KONSEP NASKAH AKADEMIK RANCANGAN PERATURAN DAERAH TENTANG PENGENDALIAN DAN PENGAWASAN MINUMAN BERALKOHOL. https://doi.org/10.46839/lljih.v0i0.93
644. Santos, R. A., Jesus, C. S. D., & Markus, G. W. S. (2022). A nova faceta do tabagismo: o uso do cigarro eletrônico no contexto da saúde pública. Research Society and Development. https://doi.org/10.33448/rsd-v11i12.34484
645. Sargent, J. D., & DiFranza, J. R. (2003). Tobacco Control for Clinicians Who Treat Adolescents. CA A Cancer Journal for Clinicians. https://doi.org/10.3322/canjclin.53.2.102
646. Satcher, D. (1994). The paradox of tobacco control. JAMA. https://doi.org/10.1001/jama.271.8.627
647. Sather, T. E., Woolsey, C. L., Williams, R. D., Evans, M. W., & Cromartie, F. (2015). Age of first use of energy beverages predicts future maximal consumption among naval pilot and flight officer candidates. Addictive Behaviors Reports. https://doi.org/10.1016/j.abrep.2015.12.001
648. Satre, D. D. (2015). Alcohol and drug use problems among older adults.. Clinical Psychology Science and Practice. https://doi.org/10.1111/cpsp.12104
649. Schaub, M. P., & Stohler, R. (2006). Langzeitschäden durch Cannabis - ein unterschätztes Problem?. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. https://doi.org/10.4414/smf.2006.06048
650. Schiffman, S. S., Zervakis, J., Graham, B. G., & Westall, H. L. (2002). Age-Related Chemosensory Losses: Effect of Medications. ACS symposium series. https://doi.org/10.1021/bk-2002-0825.ch008
651. Schlagintweit, H. E., & Barrett, S. P. (2016). Does acute tobacco smoking prevent cue-induced craving?. Journal of Psychopharmacology. https://doi.org/10.1177/0269881116639288
652. Schraufnagel, D. E. (2015). Electronic Cigarettes: Vulnerability of Youth. Pediatric Allergy Immunology and Pulmonology. https://doi.org/10.1089/ped.2015.0490
653. Schrieks, H. F. H. I. C. (2015). Adolescent Alcohol Consumption: Brain Health Outcomes. Journal of Child and Adolescent Behaviour. https://doi.org/10.4172/2375-4494.1000238
654. Schuurmans, M. M. (2015). Elektronische Zigaretten: Lifestyle-Gadget oder Hilfsmittel zum Rauchstopp?. Praxis. https://doi.org/10.1024/1661-8157/a002057
655. Schwarzer, R., Scholz, U., Lippke, S., Sniehotta, F. F., & Ziegelmann, J. P. (2019). Self-regulatory processes in health behavior change. Routledge eBooks. https://doi.org/10.4324/9781315793184-11
656. Scripcaru, C., Iliescu, D. B., Iov, T., & Scripcaru, A. (2022). Alcohol consumption - Antisocial effects and legislative protocols. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2022.1.03
657. Scully, C., & Warnakulasuriya, S. (2005). The Role of the Dental Team in Preventing and Diagnosing Cancer: 4. Risk Factor Reduction:Tobacco Cessation. Dental Update. https://doi.org/10.12968/denu.2005.32.7.394
658. Selby, P. (2006). Psychopharmacology of smoking cessation in patients with mental illness. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0639
659. Semwal, V., & Patil, M. S. (2022). Role of Yoga in Drugs Abuse. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-4858
660. Seol, W., Kim, H. J., & Son, I. (2021). Effect of Coffee, Tobacco, and Alcohol on Parkinson’s Disease. Journal of the Korean Neurological Association. https://doi.org/10.17340/jkna.2021.3.3
661. Sesia, T., & Grace, A. A. (2012). Shifting pharmacology of nicotine use and withdrawal: Breaking the cycle of drug abuse. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1200179109
662. Shah, K. T. B. M. (2018). Drug in The Workplace. https://doi.org/10.2991/acpch-17.2018.54
663. Sharma, G., & Nagpal, A. (2015). Tobacco based dentifrices: still not squeezed out. Journal of Family Medicine and Primary Care. https://doi.org/10.4103/2249-4863.154680
664. Sharma, M., bairwa, J. P., & Goyal, S. (2025). Role of Ayurveda in the Management of Alcohol Addiction: A Case Report. International Research Journal of Ayurveda & Yoga. https://doi.org/10.48165/irjay.2025.80505
665. Shasho, R., & Shasho, M. (2022). Diagnostic Approach Common Cases of Vitamins Toxicity in Children. Scholars Journal of Applied Medical Sciences. https://doi.org/10.36347/sjams.2022.v10i01.001
666. Shaykin, J. D., Olyha, L. N., Doorn, C. E. V., Hales, J. D., Chandler, C. M., Hopkins, D. M., Nixon, K., Beckmann, J. S., Pauly, J. R., & Bardo, M. T. (2024). Effects of isolation stress and voluntary ethanol exposure during adolescence on ethanol and nicotine co-use in adulthood using male rats. Drug and Alcohol Dependence Reports. https://doi.org/10.1016/j.dadr.2024.100277
667. Shazzad, M. N., Abdal, S. J., Majumder, M. S. M., Sohel, J. U. A., Ali, S. M. M., & Ahmed, S. (2014). Drug Addiction in Bangladesh and its Effect. Medicine Today. https://doi.org/10.3329/medtoday.v25i2.17927
668. Shields, P. G., Berman, M. L., Brasky, T. M., Freudenheim, J. L., Mathé, E. A., McElroy, J. P., Song, M., & Wewers, M. D. (2017). A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation. Cancer Epidemiology Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-17-0358
669. Shiffman, S., & Balabanis, M. H. (1996). Do Drinking and Smoking Go Together?. PubMed.
670. Shiffman, S., & Paton, S. M. (1999). Individual differences in smoking: Gender and nicotine addiction. Nicotine & Tobacco Research. https://doi.org/10.1080/14622299050011991
671. Shiffman, S., Hickcox, M., Paty, J., Gnys, M., Kassel, J. D., & Richards, T. J. (1996). Progression from a smoking lapse to relapse: Prediction from abstinence violation effects, nicotine dependence, and lapse characteristics.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.64.5.993
672. Shirreffs, S. M., & Maughan, R. J. (2006). The Effect of Alcohol on Athletic Performance. Current Sports Medicine Reports. https://doi.org/10.1097/01.csmr.0000306506.55858.e5
673. Shorey-Fennell, B., Magnan, R. E., Ladd, B. O., & Fales, J. (2021). What’s Pain Got To Do With It?: Young Adults With and Without Chronic Pain Perceive Minimal Risks and Moderate Benefits from Cannabis Use. https://doi.org/10.26828/cannabis.2021.01.000.9
674. Sianipar, B., Cahayani, K., Santika, K., Handoko, B., Apryani, & Silitonga, F. (2024). Sosialisasi Bahaya Narkoba dan Jenis Penanggulangannya di Kampung Tua Tiangwangkang Barelang Batam. JURNAL KEKER WISATA. https://doi.org/10.59193/jkw.v2i2.270
675. Silva, B. V. N., Pereira, C. N. P., & Vacanti, L. J. (2024). Cigarros eletrônicos e saúde cardiovascular: análise do cronotropismo e inotropismo ao repouso e ao esforço. Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa. https://doi.org/10.5102/pic.n0.2022.9554
676. Simangunsong, S. (2013). Pencegahan Narkoba dari Keluarga.
677. Simas, P., Marinho, A. R., & Dias, T. (2015). Cessação tabágica e ganho ponderal: linhas de orientação.
678. Simmons‐Horton, S. Y., & Gibson, C. (2017). Underage Drinking. The Encyclopedia of Juvenile Delinquency and Justice. https://doi.org/10.1002/9781118524275.ejdj0235
679. Simojoki, K. (2000). A patient with drug addiction in primary care. EBM Guidelines.
680. Simonavičius, E., McNeill, A., Arnott, D., & Brose, L. S. (2017). What factors are associated with current smokers using or stopping e-cigarette use?. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2017.01.002
681. Sinniah, D. (2015). E-cigarettes: Facts and legal status. International e-Journal of Science Medicine & Education. https://doi.org/10.56026/imu.9.3.10
682. Siregar, H. R. (2021). PENYULUHAN KESEHATAN: DAMPAK PAPARAN ASAP ROKOK TERHADAP KESEHATAN KELUARGA DI DESA MANUNGGANG JAE KECAMATAN PADANGSIDIMPUAN TENGGARA KOTA PADANGSIDIMPUAN. Jurnal Pengabdian Masyarakat Aufa (JPMA). https://doi.org/10.51933/jpma.v3i2.444
683. Smith, V. C., & Jones, K. L. (2021). What a birth mother wants paediatricians to know about diagnosing a fetal alcohol spectrum disorder. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2021-322333
684. Smyth, D. (2007). Journal scan. Cancer Nursing Practice. https://doi.org/10.7748/cnp.6.8.22.s19
685. Sokolović, M. (2016). Utjecaj duhanskih proizvoda na zdravlje.
686. Sommers, M. S., Savage, C., Wray, J. N., & Dyehouse, J. M. (2003). Laboratory Measures of Alcohol (Ethanol) Consumption: Strategies to Assess Drinking Patterns with Biochemical Measures. Biological Research For Nursing. https://doi.org/10.1177/1099800402239624
687. Soulet, M., Zufferey, M. C., & Oeuvray, K. (2002). Gérer sa consommation. Drogues dures et enjeux de conventionnalité. Editions universitaires eBooks.
688. Sousa, J., Sousa, J. L. B. D., Martins, J., Titato, L. D. R., Martins, M., Prado, C. M., Armelin, R. B. S., & Lima, J. F. D. (2025). IMPACTOS DO CIGARRO ELETRÔNICO NA SAÚDE DOS JOVENS: ESTRATÉGIAS DE ENFERMAGEM PARA PREVENÇÃO. Editora Científica Digital eBooks. https://doi.org/10.37885/250619447
689. Souza, A. V. A. D., Linhares, M. R., Araujo, P. D. P., Pucci, L. F., Figueiredo, G. D. R., Vieira, A. F., Jalal, H. B., Carvalho, K. A. D. S., Souza, N. Q. D., Brito, B. F. D., Mamede, T. F., Moreira, B. A. D., Sá, A. P. D., Galvão, R. G. D. O., Campos, N. L. D. S., Ferreira, A. C., Scandolara, L., Iqueda, R. M., Oliveira, K. S. D., & Rosa, A. A. (2024). EVALI: consequências do cigarro eletrônico. STUDIES IN HEALTH SCIENCES. https://doi.org/10.54022/shsv5n1-010
690. Srivastava, P., Currie, G. P., & Britton, J. (2006). Smoking cessation. BMJ. https://doi.org/10.1136/bmj.332.7553.1324
691. Stage, K. B., Glassman, A. H., & Covey, L. S. (1996). Depression After Smoking Cessation. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v57n1005
692. Stanwick, R. (2015). E-cigarettes: Are we renormalizing public smoking? Reversing five decades of tobacco control and revitalizing nicotine dependency in children and youth in Canada. Paediatrics & Child Health. https://doi.org/10.1093/pch/20.2.101
693. Stanwick, R. (2015). La cigarette électronique : renormalisons-nous le tabagisme en public? Anéantir cinq décennies de lutte contre le tabac et revitaliser la dépendance à la nicotine chez les enfants et les adolescents du Canada. Paediatrics & Child Health. https://doi.org/10.1093/pch/20.2.106
694. Stein, R. J., Pyle, S. A., Haddock, C. K., Poston, W. S. C., Bray, R. M., & Williams, J. (2008). Reported Stress and Its Relationship to Tobacco Use among U.S. Military Personnel. Military Medicine. https://doi.org/10.7205/milmed.173.3.271
695. Steinberg, M. L., & Williams, J. M. (2013). Extinction Burst after Varenicline Titration: A Case Report. The Journal of Smoking Cessation. https://doi.org/10.1017/jsc.2013.7
696. Stern, T. A., Gross, A. F., Stern, T. W., Nejad, S. H., & Maldonado, J. R. (2010). Current Approaches to the Recognition and Treatment of Alcohol Withdrawal and Delirium Tremens: “Old Wine in New Bottles” or “New Wine in Old Bottles”. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.10r00991ecr
697. Stone, M. H. (2015). Marijuana and Psychosis: The Effects of Adolescent Abuse of Marijuana and other Drugs in a Group of Forensic Psychiatric Patients. Journal of Child and Adolescent Behaviour. https://doi.org/10.4172/2375-4494.1000188
698. Straussner, S. L. A., Straussner, S. B., & Einstein, S. (2012). Alcohol Use Disorder. Social Work. https://doi.org/10.1093/obo/9780195389678-0025
699. Stöver, H. (2016). Drogenprohibition, soziale Ausgrenzung, Stigmatisierung und Kriminalisierung. Suchttherapie. https://doi.org/10.1055/s-0042-111460
700. Subagiono, S., Elfistoni, A., Armensyah, H., Nurlina, A., Suharsyah, H., Azri, B., Dendi, I., Inarno, J., Kurniati, F. D., & Restuti, P. D. (2017). PENYULUHAN KESEHATAN BAHAYA DAMPAK ROKOK BAGI KESEHATAN ANAK-ANAK TANJUNG DALAM KECAMATAN LEMBAH MASURAI KABUPATEN MERANGIN.
701. Sugintaitė, E., & Dailidė, G. (2024). PAAUGLIŲ IR JAUNŲ VYRŲ VALGYMO SUTRIKIMAI. Health Sciences. https://doi.org/10.35988/sm-hs.2024.030
702. Surati, L., Arya, A., Nehra, V., Chaudhari, B., & Saldanha, D. (2021). Polysubstance abuse in adolescence. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.328867
703. Sweerts, S. J. (2016). Treat or Enhance Cognitive Restraint in Individuals Suffering from Overweight or Obesity? Systematic Revue of the Literature. SOJ Psychology. https://doi.org/10.15226/2374-6874/3/1/00125
704. Sánchez, J. D. A., Fonayet, F. V., Sánchez-Aragón, A., Pastor, I., & Eraso, Á. G. B. (2024). Explanatory factors of polydrug use in mid-late teens and the relevance of information sources: Correlational and configurational assessment in Tarragona (Spain). AIMS Public Health. https://doi.org/10.3934/publichealth.2024039
705. Sánchez, L. U., & Pascual, M. R. (2019). Relación entre el consumo de cannabis y las ideas y/o tentativas suicidas en la población joven.
706. Sánchez-Padilla, M. L., Gutiérrez, V. R., Arias‐Rico, J., Gálvez, R. B., Sánchez, R. C. J., Ortíz, M. L., Rubio, K. C., & Alamilla, A. M. (2019). Tabaquismo en adolescentes de un rango de 10 a 18 años. Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo. https://doi.org/10.29057/icsa.v8i15.4799
707. Tanasić, B. R. (2019). Fear of Cigarette Smoke and the Brain Reaction on Nicotine. European Journal of Medical and Health Sciences. https://doi.org/10.24018/ejmed.2019.1.5.110
708. Tandon, P., Chandra, C., Gupta, K., Kumar, V., & Kumar, S. (2013). Smokeless Tobacco - An Inferno Without Smoke- A Case Series. Indian Journal of Public Health Research & Development.
709. Tandon, R., Verma, S. K., & Singh, N. (2018). Brainstem and thalamic haemorrhage following cannabis consumption. Postgraduate Medical Journal. https://doi.org/10.1136/postgradmedj-2018-135582
710. Tardiff, K., & Marzuk, P. M. (1995). Cocaine and Injuries. Humana Press eBooks. https://doi.org/10.1007/978-1-4612-0233-2_8
711. Tarragona-Camacho, A., Avilés, N. R., Marquina-Márquez, A., Gil‐García, E., & Marcos‐Marcos, J. (2017). "Pasar el mal trago": un estudio etnográfico de jóvenes que experimentan una intoxicación etílica aguda en un servicio de urgencias. Revista Española de Drogodependencias.
712. Tassel, M. V. (2017). Impact de l’anxiété, de la dépression et de l’hostilité en tant que composants de la détresse psychologique sur la typologie de consommation d’alcool et de cannabis chez l’adolescent selon l’âge et le sexe.
713. Tattan‐Birch, H., & Shahab, L. (2020). The Psychobiology of Nicotine Vaping. Routledge eBooks. https://doi.org/10.4324/9780429296345-13
714. Tegin, G., Mekala, H. M., Sarai, S. K., & Lippmann, S. (2018). E-Cigarette Toxicity?. Southern Medical Journal. https://doi.org/10.14423/smj.0000000000000749
715. Teixeira, T. M. (2016). Estudo sobre o polimorfismo dos genes álcool desidrogenase e aldeído desidrogenase (gene adh e aldh) e a dependência ao álcool em uma população da cidade de Goiânia-GO, Brasil.
716. Teychenne, M. (2013). Use it or lose it: The benefits of physical activity.
717. Thamotharan, S., & Conrad, S. M. (2015). Gender‐responsive considerations for substance‐using adolescent girls. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30085
718. Thöns, M., & Zenz, M. (2006). Restriktive Flüssigkeitszufuhr in der Terminalphase kann Leiden reduzieren. Zeitschrift für Palliativmedizin. https://doi.org/10.1055/s-2006-954155
719. Tipton, K. D. (2015). Nutritional Support for Exercise-Induced Injuries. Sports Medicine. https://doi.org/10.1007/s40279-015-0398-4
720. Tomko, R. L., Saladin, M. E., Baker, N. L., McClure, E. A., Carpenter, M. J., Ramakrishnan, V., Heckman, B. W., Wray, J. M., Foster, K. T., Tiffany, S. T., Metts, C., & Gray, K. M. (2018). Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/nty234
721. Tonstad, S. (1999). [Nicotine preparations and other preparations for smoking cessation].. PubMed.
722. Tonstad, S., & Els, C. (2010). Varenicline: Smoking Cessation in Patients with Medical and Psychiatric Comorbidity. Clinical Medicine Insights Therapeutics. https://doi.org/10.4137/cmt.s4012
723. Toro, F. V., & Ruiz‐Fernández, M. D. (2016). Alcohol y tabaco en la población joven y su efecto en el árbol vascular. Revista de Estudios de Juventud.
724. Torpy, J. M., Lynm, C., & Glass, R. M. (2006). Dyspepsia. JAMA. https://doi.org/10.1001/jama.295.13.1612
725. Torres, V. A., Cohen, L. M., & Gulliver, S. B. (2020). Tobacco Use Disorder and Its Treatment. The Wiley Encyclopedia of Health Psychology. https://doi.org/10.1002/9781119057840.ch156
726. Tran, A. N., & Ishino, R. (2021). Antidepressants: Is a higher dose always better?. Current psychiatry. https://doi.org/10.12788/cp.0102
727. Trejo, C. A., Cisneros, J. T. C. N., & Vera, N. J. J. (2015). Â¿EL USO DE LAS DROGAS AFECTA A LA SOCIEDAD O â€œCONTRIBUYE AL TURISMOâ€ ? Y SUS RIESGOS EN LOS JÃ“VENES Y ADOLESCENTES. Contribuciones a las Ciencias Sociales.
728. Treviño, V., & Esmeralda, M. (2016). Factores de riesgo para el consumo de tabaco en la adolescencia: Estado Tamaulipas, México.
729. Tripathy, J. P. (2013). Does a smoker have to remain a smoker always-evidence based tobacco cessation interventions: challenges and way forward in the Indian context.. PubMed.
730. Tripković, M., Frančišković, T., Marković, H., Paradžik, L., & Andric, A. (2014). Alcohol consumption among adolescents in the City of Zagreb and the presence of alcohol drinking among their parents. Alcoholism and psychiatry research Journal on psychiatric research and addictions.
731. Trovato-Abdellali, N., Knob, C., & Delacrétaz, R. (2024). Puffs à l’adolescence : enjeux et stratégies d’intervention. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2024.20.870.778
732. Tuharea, R. (2024). SOSIALISASI DAMPAK MEROKOK BAGI SISWA/I REMAJA DI DESA TENGAH-TENGAH. Pattimura Mengabdi Jurnal Pengabdian Kepada Masyarakat. https://doi.org/10.30598/pattimura-mengabdi.2.4.341-345
733. Tullis, L. M., DuPont, R. L., Frost-Pineda, K., & Gold, M. S. (2003). Marijuana and Tobacco. Journal of Addictive Diseases. https://doi.org/10.1300/j069v22n03_05
734. Turlej, K., Kowalczuk, D., Lazitskaya, D., Kasianik, V., Sobchynskyi, M., Milasheuskaya, V., Myrnyi, A., Kiełbaszewska, I., Surosz, N., & Miraniuk, K. (2025). E-Cigarettes: Biological Effects, Addiction Risk, and Public Health Challenges – A Narrative Review. Quality in Sport. https://doi.org/10.12775/qs.2025.41.60361
735. Tux, J. (2014). Syndrome d' apnées du sommeil révélé à l'arrêt du tabac.
736. Tuñas, M. F., Bonete, R. P., & Pérez‐Muñuzuri, A. (2008). Drogadicción en el embarazo: un problema emergente. Metas de Enfermería.
737. Uddin, M. S., Sufian, M. A., Hossain, M. F., Kabir, M. T., Islam, M. T., Rahman, M. M., & Rafe, M. R. (2017). Neuropsychological Effects of Caffeine: Is Caffeine Addictive?. Journal of Psychology & Psychotherapy. https://doi.org/10.4172/2161-0487.1000295
738. Ulloa, S. A. B., Vargas, L. F. S., & Ruiz, M. D. R. P. (2017). Active Always Colombia. instname:Universidad Santo Tomás.
739. Vaibhavi, P. S., & Shivakumar, B. K. (2024). Inhalant Abuse in a Teenager with Depression: A Case Report. Journal of Medical Sciences and Health. https://doi.org/10.46347/jmsh.v10.i2.23.12
740. Vanderschuren, L. J. M. J., & Everitt, B. J. (2004). Drug Seeking Becomes Compulsive After Prolonged Cocaine Self-Administration. Science. https://doi.org/10.1126/science.1098975
741. Varghese, J., & Gharde, P. M. (2023). A Comprehensive Review on the Impacts of Smoking on the Health of an Individual. Cureus. https://doi.org/10.7759/cureus.46532
742. Vasconcelos, E. F., Oliveira, J. D. S. D., Hirata, G. R. T., Silva, M., Vieira, F. A., & Filho, G. A. N. (2025). O impacto do uso do cigarro eletrônico na odontologia. Caderno Pedagógico. https://doi.org/10.54033/cadpedv22n9-066
743. Verhaegen, A., & Gaal, L. V. (2017). Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future. Obesity Reviews. https://doi.org/10.1111/obr.12568
744. Vescovi, J. D. (2007). Consecuencias de la Deficiencia de Energía en Mujeres Deportistas. Alto rendimiento: ciencia deportiva, entrenamiento y fitness.
745. Vicente, J., Flores, G., Talvinder, S., & Moreno, A. R. (2012). Addictive Drugs and Synaptic Plasticity. InTech eBooks. https://doi.org/10.5772/33299
746. Vicol, M., Stîngă, O. C., Caba, L., Ioan, B. G., & Astărăstoae, V. (2013). Drug adiction – it is just a medical problem?. Revista română de bioetică.
747. Villareal-Calderón, L. A., Castro-Jalca, J. E., Pihuave-Cajape, M. A., & Valverde-Balladares, K. M. (2023). Consumo de sustancias psicoactivas y su efecto en la salud de la población. MQRInvestigar. https://doi.org/10.56048/mqr20225.7.3.2023.4200-4224
748. Virós, M. C., & López, A. S. (2015). Adicción al ejercicio físico. Tándem: Didáctica de la educación física.
749. Vives‐Mestres, M., Puig, X., Ginebra, J., Casanova, A., & Rosen, N. (2022). Alcohol as a risk factor for migraine attacks. Results from a large prospective cohort study in English-speaking countries. (P5-2.005). Neurology. https://doi.org/10.1212/wnl.98.18_supplement.1587
750. Vlad, R.-A., Hancu, G., Popescu, G. C., & Lungu, I. A. (2018). Doping in Sports, a Never-Ending Story ?. Advanced Pharmaceutical Bulletin. https://doi.org/10.15171/apb.2018.062
751. Vonasch, A., Clark, C. J., Lau, S., Vohs, K. D., & Baumeister, R. F. (2017). Ordinary people associate addiction with loss of free will. Addictive Behaviors Reports. https://doi.org/10.1016/j.abrep.2017.01.002
752. Vs, M. (2016). How Tobacco and Cannabis Smoking Effects Human Physiology. Research and reviews: journal of nursing and health sciences.
753. và, B. N., Mửa, Ó., Thời, T., Nghén, K. T., & nôn, B. (2007). Nausea and Vomiting During Pregnancy.
754. Vázquez, F. L., Becõna, E., & Míguez, M. C. (2003). Smoking and depression: current situation in Spain / Fumar y depresión: situación actual en España. African journal of rhetoric. https://doi.org/10.21134/haaj.v2i1.166
755. Waddell, J. T., Bartholow, B. D., & Piasecki, T. M. (2022). Changes in affect and alcohol craving during naturally occurring drinking episodes: The role of day-level drinking motives.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000600
756. wahono, Q. L. S. (2021). Bahaya Merokok bagi kesehatan. https://doi.org/10.31219/osf.io/su9qn
757. Waldum, H. L., & Martinsen, T. C. (2006). Tobacco and Cancer in the Digestive Tract. KARGER eBooks. https://doi.org/10.1159/000095075
758. Walker, N., Bullen, C., & McRobbie, H. (2009). Reduced–nicotine content cigarettes: Is there potential to aid smoking cessation?. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntp147
759. Walsh, R. A., Lowe, J. B., & Hopkins, P. J. (2001). Quitting smoking in pregnancy. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2001.tb143592.x
760. Walukevich‐Dienst, K., Calhoun, B. H., Fairlie, A. M., Cadigan, J. M., Patrick, M. E., & Lee, C. M. (2022). Using substances to cope with social anxiety: Associations with use and consequences in daily life.. Psychology of Addictive Behaviors. https://doi.org/10.1037/adb0000899
761. Wang, G. S., & Hoyte, C. (2018). Common Substances of Abuse. Pediatrics in Review. https://doi.org/10.1542/pir.2017-0267
762. Warburton, D. M. (1989). Nicotine: An addictive substance or a therapeutic agent?. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-9146-2_1
763. Ward, K. D., Klesges, R. C., & Weg, M. W. V. (2001). Cessation of Smoking and Body Weight. https://doi.org/10.1002/0470846739.ch22
764. Weaver, M. F., Breland, A., Spindle, T. R., & Eissenberg, T. (2014). Electronic Cigarettes. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000043
765. Wesnes, K., Parrott, A. C., Garnham, N. J., & Pincock, C. (1996). Cigarette Smoking and Abstinence: Comparative Effects Upon Cognitive Task Performance and Mood State over 24 Hours. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/(sici)1099-1077(199609)11:5<391::aid-hup780>3.0.co;2-z
766. West, R., & SCHNEIDERS, N. (1987). Craving for Cigarettes. British Journal of Addiction. https://doi.org/10.1111/j.1360-0443.1987.tb01496.x
767. Wheeler, M. G., Duncan, E., & Davis, M. (2016). Low startle magnitude may be a behavioral marker of vulnerability to cocaine addiction. Synapse. https://doi.org/10.1002/syn.21943
768. Wilkinson, T. D. (2025). Applications. Oxford University Press eBooks. https://doi.org/10.1093/9780191997976.003.0006
769. Willemsen, M. C., Croes, E. A., Kotz, D., & Schayck, O. C. P. V. (2015). [Electronic cigarettes: use, health risks, and effectiveness as a cessation method].. PubMed.
770. Wind, L., Chavannes, N. H., Kaper, J. B., Frijling, B. D., Laan, J. R. V. D., Wiersma, T., Goudswaard, A. N., & Genootschap, N. H. (2008). [Summary of the practice guideline 'Smoking cessation' from the Dutch College of General Practitioners].. PubMed.
771. Winslow, B. T., Onysko, M., & Hébert, M. (2016). Medications for Alcohol Use Disorder.. PubMed.
772. Winters, K. C., & Ingwalson, A. (2022). Overview of Psychoactive Substances. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0004
773. Wittmann, H., Prediger, S., & Harendza, S. (2024). "Do you smoke?" - content and linguistic analysis of students' substance histories in simulated patient interviews.. PubMed. https://doi.org/10.3205/zma001698
774. Wodarz, N., Kraus, B., Kuchlmaier, K., Kliegel, P., Binder, H., & Johann, M. (2007). Rauchen erhöht den Konsum psychoaktiver Substanzen - Ergebnisse einer Repräsentativerhebung bei Schülern der 9. Klasse. Psychiatrische Praxis. https://doi.org/10.1055/s-2006-940184
775. Wongwandee, M. (2015). Alcohol consumption and dementia prevention. วารสารการแพทย์และวิทยาศาสตร์สุขภาพ (Journal of Medicine and Health Sciences).
776. Wurdak, M., & Wolstein, J. (2015). Alkohol und Familie. Teil I: Konsum der Eltern. Teil II. Konsum der Kinder.
777. Wylie, B. J., Hauptman, M., Hacker, M. R., & Hawkins, S. S. (2021). Understanding Rising Electronic Cigarette Use. Obstetrics and Gynecology. https://doi.org/10.1097/aog.0000000000004282
778. Yadav, G. (2020). Electronic Nicotine Delivery Systems (ENDS) - Risk Factors and Comorbidities.
779. Yager, J. (2014). How Heavy Marijuana Use May Hurt the Developing Brain: An Animal Study. Journal watch. https://doi.org/10.1056/nejm-jw.na33880
780. Yang, J. C. (2009). Drugs in College. Berkeley Scientific Journal. https://doi.org/10.5070/bs3122007603
781. Yıldırım, G., Kaya, A. D., & Ateş, M. (2010). SİGARA İÇEN VE İÇMEYEN GENÇ BİREYLERDE BAZI TÜKÜRÜK ÖZELLİKLERİNİN KARŞILAŞTIRILMASI / COMPARING SOME CHARACTERISTICS OF SALIVA IN SMOKING AND NONSMOKING YOUNG PEOPLE. European Oral Research. https://doi.org/10.17096/jiufd.54380
782. Zacny, J. P. (1990). Behavioral aspects of alcohol-tobacco interactions.. PubMed.
783. Zhang, B., Mei, S., & Ti, H. (2024). The Effects of Second-hand Smoke on Liver Cancer. Advances in Engineering Technology Research. https://doi.org/10.56028/aetr.9.1.502.2024
784. Zhang, Y., Deneen, K. M. V., Tian, J., Gold, M. S., & Liu, Y. (2011). Food Addiction and Neuroimaging. Current Pharmaceutical Design. https://doi.org/10.2174/138161211795656855
785. Zheng, R. (2022). Pleasure and Achievement: Dopamine and Endorphins. Highlights in Science Engineering and Technology. https://doi.org/10.54097/hset.v6i.948
786. Zickgraf, H. F. (2016). Adult Picky Eaters With Symptoms Of Avoidant/Restrictive Food Intake Disorder: Comparable Distress And Comorbidity But Different Eating Behaviors Compared To Those With Disordered Eating Symptoms. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.56471
787. Ziedonis, D., Steinberg, M. L., Fiester, S. J., Cimpeanu, C., & First, M. B. (2008). Substance Abuse: Nicotine Dependence. Psychiatry. https://doi.org/10.1002/9780470515167.ch62
788. Zuluaga, H. A. B. (2011). Por qué los adolescentes consumen drogas. Poiésis. https://doi.org/10.21501/16920945.218
789. Żórawska, H., Makuch, O., Niczyporuk, P., Jastrzębski, P., Żórawski, M., Bielska, K., & Wojewódzka‐Żeleźniakowicz, M. (2024). Energy drinks - an ongoing problem. Acta Poloniae Pharmaceutica - Drug Research. https://doi.org/10.32383/appdr/196081
790. ̌Simovic, M. N. (2022). RIZIČNA PONAŠANJA ADOLESCENATA I MJERE PREVENCIJE. DRUŠTVENE DEVIJACIJE. https://doi.org/10.7251/zcmz0122037s